{"BGC0000049.1|E-492_2 # 749 # 1465 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=TGG;rbs_spacer=9bp;gc_cont=0.728": {"gnl|BL_ORD_ID|207|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "sdiA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "470", "model_id": "228", "ARO_accession": "3000826", "ARO_name": "sdiA", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.69113e-05, "max_identities": 22, "bit_score": 40.0466, "cvterm_id": "35734", "query": "LLGSDPLPAMSRILLDPL----------DAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLL", "match": "LL  + L A++R   D +          + +IL+  A G ++ ++A  L +S   V +H + M ++  APN+  +   A + GL+", "sequence_from_db": "LLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI", "sequence_from_broadstreet": "MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI", "dna_sequence_from_broadstreet": "ATGCAGGAAAATGATTTCTTCACCTGGCGACGCGCAATGTTGTTACGCTTTCAGGAGATGGCGGCAGCAGAGGATGTTTATACTGAATTGCAATATCAGACACAGCGGCTGGAATTTGATTATTATGCCCTGTGTGTTCGTCATCCCGTCCCCTTTACCCGGCCTAAAATATCGCTTCGTACCACTTATCCTCCGGCGTGGGTAACGCATTACCAGTCCGAAAACTATTTCGCGATCGATCCGGTATTAAAGCCGGAAAATTTCAGGCAGGGTCATTTACATTGGGATGACGTGCTATTTCATGAAGCGAAGGCGATGTGGGATGCCGCCCAGCGTTTCGGATTACGCAGAGGCGTAACCCAGTGTGTGATGTTGCCGAACCGGGCGCTGGGCTTTTTATCTTTCTCCCGTAGCAGTTTACGCTGCTCCTCGTTTACCTACGACGAAGTGGAGCTGAGGTTGCAACTGCTGGCGCGGGAGAGTCTTTCGGCGCTGACAAGATTTGAAGACGACATGGTGATGGCGCCTGAAATGCGTTTCAGTAAACGTGAGAAAGAGATTCTGAAGTGGACGGCGGAAGGGAAGACCTCATCGGAGATCGCCATTATTCTGTCGATTTCTGAAAATACCGTTAACTTCCATCAGAAAAATATGCAGAAGAAATTCAATGCGCCAAATAAAACACAGATTGCCTGCTACGCTGCGGCGACAGGTCTGATATGA", "partial": "0", "query_start": 1184, "query_end": 1408, "hit_start": 465, "hit_end": 720, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 25.88}, "gnl|BL_ORD_ID|525|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.3518, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A + ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|764|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.40166, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "39585", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A + ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1084|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.44371, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "39583", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A + ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVT", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 324, "hit_end": 519, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1568|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.45336, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A + ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|821|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.46658, "max_identities": 15, "bit_score": 26.9498, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A + ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|961|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.50697, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G   +G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFT", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1455|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.62016, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G   +G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFT", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|973|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.69518, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G   +G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFT", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|503|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.75768, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G   +G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFT", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|901|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.82248, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "35915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|327|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.01323, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1153|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.2645, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|436|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.32341, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1435|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.54272, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|291|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.59353, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4921|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.61709, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|787|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.68409, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|238|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.68409, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1175|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.71955, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39583", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 324, "hit_end": 519, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1882|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.73294, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1668|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.73294, "max_identities": 15, "bit_score": 26.1794, "cvterm_id": "35665", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|371|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.74424, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 324, "hit_end": 519, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1788|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.78267, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1714|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.80788, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1163|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.81342, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|316|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.85897, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|349|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.89078, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4925|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.93736, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "43754", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1296|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.93736, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1506|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.96396, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|779|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.96396, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|490|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.96396, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|377|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.96396, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36950", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|99|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.04522, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|32|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.04522, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|542|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.07874, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1255|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.07962, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|459|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.10063, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|499|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.12871, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4920|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.13581, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1549|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.13581, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1072|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.1427, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39583", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 324, "hit_end": 519, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|323|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.15704, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|120|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.15704, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4917|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.16428, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39643", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|529|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.16428, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1009|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.18563, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1886|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.222, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39586", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1453|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.28078, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|322|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.28078, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36771", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|244|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.28078, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1392|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.37095, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|48|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.43243, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1346|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.45483, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36943", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|863|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.4636, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|661|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.49504, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1445|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.52677, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|354|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.55878, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "39584", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1111|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.75705, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4919|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.79116, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4918|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.79116, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|869|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.79116, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1643|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.82556, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|703|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.89532, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "36884", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|61|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.89532, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1868|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.69212, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|571|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.98494, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "35915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F++    +C+ +  R +G    G  FSG +L+G      D R A   ", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFT", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 357, "hit_end": 552, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1159|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.66763, "max_identities": 14, "bit_score": 24.6386, "cvterm_id": "36915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGR", "match": "R+ F   + +     +  F+++   +C+ +  R +G    G  FSG +L+G      D R", "sequence_from_db": "RTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWR", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 962, "query_end": 1138, "hit_start": 357, "hit_end": 537, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.33}, "gnl|BL_ORD_ID|2118|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.81819, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35915", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R  G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|2119|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.94235, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "RSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSG-ELTGVAVQNLDGRLAGIV", "match": "R+ F   + +     +  F+++   +C+ +  R  G    G  FSG +L+G    + D R A   ", "sequence_from_db": "RTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFT", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 962, "query_end": 1153, "hit_start": 321, "hit_end": 516, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 23.08}, "gnl|BL_ORD_ID|4916|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 749, "orf_end": 1465, "orf_from": "BGC0000049.1|E-492_2 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.16954, "max_identities": 10, "bit_score": 24.2534, "cvterm_id": "46173", "query": "HGQFARLSRGRCDRFSERMVGVGRSGRVFSG", "match": "+  F RL   +CD F  +  G    G  F G", "sequence_from_db": "YANFERLCIEKCDLFENKWNGANLQGASFKG", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 1007, "query_end": 1099, "hit_start": 375, "hit_end": 468, "orf_dna_sequence": "GTGACCAGGCGAACAGCAGGCAGTCCGCTCAACGCAGACCCGATGACGACGTCACCCGCCCGCCTCCTCCCCCGGCACCCCGGTGAGGGGCGGGCCCTCCCCCACCACGGCCACGGCGCCTACACGGCGCACGTCGACCCGGACATGTGCATCGTCGCGGCCGAACCGGACTTCGCGCGCCAGTTCGACCGCACATCGGCCGACACCTGCGGCCGCAGCCTCTTCGACCTGCTGCACCCGAGCTGCCCGCCCACGCTCCACGGGCAGTTCGCCCGGCTCTCACGGGGCCGCTGCGACCGCTTCAGCGAGCGCATGGTCGGCGTGGGCAGGTCCGGCCGCGTCTTCTCGGGCGAGTTGACCGGTGTGGCGGTGCAGAACCTGGACGGCCGGCTCGCCGGCATCGTCGTGCAAGTCCGCCCGGACGCGCAGCCGCCGCTCCTCGGCAGCGACCCGCTCCCGGCCATGTCGCGGATCCTCCTTGACCCGCTCGACGCACAGATCCTGGAGGGCATCGCGAGCGGCGCTTCGACGGTCCAGTTGGCGGCCAGGCTGTACCTGAGCCGACAGGGGGTCGAGTACCACATCCGGCTGATGCTGCGCCGGTTGGAGGCGCCCAACCGGGCCGCGCTGGTCGCTCGCGCGCATTCCCTCGGCCTGCTCGCCGTCGGGCAGTGGCCACCGCGCGTCCTGCCCGAGTTCGTCGAGCGAGAGCGCTGA", "orf_prot_sequence": "MTRRTAGSPLNADPMTTSPARLLPRHPGEGRALPHHGHGAYTAHVDPDMCIVAAEPDFARQFDRTSADTCGRSLFDLLHPSCPPTLHGQFARLSRGRCDRFSERMVGVGRSGRVFSGELTGVAVQNLDGRLAGIVVQVRPDAQPPLLGSDPLPAMSRILLDPLDAQILEGIASGASTVQLAARLYLSRQGVEYHIRLMLRRLEAPNRAALVARAHSLGLLAVGQWPPRVLPEFVERER", "perc_identity": 32.26}}, "BGC0000049.1|E-492_3 # 1731 # 4466 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGGGG;rbs_spacer=6bp;gc_cont=0.764": {"gnl|BL_ORD_ID|2431|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1731, "orf_end": 4466, "orf_from": "BGC0000049.1|E-492_3 ", "model_name": "rpoB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2200", "model_id": "2831", "ARO_accession": "3000501", "ARO_name": "rpoB2", "ARO_category": {"36349": {"category_aro_accession": "3000210", "category_aro_cvterm_id": "36349", "category_aro_name": "rifamycin-resistant beta-subunit of RNA polymerase (rpoB)", "category_aro_description": "Rifampin resistant RNA polymerases include amino acids substitutions which disrupt the affinity of rifampin for its binding site. These mutations are frequently concentrated in the rif I region of the beta-subunit and most often involve amino acids which make direct interactions with rifampin. However, mutations which also confer resistance can occur outside this region and may involve amino acids which do not directly make contact with rifampin.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.600114, "max_identities": 29, "bit_score": 30.8018, "cvterm_id": "41346", "query": "APGRPLVITVDDLHWCDAASLRSLVTLLAHG----VPGGVVLVVSV-----------------LSGHVRVGRPRLRAVLARATSTVDLCPLGPRSVRAL", "match": "APG P V+T DD+    AA++  LV L A       PGGV + V V                 +   +RVG  R+  V+    +T D+  + P+S+  +", "sequence_from_db": "APGAPRVLTEDDI----AATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNI", "sequence_from_broadstreet": "MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG", "dna_sequence_from_broadstreet": "GTGCTGGAAGGACGCATCGTGACAGTCTCGAGTCGGACCGAGTCCCCGCTCGCCGCGCCCGGAGTCCCGGGTGCGCCCCGGCGGCTCTCGTTCGCCAGAATCCGCGAGCCCCTGGCGGTTCCGGGCCTGCTGGACATTCAGACCGAATCGTTCGGGTGGCTGATCGGCGCACCCGACTGGTGCGCCCGCGCGGCAGCCCGCGGGACGGAACCGGTCGCCGGGCTGGCCGAGGTGCTCGCCGAGATCAGCCCCATCGAGGACTTCGCGGGCACGATGTCGCTGACGTTGTCCGATCCGCGGTTCGAGGAGGTCAAGGCCTCCGTCGAGGAGTGCAAGGACAAGGATCTGACCTATGCCGCGCCGTGGTTCGTCACGGCGGAATTCGTGAACAACAACACCGGCGAGATCAAGAGCCAGACCGTTTTCATGGGTGATTTCCCCATGATGACCGCGCACGGGACATTCGTCGTCAACGGCACCGAACGGGTGGTCGTGTCGCAACTGGTGCGCTCGCCGGGCGTGTACTTCGACCACGCGATCGACAAGGGTTCGGAGAAGGACGTGCACAGCGCGCGGGTGATCCCGTCGCGCGGTGCCTGGCTGGAGTTCGACGTCGACAAGCGCGACACCCTGGGCGTGCGCATCGACCGCAAGCGCCGTCAGCCGGTAACGGTGCTGCTCAAGGCGCTGGGCTGGAGTGCGGAGCGAATCGCCGAGCGATTCGGGTTCGCCCCGCTGATCATGGCCTCGCTGGCCAAGGACAACGTGGCGGGCACCGACGACGCTTTGCTCGAGATCCATCGCAAGCTGCGTCCGGGCGAGCCGCCGACCAAGGAGTCGGCACAGAACCTGCTGGCAAATCTGTTCTTCACCGAGAAGCGCTACGACCTGGCGCGGGTGGGCCGTTACAAGATCGACAAGAAGCTCGGGCTGCGCGCTCCGGGGGCACCGCGGGTGCTCACCGAGGACGACATCGCGGCCACCATCGAGTACCTGGTGCGCCTGCACGCCGGGGAGAGGACGATGATCGCGCCCGGCGGGGTCGAGGTGCCGGTGGAGGTCGACGACATCGACCATTTCGGTAACCGCCGGGTGCGCACCGTGGGTGAGCTGATCCAGAACCAGATCCGCGTGGGTCTGTCCCGGATGGAACGGGTGGTGCGGGAGCGCATGACCACCCAGGACGTCGAGGCGATCACGCCGCAGTCGCTGATGAACATCCGCCCGGTGGTCGCGGCGATGAAGGAGTTCTTCGGCACCTCGCAGCTGTCGCAGTTCATGGACCAGCGCAACCCGCTGGCGAGCCTGACCAACAAGCGGCGGCTGTCCGCGCTCGGGCCGGGCGGGCTCTCGCGCGAACGGGCCGGCTTGGAGGTCCGCGACGTGCACTACAGCCACTACGGCCGGATGTGCCCGATCGAGACGCCGGAGGGGCCGAACATCGGCCTGATGGGGTACCTGTCGGTGTACGCGCGGGTCAACCCGTTCGGTTTCGTCGAGACCCCCTACCGGCGGGTGGTGGACGGCCGGGTCACCGACGAGGTCGATTACCTCACCGCCGACGAGGAGGACCGGCACGTGGTGGCCCAGGCGAACGAACCGCTGGACGCCGAGGGCCGCTTCCTGGCCGCGCGAATCCCGGTGCGCCGGAAGAACTCCGAGGTGGAACTCGTCGATTCCGCCGCGGTGGATTACATGGATGTGTCGCCGCGGCAGATGGTGTCGGTGGCGACGGCGATGATTCCGTTCCTCGAGCATGATGATGCCAACCGTGCGCTGATGGGTGCGAATATGCAGCGTCAGGCGGTGCCGTTGATTCGGTCGGAGGCGCCGATCGTGGGTACCGGTATGGAGCTGCGTGCGGCGGTGGATGCCGGTGATGTGGTGGTGAACGAGAAGGCCGGTGTGGTCGAGGAGGTTTCGGCCGATTACGTCACGGTGATGGCCGATGACGGGACTCGTAAGTCGTATCGGATGCGGAAGTTCAACCGGTCGAATCAGGGGACGTGTTCGAATCAGCGGCCGATCGTGGACGAGGGTCAGCGGGTCGAGGCCGGGCAGGTGTTGGCTGATGGGCCGTGCACCGAGAACGGTGAGATGGCGCTGGGTAAGAACCTGTTGGTGGCGATCATGCCGTGGGAGGGGCACAACTACGAGGACGCGATCATCCTGTCGCAGCGGTTGGTGGAGCAGGATGTGTTGACCTCGATCCATATCGAGGAGCACGAGATCGATGCTCGTGACACCAAGCTCGGTGCCGAGGAGATCACTCGCGACATTCCGAATGTCTCCGATGAGGTGTTGGCGGATCTGGACGAGCGTGGCATCGTGCGGATCGGTGCGGAGGTGCGTGATGGTGACATCCTGGTCGGTAAGGTCACGCCCAAGGGTGAGACCGAGCTGACGCCGGAGGAGCGGTTGCTGCGGGCGATCTTCGGGGAGAAGGCGCGTGAGGTGCGTGATACCTCGTTGAAGGTGCCCCACGGTGAGTCGGGCAAGGTCATCGGGATCCGGGTGTTCTCTCGGGAGGACGATGACGATCTGCCGCCCGGTGTCAACGAGTTGGTGCGGGTGTATGTGGCGCAGAAGCGCAAGATCCAAGACGGTGACAAGCTGGCCGGTCGGCACGGGAACAAGGGTGTGATCGGCAAGATCCTGCCCACCGAGGACATGCCGTTCCTGCCCGATGGCACCCCGGTCGACATCATCCTCAACACCCACGGTGTGCCGCGGCGTATGAACATCGGCCAGATCCTGGAAACCCACCTCGGCTGGATCGGCAAAGCCGGCTGGAAGGTCGAGGGCAACCCCGAGTGGGCCAAGGATCTGCCGGAGGAGATGTGGGAGGCCCCCGCGGACTCCAACATCGCGACTCCGGTGTTCGACGGTGCCCGCGAGGAGGAGCTGACGGGTCTGCTGGGCTCGACGCTGCCCAACCGTGACGGTGAGCGGATGGTCGACGACAACGGCAAGGCCGTGCTGTTCGACGGTCGTTCCGGTGAGCCGTTCCCGTACCCGGTGGCGGTGGGCTACATGTACATCCTGAAGCTGCACCACCTGGTCGACGACAAGATCCACGCTCGCTCCACCGGCCCGTACTCGATGATCACCCAGCAGCCGCTCGGTGGTAAGGCCCAGTTCGGTGGCCAGCGCTTCGGTGAGATGGAGTGCTGGGCGATGCAGGCCTACGGCGCGGCCTACACCCTGCAGGAACTGCTCACGATCAAGTCCGACGACGTCGTCGGCCGCGTGAAGGTCTACGAGGCGATCGTCAAGGGCGACAACATCCCGGAACCCGGTGTGCCGGAATCGTTCAAGGTGTTGTTGAAGGAACTCCAGGCACTGTGCCTCAACGTCGAGGTGCTGTCCGCCGGTGCCGCGGTCGAACTGGCGCACGGGGTCGACGACGATCACGAGCGGACGGCCGCGAACCTCGGCATCAACCTGTCCCGCGCCGAATCCATCACGGAGACCGAGCTGTCCGGGTGA", "partial": "0", "query_start": 2025, "query_end": 2258, "hit_start": 936, "hit_end": 1221, "orf_dna_sequence": "ATGCTGTGGGAGCGTGAGACGGCGACGGCCGCTGCCGAAGCCGCCCTGCGGCGGGCTGCGCGCGGCCGGGGCTCCCTGCTCCTGGTCGAGGGAGCGCTCGGCGCCGGCAAGTCCGCCTTCCTGGACTCCTTGACCTCCCTGTCCGACCGTCACGGGGCCCTGGTGCTGGCGGCGCACGCGTCGCCGGGCGAGGAGGGCTTCGAGTACGGCGTCGTACGCCAGTTGGCCGACACCTGCCCACCCGTCGGGCCCCGGTGGCCCGCCGACTCGTTCGCCGCACTCGTGGACGTCGCCGCGCCGGGCCGACCACTCGTGATCACCGTGGACGACCTGCACTGGTGTGACGCGGCGTCCTTGCGATCGCTGGTCACGTTGCTCGCTCACGGAGTGCCGGGCGGGGTGGTCCTCGTCGTCTCGGTGCTCAGCGGGCACGTGCGCGTGGGCCGCCCGCGACTTCGTGCCGTGCTCGCGCGGGCGACCTCGACCGTCGATCTGTGTCCCCTCGGACCGCGGAGCGTGCGCGCGCTCGCGGACGCCGCTTACGGCACTCCGGTCGAGGAACCGTTCGCCCGCGCCCTGCACACGGCATCCGGCGGCAGTCCCCTGGTGGTGCACGGCCTCCTGGACGAAGCCGTGTACCGCGGCCTGGAGCCGGCCGGCGCGCATGCCCAGGCCGTCGCCGCCCTCCGGCCGGACCGCGTACGGCGGCGTCTCGCCTCCTTCCTCGACACCCAGCCGGCGGACGTGCGCCGCGCCGCCCACGCCCTGGCCGTGCTGGGCACCGCCGCGGATCCTCCCCTGCTCGACTCTCTGGCAGGGCTGACCGGCCCGGCACGCGCCCGGGCCGTCGCGGTTCTGCACCGGTCGGGTCTGGTCGGCGGCGACGGGAGCGTCCTCGGCTCCCTCCTGCGGGACCTGCTCGCGGAAGCCCTGCCCGCCGACCAGCGTTCCGCGCTGCACGGTGCGGCAGCCGGCCTGTTGTACCGCGCGGGGTACCCCGCCGAGACGGTGGCCGAGCACCTGATGGCCGTACCCGCGCTGCACGGCGGGCGGACCGTCGCCCTGCTCCGCGCCGCCGCGGACAGCGCCCTGCACCGCGGTTCGCCCCGGAGCGCGGCGCGCTACCTGCGCCGGGCGCTGATGAACGTCCCCTCCGCCGACCCCGAGCGGGCACACCTGCTGGTCGACCTCGCCACCGCCGAGCGCAGCTTCGCCCCGGCGGCCTCGCTGCGCCACGTGGTCGAAGCACTGCCGCTCTTGCCCGACGCGCGCGAACGCGCCGCCGCGCTGGTACGGCTGGGCCCGCTGCACCTGGACCCGGCGGCCTTCCGCATCCGCTCCACCTTCCGGCGGCTGATACACGACCTGCGGCGGTGTCCTCCGGCCGAGCGCCCCTCGACGATCTCCGAGAAAGCCGACCGGGACCTGCTGCTGCGTCTGCGAGCCCGTGCGTACGTGCTCTCCACCGACGACCGGGACGCCCACGCCATGCTGTCCGCATTCCAGGGCCTCGGACCGGACCCGGCGACGCGGACACCCGGCGAGCGCGAGATGGCCGCGTTCCTCATCCACCACGCTCTGGTGACCAACTCCGCGCCGGCCCGCCGACTCGCCGCGCTCGCGGCCCGGTTGCTGCAGCGGGAGCCCGCCGCACCGGACCGGATCCACACGGTGCTGCCGCTCGCGCTGAACGTCCTGGCCGCCACCGGGCACCCCGGTGACGCGGCGGCCTGGCTGCGTGCCGCGGCACCGGCCGCCGCGCGGCAGGGCGCCGAAGCGGAACTCGTCGTCATCCGGGCCACACAGGCGCTGGTCGCCCTCGCCGCGGGCCGCCCGGGCCGGGCCCGCCGTGAGGCGCAGGCGATCGAGGCCGCGGCGGAGGGCGGGGACGGGGACCTTCCCCCGGTCTGTCTGGCGGCCGTCGCCCTGATCGCCCTGGACACCGAGGAGCCGGAGCGCGCGGAGCGGGTCCTGGCCCGGCACCCGCTGCACGCCGAGGACCCGCGGCTGACGGCGCTGCTGCACGCGGCGCGGGGCGCTCTGTCGGCGCGCGGCGGGGACCCGCGCACCGCGCTGCACCGGTTCCGGACGGCCGGGCACGTACTGGAGCGGATCGGCTGGCGCAATCCGGTCATGCTGCCGTGGTCCGGTTGCGCCGCGCTCATGCACCACCGCCTCGGCGAGGACAAGGAGGCGGTGACCGCCGCCCGCCAGGACGTGGAGCGGGCGCGGGCGTTCGGTGCCCCCCTGCCCCTCGGCCGGGCGCTCGGTGTCCTCGGCCGGGTCACGGCGGGCCGAGCGGGTACCGAACGGCTGGAGGAGTCCGTGGCCGTGCTCGAACAGGGTTCCAGCCCCTACGAGTTGAGCCGTGCGCTCCACGCGCTCGGCGGCCGGCCGGAGCAGGACCCGGCCCGTCGCCTGGCCCTGTGCCGACGGGCTCTGGAGCTCGCCGTCGACTGCGGCGCACCCTGGCTCGCCGACCGCGTCCGGCGGCGCCTGGACGACACCCGGGCGGAGACGGCGGCCTCGTCCGCGGACCACCTCACACCCTCCGAGCGACGGGTGGCCCGTCTGGCCGCCTCCGGGCTGAGCAACTCCGCGATCTCCCTCCGGCTGGGCATCTCCTCGCGCATGGTGGAGAGGCACCTGACCCAGTCGTACCGGAAGTTGGACATCCCCGGGAAGACCCACCTGCCGTACGCCTTGGAGGGGGCCCCCGCCGAGCCCGCCGAGTGA", "orf_prot_sequence": "MLWERETATAAAEAALRRAARGRGSLLLVEGALGAGKSAFLDSLTSLSDRHGALVLAAHASPGEEGFEYGVVRQLADTCPPVGPRWPADSFAALVDVAAPGRPLVITVDDLHWCDAASLRSLVTLLAHGVPGGVVLVVSVLSGHVRVGRPRLRAVLARATSTVDLCPLGPRSVRALADAAYGTPVEEPFARALHTASGGSPLVVHGLLDEAVYRGLEPAGAHAQAVAALRPDRVRRRLASFLDTQPADVRRAAHALAVLGTAADPPLLDSLAGLTGPARARAVAVLHRSGLVGGDGSVLGSLLRDLLAEALPADQRSALHGAAAGLLYRAGYPAETVAEHLMAVPALHGGRTVALLRAAADSALHRGSPRSAARYLRRALMNVPSADPERAHLLVDLATAERSFAPAASLRHVVEALPLLPDARERAAALVRLGPLHLDPAAFRIRSTFRRLIHDLRRCPPAERPSTISEKADRDLLLRLRARAYVLSTDDRDAHAMLSAFQGLGPDPATRTPGEREMAAFLIHHALVTNSAPARRLAALAARLLQREPAAPDRIHTVLPLALNVLAATGHPGDAAAWLRAAAPAAARQGAEAELVVIRATQALVALAAGRPGRARREAQAIEAAAEGGDGDLPPVCLAAVALIALDTEEPERAERVLARHPLHAEDPRLTALLHAARGALSARGGDPRTALHRFRTAGHVLERIGWRNPVMLPWSGCAALMHHRLGEDKEAVTAARQDVERARAFGAPLPLGRALGVLGRVTAGRAGTERLEESVAVLEQGSSPYELSRALHALGGRPEQDPARRLALCRRALELAVDCGAPWLADRVRRRLDDTRAETAASSADHLTPSERRVARLAASGLSNSAISLRLGISSRMVERHLTQSYRKLDIPGKTHLPYALEGAPAEPAE", "perc_identity": 29.29}}, "BGC0000049.1|E-492_6 # 8530 # 9084 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.681": {"gnl|BL_ORD_ID|4734|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8530, "orf_end": 9084, "orf_from": "BGC0000049.1|E-492_6 ", "model_name": "vanS gene in vanL cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "744", "ARO_accession": "3002938", "ARO_name": "vanS gene in vanL cluster", "ARO_category": {"36210": {"category_aro_accession": "3000071", "category_aro_cvterm_id": "36210", "category_aro_name": "vanS", "category_aro_description": "VanS is similar to histidine protein kinases like EnvZ and acts as a response regulator by activating VanR. VanS is required for high level transcription of other van glycopeptide resistance genes.", "category_aro_class_name": "AMR Gene Family"}, "36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.37762, "max_identities": 11, "bit_score": 25.409, "cvterm_id": "35918", "query": "AFELMAAGAGRYDLARFGMEVFRGSPRQADLMIVAGRVSQKMAPVLRQ", "match": "AF L    +  +D+ RF +     +    DL ++  ++S +  P+L +", "sequence_from_db": "AFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEE", "sequence_from_broadstreet": "MKSKAETTTIKQILIKYLVTIGLSMLAYLVFLLTILIIMRNFVWDGTEPIYRVLHFFYRLFNFEGILIIGVILILFVVTLFFVMKIIGYLKQIIEATKQLLEKPEQRVKLSSGLFELQEEMNQLREKNNADNRAAKEAEKRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPEISVQTRAKYTNIALSKAFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEEKKLSWNLHVESNIKSLLDPGKMERVFDNLMRNAINYSFEDTIIDLSLEKKESQAIFKITNRTYTIPKEKLEKIFEPFYRMDTSRSSSTGGTGLGLPIVREIIEASKGTINVSSSNNEMTFIIYLPYID", "dna_sequence_from_broadstreet": "TTGAAAAGTAAGGCGGAAACTACAACTATAAAACAGATACTAATAAAATATTTAGTAACTATAGGTTTATCGATGCTTGCCTATTTAGTATTTCTTCTAACAATACTTATTATAATGAGAAATTTTGTATGGGACGGCACGGAGCCTATCTATCGTGTCTTGCACTTTTTTTATCGTCTTTTTAATTTTGAAGGGATATTGATTATCGGTGTGATACTTATCCTATTCGTTGTTACATTGTTTTTTGTTATGAAGATAATTGGCTATTTAAAACAAATCATCGAGGCGACGAAACAATTGCTTGAAAAACCAGAACAGCGTGTTAAGCTATCAAGTGGCCTGTTCGAATTACAAGAAGAAATGAACCAACTACGTGAAAAAAATAATGCTGACAATCGCGCAGCTAAAGAAGCGGAAAAGAGAAAAAACGATTTGATTGTTTATTTAGCTCATGATTTACGTACGCCATTAACTAGCGTAATTGGGTATTTAACGCTGTTAAAAGAAGAACCGGAAATATCGGTTCAAACTAGAGCTAAGTATACGAACATCGCTTTGAGTAAAGCTTTTCGCCTTGAAGAATTATTGAGTGAATTTTTTGATGTGACGAGATTTAATTTGACTAACTTAACAATAAATGAAGAACTAGTAGATTTAAGTGTGATGTTAGAGCAAATCAGCTACGAATTTTTACCTATTTTGGAAGAAAAAAAACTTTCTTGGAATCTACACGTCGAGAGTAATATAAAATCTCTTTTAGATCCAGGAAAAATGGAACGTGTTTTTGATAACTTGATGCGAAATGCTATTAATTATAGCTTTGAAGATACAATAATTGATTTAAGTTTAGAAAAAAAAGAATCTCAAGCTATTTTTAAAATTACAAATAGGACCTATACAATCCCAAAAGAAAAATTAGAAAAAATATTCGAACCGTTTTACCGAATGGACACATCTAGAAGTAGCAGTACAGGTGGAACTGGGCTTGGTCTACCGATTGTAAGGGAAATTATTGAAGCTTCCAAAGGAACTATAAACGTTAGTAGTAGCAATAATGAAATGACTTTTATAATCTATTTACCATACATAGATTAA", "partial": "0", "query_start": 8644, "query_end": 8787, "hit_start": 564, "hit_end": 708, "orf_dna_sequence": "ATGGGACTGGAAGAGAGCCTGCCGAGCGGCTTCCTGCTGAGTACCGTCGAGCAGGCCGCGGGCTGGGTGCGCAAGGCGTCGGTGTTCCCGGCGACCTTCGGACTGGCCTGCTGCGCATTCGAGTTAATGGCGGCCGGCGCCGGGCGCTACGACCTGGCGCGGTTCGGTATGGAGGTCTTCCGCGGCTCACCCCGCCAGGCCGACCTCATGATCGTCGCCGGGCGGGTCAGCCAGAAGATGGCCCCGGTCCTGCGCCAGATCTACGACCAGATGCCCAACCCCAAGTGGGTCATCTCCATGGGGGTCTGCGCCTCCTCGGGCGGCATGTTCAACAACTACGCGATCGTGCAGGGCGTCGACCACATCGTCCCGGTCGACATCTACCTGCCCGGCTGTCCGCCCCGCCCCGAGATGCTGATGGACGCGATCCTGAAGCTGCACGAGAAGATCCGTACCTCCAAGCTGGGCGTGAACGCCGAGGAGGCCGCCCGCGAGGCGGAGGAGGCGGCCCGCACGGCGCTGCCCACCATCGAGATGAAGGGGCTCCTGCGATGA", "orf_prot_sequence": "MGLEESLPSGFLLSTVEQAAGWVRKASVFPATFGLACCAFELMAAGAGRYDLARFGMEVFRGSPRQADLMIVAGRVSQKMAPVLRQIYDQMPNPKWVISMGVCASSGGMFNNYAIVQGVDHIVPVDIYLPGCPPRPEMLMDAILKLHEKIRTSKLGVNAEEAAREAEEAARTALPTIEMKGLLR", "perc_identity": 22.92}, "gnl|BL_ORD_ID|2409|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8530, "orf_end": 9084, "orf_from": "BGC0000049.1|E-492_6 ", "model_name": "AxyX", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2797", "ARO_accession": "3004143", "ARO_name": "AxyX", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35976": {"category_aro_accession": "0000059", "category_aro_cvterm_id": "35976", "category_aro_name": "cefepime", "category_aro_description": "Cefepime (INN) is a fourth-generation cephalosporin antibiotic developed in 1994. It contains an aminothiazolyl group that decreases its affinity with beta-lactamases. Cefepime shows high binding affinity with penicillin-binding proteins and has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.12686, "max_identities": 11, "bit_score": 24.2534, "cvterm_id": "41271", "query": "PKWVISMGVCASSGGMFNNYAIVQGVDHIVPVDIYLPGCP", "match": "P WV++ G+      +  N A +     I PV+   P  P", "sequence_from_db": "PNWVVTEGLAGGERVVVENAAQLAPGQKIKPVERTAPSAP", "sequence_from_broadstreet": "MTHRVPFRTLAFASVLVLVSACSKQEAPEAAKAPAEVGVIVARATPTAVASELPGRLEPYREAEVRARVAGIVTRRLYEEGQEVTRGTPLFQIDPAPLQAAYDSEAAALARAQANLSAAADKLRRYADLVSDRAISERDHAESVAQERQARAEVALAKANLQSARLRLEYARVTSPIDGRARRALVTEGALVGEGQATPLTVVQQLDPIYVNFSQPAAEVMQLQKQIRAGALQGVAPDKMRVRLLLPDGSEYGQGGTLSFADLAVDPGTDNVTMRALFANPGRELLPGMYVRVRLEQAVNRDTFLVPRNALLRNADGAHVLVAGDDGELRSVAVTAHRLLGPNWVVTEGLAGGERVVVENAAQLAPGQKIKPVERTAPSAPVATAGNNEKR", "dna_sequence_from_broadstreet": "ATGACGCACCGAGTTCCCTTCAGAACGCTCGCATTCGCATCCGTACTGGTTCTCGTTTCCGCATGCTCGAAGCAGGAAGCCCCCGAAGCCGCCAAGGCCCCCGCCGAAGTCGGCGTCATCGTGGCCAGGGCCACGCCCACCGCCGTCGCCAGCGAGCTGCCCGGCCGGCTGGAGCCCTATCGCGAGGCCGAGGTCCGCGCCCGCGTGGCCGGCATCGTCACCCGCCGCCTGTATGAAGAAGGCCAGGAAGTGACGCGCGGCACGCCGCTGTTCCAGATCGATCCGGCGCCGCTGCAGGCGGCCTACGATTCCGAGGCGGCCGCGTTGGCGCGTGCCCAGGCCAACCTGTCGGCCGCCGCCGACAAGCTGCGCCGCTACGCCGACCTGGTGTCGGACCGCGCCATCAGCGAACGCGACCACGCCGAGAGCGTGGCCCAGGAACGCCAGGCCCGCGCCGAAGTGGCGTTGGCCAAGGCCAACCTGCAGAGCGCCAGGCTGCGGCTGGAATACGCCCGCGTCACCTCGCCGATCGACGGCCGCGCGCGCCGCGCGCTGGTCACCGAGGGCGCGCTGGTGGGCGAAGGCCAGGCCACGCCGCTGACGGTGGTGCAGCAACTCGACCCGATCTACGTCAACTTCTCGCAACCCGCGGCCGAGGTCATGCAGTTGCAGAAGCAGATCCGCGCCGGCGCCCTGCAAGGCGTCGCGCCCGACAAGATGCGGGTGCGCCTGCTGCTGCCGGACGGCTCCGAGTATGGCCAGGGCGGCACGCTGTCGTTCGCCGACCTGGCGGTCGACCCCGGCACCGACAACGTGACCATGCGCGCGCTGTTCGCCAACCCGGGCCGCGAACTGTTGCCGGGCATGTACGTGCGGGTGCGGCTGGAGCAGGCGGTCAACCGCGACACCTTCCTGGTGCCGCGCAACGCCCTGCTGCGCAACGCCGACGGCGCGCACGTGCTGGTGGCCGGCGACGACGGCGAGCTGCGCAGCGTGGCGGTGACCGCGCACCGGCTGCTGGGCCCGAACTGGGTCGTCACCGAGGGCCTGGCGGGCGGCGAACGCGTGGTGGTGGAAAACGCCGCGCAGCTGGCCCCCGGCCAGAAAATCAAACCGGTCGAGCGGACCGCGCCGAGCGCGCCCGTGGCGACCGCGGGAAATAACGAAAAAAGGTAA", "partial": "0", "query_start": 8809, "query_end": 8928, "hit_start": 1023, "hit_end": 1143, "orf_dna_sequence": "ATGGGACTGGAAGAGAGCCTGCCGAGCGGCTTCCTGCTGAGTACCGTCGAGCAGGCCGCGGGCTGGGTGCGCAAGGCGTCGGTGTTCCCGGCGACCTTCGGACTGGCCTGCTGCGCATTCGAGTTAATGGCGGCCGGCGCCGGGCGCTACGACCTGGCGCGGTTCGGTATGGAGGTCTTCCGCGGCTCACCCCGCCAGGCCGACCTCATGATCGTCGCCGGGCGGGTCAGCCAGAAGATGGCCCCGGTCCTGCGCCAGATCTACGACCAGATGCCCAACCCCAAGTGGGTCATCTCCATGGGGGTCTGCGCCTCCTCGGGCGGCATGTTCAACAACTACGCGATCGTGCAGGGCGTCGACCACATCGTCCCGGTCGACATCTACCTGCCCGGCTGTCCGCCCCGCCCCGAGATGCTGATGGACGCGATCCTGAAGCTGCACGAGAAGATCCGTACCTCCAAGCTGGGCGTGAACGCCGAGGAGGCCGCCCGCGAGGCGGAGGAGGCGGCCCGCACGGCGCTGCCCACCATCGAGATGAAGGGGCTCCTGCGATGA", "orf_prot_sequence": "MGLEESLPSGFLLSTVEQAAGWVRKASVFPATFGLACCAFELMAAGAGRYDLARFGMEVFRGSPRQADLMIVAGRVSQKMAPVLRQIYDQMPNPKWVISMGVCASSGGMFNNYAIVQGVDHIVPVDIYLPGCPPRPEMLMDAILKLHEKIRTSKLGVNAEEAAREAEEAARTALPTIEMKGLLR", "perc_identity": 27.5}}, "BGC0000049.1|E-492_7 # 9137 # 10474 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=9bp;gc_cont=0.692": {"gnl|BL_ORD_ID|1201|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9137, "orf_end": 10474, "orf_from": "BGC0000049.1|E-492_7 ", "model_name": "SIM-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1282", "ARO_accession": "3000846", "ARO_name": "SIM-1", "ARO_category": {"41370": {"category_aro_accession": "3004206", "category_aro_cvterm_id": "41370", "category_aro_name": "SIM beta-lactamase", "category_aro_description": "SIM beta-lactamases are Class B beta-lactamases that are capable of hydrolyzing a wide variety of beta-lactams, including penicillins, narrow- to expanded-spectrum cephalosporins, and carbapenem. The SIM family of beta-lactamases appear to be transferable through integrons.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.24049, "max_identities": 17, "bit_score": 27.335, "cvterm_id": "39090", "query": "TTDTCDAYGRFLIRLEEMRQSLRIVDQCLDRLEPGPVMVADKKIAW-PAQLAL------GPDGLGNSPD", "match": "T +  +  G+   +    ++S  +V   ++   PGP    D ++ W P +  L       P+GLGN  D", "sequence_from_db": "TNELLNKNGKTQAKHSFDKESFWLVKNKIEIFYPGPGHTQDNEVVWIPNKKILFGGCFIKPNGLGNLSD", "sequence_from_broadstreet": "MRTLLILCLFGTLNTAFAEEAQPDLKIEKIEEGIYLHTSFQEYKGFGIVKKQGLVVLDNHKAYLIDTPASAGDTEKLVNWLEKNDFTVNGSISTHFHDDSTAGIEWLNTKSIPTYASKLTNELLNKNGKTQAKHSFDKESFWLVKNKIEIFYPGPGHTQDNEVVWIPNKKILFGGCFIKPNGLGNLSDANLEAWPGSAKKMISKYSKAKLVIPSHSEIGDASLLKLTWEQAIKGLNESKSKPPLIN", "dna_sequence_from_broadstreet": "ATGAGAACTTTATTGATTTTATGTTTATTCGGCACTTTAAATACCGCGTTTGCGGAAGAAGCCCAGCCAGATTTAAAAATTGAAAAAATAGAAGAAGGGATCTATCTTCATACATCTTTTCAAGAGTACAAGGGATTCGGCATCGTTAAAAAACAAGGCTTAGTAGTTCTTGACAATCACAAGGCATATCTCATCGACACTCCAGCTTCCGCAGGAGATACTGAAAAGCTAGTAAACTGGCTCGAAAAAAATGATTTCACTGTCAATGGAAGCATTTCAACACATTTCCACGACGACAGTACTGCTGGGATAGAGTGGCTTAATACAAAGTCCATCCCCACATATGCATCTAAATTGACAAATGAATTGCTAAATAAAAATGGCAAAACTCAAGCCAAGCACTCTTTTGATAAAGAGAGCTTTTGGTTGGTCAAAAATAAAATTGAAATTTTTTATCCAGGCCCAGGACACACTCAAGATAACGAAGTTGTCTGGATACCTAATAAAAAAATCCTATTCGGGGGCTGTTTTATAAAACCGAATGGCCTTGGCAATCTAAGTGACGCAAATTTGGAAGCTTGGCCAGGCTCCGCAAAAAAAATGATATCAAAATACAGTAAGGCAAAACTTGTTATCCCAAGCCACAGTGAAATCGGAGACGCATCACTATTGAAACTCACATGGGAACAGGCCATTAAAGGTTTAAATGAAAGCAAATCAAAACCGCCGCTCATTAATTAA", "partial": "0", "query_start": 9992, "query_end": 10177, "hit_start": 357, "hit_end": 564, "orf_dna_sequence": "ATGACGACGACGCCCACGCCCACCTCGCCCCGTGCCGGCCGGGAGACGACGGAAGGCACCGTCTACACGGTCACCGGCGGCGACTGGGACGAGATCGTCAGCTCGGCGGCCCGCGCCAACGACGAACGCATCGTCGTCAACATGGGCCCCCAGCACCCCTCCACCCACGGGGTGCTGCGGCTGATCCTGGAGATCGACGGCGAGACGGTCACCGAGGCCCGCTGCGGCATCGGCTACCTCCACACCGGCATCGAGAAGCAGACCGAGTACCGCACGTGGACCCAGGGCACCACCCTGGTCACCCGCATGGACTACCTCACGTCGTTCTTCAACGAGACGGCGTACTGCCTGGCCGTCGAGAAGCTGCTGGGCATCGAGGACCAGGTCCCCGACCGGGCCACCGTCGTGCGCGTCCTGCTGATGGAGCTCAACCGCATCTCCTCGCACCTGGTGGCCATCGCCACGGGCGGCATGGAGCTCGGTGCCTCCACGGTCATGATCTACGGCTTCCGCGACCGCGAACTGATCCTGGACGCCTACGAGCTGATCACCGGACTGCGGATGAACCACGCGTTCATCCGGCCCGGCGGACTCGCCCAGGACCTGCCGGCCGGGGCCGTCGACCAGCTGCGCGAACTGGTCGGGACGCTGCGCAAGAACCTGCCCGAGTACGACAAGCTCGCCTCCGGCAACCCGGTCTTCAAGGCGCGCATGCAGGACGTCGCCCACCTCGACCTGACCGGGTGCATGGCCCTCGGTGTCACCGGCCCGATCCTGCGCTCCACCGGCCTGCCGCACGACCTGCGCAAGGCGCAGCCGTACTGCGGCTACGAGACGTACGACTTCGACGTCCCGACCACCGACACCTGCGACGCCTACGGCCGCTTCCTCATCCGGCTCGAGGAGATGCGCCAGTCCCTGCGGATCGTCGACCAGTGCCTGGACCGGCTCGAGCCGGGCCCGGTGATGGTCGCCGACAAGAAGATCGCCTGGCCCGCCCAGCTGGCTCTCGGACCGGACGGCCTGGGCAACTCGCCCGACCACATCAAGCAGATCATGGGCACCTCCATGGAGTCCCTGATCCACCACTTCAAGCTGGTCACCGAGGGCTTCCGGGTCCCGCCGGGGCAGATCTACGTGTCCGTGGAGTCGCCCAAGGGCGAACTCGGCGCCCACGTCGTCTCGGACGGGGGCACGCGCCCCTTCCGGGTCCACTTCCGCGACCCGTCGTTCACCAACCTGCAGGCCATGGCGGCGATGGCCGAGGGCGGCCAGGTCGCCGACGTCATCGTCGTCATCGCCTCCATCGACCCCGTCCTGGGCGGCGTCGACCGGTGA", "orf_prot_sequence": "MTTTPTPTSPRAGRETTEGTVYTVTGGDWDEIVSSAARANDERIVVNMGPQHPSTHGVLRLILEIDGETVTEARCGIGYLHTGIEKQTEYRTWTQGTTLVTRMDYLTSFFNETAYCLAVEKLLGIEDQVPDRATVVRVLLMELNRISSHLVAIATGGMELGASTVMIYGFRDRELILDAYELITGLRMNHAFIRPGGLAQDLPAGAVDQLRELVGTLRKNLPEYDKLASGNPVFKARMQDVAHLDLTGCMALGVTGPILRSTGLPHDLRKAQPYCGYETYDFDVPTTDTCDAYGRFLIRLEEMRQSLRIVDQCLDRLEPGPVMVADKKIAWPAQLALGPDGLGNSPDHIKQIMGTSMESLIHHFKLVTEGFRVPPGQIYVSVESPKGELGAHVVSDGGTRPFRVHFRDPSFTNLQAMAAMAEGGQVADVIVVIASIDPVLGGVDR", "perc_identity": 24.64}, "gnl|BL_ORD_ID|4589|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9137, "orf_end": 10474, "orf_from": "BGC0000049.1|E-492_7 ", "model_name": "SIM-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5659", "ARO_accession": "3005494", "ARO_name": "SIM-2", "ARO_category": {"41370": {"category_aro_accession": "3004206", "category_aro_cvterm_id": "41370", "category_aro_name": "SIM beta-lactamase", "category_aro_description": "SIM beta-lactamases are Class B beta-lactamases that are capable of hydrolyzing a wide variety of beta-lactams, including penicillins, narrow- to expanded-spectrum cephalosporins, and carbapenem. The SIM family of beta-lactamases appear to be transferable through integrons.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.34176, "max_identities": 19, "bit_score": 27.335, "cvterm_id": "36752", "query": "TTDTCDAYGRFLIRLEEMRQSLRIVDQCLDRLEPGPVMVADKKIAW-PAQLAL------GPDGLGNSPDHIKQIMGTSMESLIHHF", "match": "T +  +  G+   +    ++S  +V   ++   PGP    D ++ W P +  L       P+GLGN  D   +    S + +I  +", "sequence_from_db": "TNELLNKNGKTQAKHSFDKESFWLVKNKIEIFYPGPGHTQDNEVVWIPNKKILFGGCFIKPNGLGNLSDANLEAWPDSAKKMISKY", "sequence_from_broadstreet": "MRTLLILCLFGTLNTAFAEEAQPDLKIEKIEEGIYLHTSFQEYKGFGIVKKQGLVVLDNHKAYLIDTPASAGDTEKLVNWLEKNDFTVNGSISTHFHDDSTAGIEWLNTKSIPTYASKLTNELLNKNGKTQAKHSFDKESFWLVKNKIEIFYPGPGHTQDNEVVWIPNKKILFGGCFIKPNGLGNLSDANLEAWPDSAKKMISKYSKAKLVIPSHSEIGDASLLKLTWEQAIKGLNESKSKPPLIN", "dna_sequence_from_broadstreet": "ATGAGAACTTTATTGATTTTATGTTTATTCGGCACTTTAAATACCGCGTTTGCGGAAGAAGCCCAGCCAGATTTAAAAATTGAAAAAATAGAAGAAGGGATCTATCTTCATACATCTTTTCAAGAGTACAAGGGATTCGGCATCGTTAAAAAACAAGGCTTAGTAGTTCTTGACAATCACAAGGCATATCTCATCGACACTCCAGCTTCCGCAGGAGATACTGAAAAGCTAGTAAACTGGCTCGAAAAAAATGATTTCACTGTCAATGGAAGCATTTCAACACATTTCCACGACGACAGTACTGCTGGGATAGAGTGGCTTAATACAAAGTCCATCCCCACATATGCATCTAAATTGACAAATGAATTGCTAAATAAAAATGGCAAAACTCAAGCCAAGCACTCTTTTGATAAAGAGAGCTTTTGGTTGGTCAAAAATAAAATTGAAATTTTTTATCCAGGCCCAGGACACACTCAAGATAACGAAGTTGTCTGGATACCTAATAAAAAAATCCTATTCGGGGGCTGTTTTATAAAACCGAATGGCCTTGGCAATCTAAGTGACGCAAATTTGGAAGCTTGGCCAGACTCCGCAAAAAAAATGATATCAAAATACAGTAAGGCAAAACTTGTTATCCCAAGCCACAGTGAAATCGGAGACGCATCACTATTGAAACTCACATGGGAACAGGCCATTAAAGGTTTAAATGAAAGCAAATCAAAACCGCCGCTCATTAATTAA", "partial": "0", "query_start": 9992, "query_end": 10228, "hit_start": 357, "hit_end": 615, "orf_dna_sequence": "ATGACGACGACGCCCACGCCCACCTCGCCCCGTGCCGGCCGGGAGACGACGGAAGGCACCGTCTACACGGTCACCGGCGGCGACTGGGACGAGATCGTCAGCTCGGCGGCCCGCGCCAACGACGAACGCATCGTCGTCAACATGGGCCCCCAGCACCCCTCCACCCACGGGGTGCTGCGGCTGATCCTGGAGATCGACGGCGAGACGGTCACCGAGGCCCGCTGCGGCATCGGCTACCTCCACACCGGCATCGAGAAGCAGACCGAGTACCGCACGTGGACCCAGGGCACCACCCTGGTCACCCGCATGGACTACCTCACGTCGTTCTTCAACGAGACGGCGTACTGCCTGGCCGTCGAGAAGCTGCTGGGCATCGAGGACCAGGTCCCCGACCGGGCCACCGTCGTGCGCGTCCTGCTGATGGAGCTCAACCGCATCTCCTCGCACCTGGTGGCCATCGCCACGGGCGGCATGGAGCTCGGTGCCTCCACGGTCATGATCTACGGCTTCCGCGACCGCGAACTGATCCTGGACGCCTACGAGCTGATCACCGGACTGCGGATGAACCACGCGTTCATCCGGCCCGGCGGACTCGCCCAGGACCTGCCGGCCGGGGCCGTCGACCAGCTGCGCGAACTGGTCGGGACGCTGCGCAAGAACCTGCCCGAGTACGACAAGCTCGCCTCCGGCAACCCGGTCTTCAAGGCGCGCATGCAGGACGTCGCCCACCTCGACCTGACCGGGTGCATGGCCCTCGGTGTCACCGGCCCGATCCTGCGCTCCACCGGCCTGCCGCACGACCTGCGCAAGGCGCAGCCGTACTGCGGCTACGAGACGTACGACTTCGACGTCCCGACCACCGACACCTGCGACGCCTACGGCCGCTTCCTCATCCGGCTCGAGGAGATGCGCCAGTCCCTGCGGATCGTCGACCAGTGCCTGGACCGGCTCGAGCCGGGCCCGGTGATGGTCGCCGACAAGAAGATCGCCTGGCCCGCCCAGCTGGCTCTCGGACCGGACGGCCTGGGCAACTCGCCCGACCACATCAAGCAGATCATGGGCACCTCCATGGAGTCCCTGATCCACCACTTCAAGCTGGTCACCGAGGGCTTCCGGGTCCCGCCGGGGCAGATCTACGTGTCCGTGGAGTCGCCCAAGGGCGAACTCGGCGCCCACGTCGTCTCGGACGGGGGCACGCGCCCCTTCCGGGTCCACTTCCGCGACCCGTCGTTCACCAACCTGCAGGCCATGGCGGCGATGGCCGAGGGCGGCCAGGTCGCCGACGTCATCGTCGTCATCGCCTCCATCGACCCCGTCCTGGGCGGCGTCGACCGGTGA", "orf_prot_sequence": "MTTTPTPTSPRAGRETTEGTVYTVTGGDWDEIVSSAARANDERIVVNMGPQHPSTHGVLRLILEIDGETVTEARCGIGYLHTGIEKQTEYRTWTQGTTLVTRMDYLTSFFNETAYCLAVEKLLGIEDQVPDRATVVRVLLMELNRISSHLVAIATGGMELGASTVMIYGFRDRELILDAYELITGLRMNHAFIRPGGLAQDLPAGAVDQLRELVGTLRKNLPEYDKLASGNPVFKARMQDVAHLDLTGCMALGVTGPILRSTGLPHDLRKAQPYCGYETYDFDVPTTDTCDAYGRFLIRLEEMRQSLRIVDQCLDRLEPGPVMVADKKIAWPAQLALGPDGLGNSPDHIKQIMGTSMESLIHHFKLVTEGFRVPPGQIYVSVESPKGELGAHVVSDGGTRPFRVHFRDPSFTNLQAMAAMAEGGQVADVIVVIASIDPVLGGVDR", "perc_identity": 22.09}}, "BGC0000049.1|E-492_8 # 10706 # 12010 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.723": {"gnl|BL_ORD_ID|1212|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10706, "orf_end": 12010, "orf_from": "BGC0000049.1|E-492_8 ", "model_name": "mdtC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1800", "model_id": "1315", "ARO_accession": "3000794", "ARO_name": "mdtC", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.83179, "max_identities": 30, "bit_score": 28.1054, "cvterm_id": "36849", "query": "LPAVLGGFDLSDQDRFTDGFPHEVFARLRKEAPVLRHPPGRTRDGEDFWVLSRYDDVVEAAEH-PLL--SSQGGGDREGGGTHLDDLPAGTYSGAMLN", "match": "LPAV  G  L+ Q  F  G   +        A V R P G   DG   W +   D++  AAE+ PL+   + GG  R G    + D      +  M N", "sequence_from_db": "LPAVRVG--LNPQALFNQGVSLDDVRTAVSNANV-RKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTN", "sequence_from_broadstreet": "MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE", "dna_sequence_from_broadstreet": "GTGAAGTTTTTTGCCCTCTTCATTTACCGCCCGGTGGCGACGATTTTACTGTCGGTTGCCATTACCCTGTGCGGCATACTGGGCTTCCGTATGCTGCCGGTCGCCCCGCTGCCGCAGGTCGATTTTCCGGTGATTATCGTCAGCGCCTCGCTGCCCGGTGCGTCACCAGAAACAATGGCGTCTTCCGTTGCCACGCCGCTGGAGCGCTCACTTGGGCGCATTGCCGGAGTCAGTGAAATGACCTCCAGCAGTTCGCTCGGCAGCACGCGTATTATTTTGCAGTTTGATTTTGACCGGGATATCAACGGCGCAGCGCGTGATGTGCAGGCGGCGATCAACGCTGCACAAAGTTTGCTGCCCAGTGGGATGCCCAGCCGCCCGACCTATCGCAAAGCGAACCCGTCGGATGCGCCAATTATGATCCTCACGCTGACGTCCGATACTTATTCGCAGGGTGAACTGTACGATTTCGCCTCGACGCAGCTGGCTCCGACGATTTCGCAAATCGACGGTGTTGGTGATGTCGATGTCGGAGGCAGCTCACTGCCCGCCGTACGCGTCGGGCTGAATCCGCAGGCGCTGTTTAATCAGGGCGTGTCGCTGGACGACGTACGCACCGCCGTCAGCAATGCCAACGTGCGTAAACCGCAGGGCGCGCTGGAAGATGGCACTCACCGCTGGCAGATCCAGACCAATGATGAGCTAAAAACCGCCGCTGAATATCAGCCGTTGATTATTCACTACAACAACGGCGGCGCGGTTCGTCTGGGCGATGTGGCGACGGTGACCGACTCAGTGCAGGATGTGCGCAACGCCGGGATGACCAACGCCAAACCGGCTATTTTACTGATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACGGTTGACAGCATCCGGGCAAAATTACCGGAGTTGCAGGAAACCATTCCGGCGGCGATTGATCTGCAAATTGCCCAGGATCGCTCCCCCACCATTCGCGCCTCGCTGGAAGAAGTCGAGCAAACGCTGATTATCTCGGTGGCGCTGGTGATTCTGGTGGTGTTTTTATTCCTGCGCTCGGGTCGCGCCACTATTATTCCCGCCGTTTCGGTGCCGGTTTCGCTGATTGGTACGTTTGCGGCGATGTACCTGTGCGGATTCAGTCTCAATAACCTTTCGTTAATGGCGCTCACCATCGCTACTGGTTTCGTGGTGGATGACGCCATCGTGGTGCTGGAAAACATTGCACGTCATCTGGAAGCGGGAATGAAACCGTTGCAAGCCGCACTGCAAGGTACTCGCGAAGTCGGTTTTACGGTGCTGTCGATGAGTCTGTCACTGGTGGCGGTGTTCCTGCCGCTGCTGTTGATGGGCGGATTGCCGGGCCGACTGTTACGCGAATTTGCCGTGACGCTTTCTGTCGCCATTGGTATATCGTTGCTGGTTTCTCTGACATTAACGCCAATGATGTGTGGCTGGATGCTGAAAGCCAGCAAGCCGCGCGAGCAAAAGCGACTGCGTGGTTTTGGTCGCATGTTGGTAGCCCTGCAACAAGGCTACGGCAAGTCACTAAAATGGGTGCTCAATCATACCCGTCTGGTGGGCGTGGTGCTGCTTGGCACCATTGCGCTGAATATCTGGCTGTATATCTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACTGGCGTGTTGATGGGCGGGATTCAGGCGGATCAGAGTATTTCGTTTCAGGCGATGCGCGGTAAGTTGCAGGATTTCATGAAAATTATCCGTGACGATCCGGCAGTGGATAATGTCACCGGCTTTACAGGCGGTTCGCGAGTGAACAGCGGGATGATGTTTATCACCCTCAAGCCACGCGACGAACGCAGCGAAACGGCGCAGCAAATTATCGACCGTCTGCGCGTAAAACTGGCGAAAGAACCGGGGGCGAATCTGTTCCTGATGGCGGTACAGGATATTCGCGTTGGTGGGCGTCAGTCGAACGCCAGCTACCAGTACACGTTGTTATCCGACGACCTGGCGGCACTGCGAGAATGGGAGCCGAAAATCCGCAAAAAACTGGCGACGTTGCCGGAACTGGCGGACGTGAACTCCGATCAGCAGGATAACGGCGCGGAGATGAATCTGGTTTACGACCGCGACACCATGGCACGGCTGGGAATCGACGTACAAGCCGCCAACAGTCTGTTAAATAACGCCTTCGGTCAGCGGCAAATCTCGACCATTTACCAGCCGATGAACCAGTATAAAGTGGTGATGGAAGTGGATCCGCGCTATACCCAGGACATCAGTGCGCTGGAAAAAATGTTCGTTATCAATAACGAAGGCAAAGCGATCCCGCTGTCGTATTTCGCTAAATGGCAACCGGCGAATGCCCCACTATCGGTGAATCATCAGGGATTATCGGCGGCCTCGACCATTTCGTTTAACCTGCCGACCGGAAAATCGCTCTCGGACGCCAGTGCGGCGATCGATCGCGCAATGACCCAGCTTGGTGTGCCTTCGACGGTGCGCGGCAGTTTTGCCGGCACGGCGCAGGTGTTCCAGGAGACGATGAACTCGCAGGTGATCCTGATTATCGCCGCCATCGCCACGGTGTATATCGTGCTGGGTATCCTTTACGAGAGTTACGTACATCCGCTGACGATTCTCTCCACCCTGCCCTCGGCGGGCGTTGGAGCGCTGTTGGCGCTGGAGCTGTTCAATGCCCCGTTCAGCCTAATCGCCCTGATAGGGATCATGCTATTAATCGGCATCGTGAAGAAAAACGCCATTATGATGGTCGATTTTGCGCTTGAAGCCCAACGGCACGGTAACCTGACGCCGCAGGAAGCTATTTTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATTATGATGACTACCCTGGCGGCGCTGTTTGGTGCGCTGCCGCTGGTATTGTCGGGCGGCGACGGCTCGGAGCTGCGGCAACCCCTGGGGATCACCATTGTCGGCGGACTGGTAATGAGCCAGCTCCTTACGCTGTATACCACGCCGGTGGTGTATCTCTTTTTCGACCGTCTGCGGCTGCGTTTTTCGCGTAAACCTAAACAAACGGTAACCGAGTAA", "partial": "0", "query_start": 10769, "query_end": 11053, "hit_start": 543, "hit_end": 828, "orf_dna_sequence": "ATGTCGCTGGAGCAGCCCGCCGTTCCGACGTTACGCAGCGCCGCCGAGGTGGGCGGGGAGCAACTGCCCGCCGTGCTCGGCGGTTTCGACCTCAGCGACCAGGACCGTTTCACCGACGGCTTCCCGCACGAGGTGTTCGCCCGGCTGCGCAAGGAGGCACCCGTCCTGCGCCACCCGCCCGGACGGACCCGTGACGGCGAGGACTTCTGGGTCCTCTCCCGCTACGACGACGTGGTCGAGGCGGCGGAACACCCCCTGCTGTCCTCCCAGGGCGGCGGCGACCGCGAGGGCGGCGGCACCCACCTCGACGACCTGCCCGCCGGCACCTACTCCGGCGCGATGCTCAACATGATGGACGACCCGCGCCACCGCCTGCTGCGCGACCTGGTCAGCCCGTCCGTGACCGGGCCCGTGCTCGAGGCGCTGGGCCCGCTCATCACCGAGCGGGCCGAGGCGATCGTCTCCGAGGTCGTCGAGCGCGGCTCCTGCGACTTCCAGAACGACGTCGCCGGCCGCTTCTCCGTCGAGGTCATGGCCGCGTTGATGGGCGTACCGCGCGCCGACTGGCCGCAGTTCGTCGACTGGACCGAAGTGGTGATGGGGTACGAGGACCGTGCCTCCGGCGAGTCGTCCTCGCGCAGCCAGGCCGCCCTCCTCGCGATGTACCAGTACGGGGTGCAGCTGCTCGCCCGGAAGAGGGCCGAGCCGGCGCAGGACTTCCTGTCCGTCATCGCCGCGGGTGAACTCCCCGAGGGCCACGGCGAGTCGCCGTTGCGGCCCTACGAGCGGGAGGTGTTCGTCAACCTGCTGACCCTGGCCGGGAGCGAGCCGACCCGCAACGTCATCGCCGTCGGTCTGCTCGCCCTGGCCGAGCACCCCGAGCAGTGGCAGGCCCTGCGCGCGGACCGCTCCCTGCTGGACGGCGCCGTCGAGGAGATGATGCGCTGGTCCACGCCGACGCCGTACAACCGGCGCACGGCCACCGAGGACTTCACGTTCCGGGACGTGCGGTTCCGGCGCGGCGACAAGGTGACCCTGTGGTGGTCGTCGGCCAACCGGGACGAGAGCGTCTTCCCCGACGCCATGTCCTTCGACGTGCGCCGCAACCCCAACCCGCACCTCGCCTTCGGCCGCGGCCCCCACGTCTGCCTCGCCGTGGACCTCGCCCGGCTCGAACTGCGCACCCTGTTCACCGCGCTCCTCGACCGGGTCGCCGAGGTGCGCCTGAGCGGGCCGGTGCCGTGGGCCGCCAACAGCAAGCACACGGTGGCGTTGGAGGTCCCCGTGGAGTTCGTCCGGGCCTGA", "orf_prot_sequence": "MSLEQPAVPTLRSAAEVGGEQLPAVLGGFDLSDQDRFTDGFPHEVFARLRKEAPVLRHPPGRTRDGEDFWVLSRYDDVVEAAEHPLLSSQGGGDREGGGTHLDDLPAGTYSGAMLNMMDDPRHRLLRDLVSPSVTGPVLEALGPLITERAEAIVSEVVERGSCDFQNDVAGRFSVEVMAALMGVPRADWPQFVDWTEVVMGYEDRASGESSSRSQAALLAMYQYGVQLLARKRAEPAQDFLSVIAAGELPEGHGESPLRPYEREVFVNLLTLAGSEPTRNVIAVGLLALAEHPEQWQALRADRSLLDGAVEEMMRWSTPTPYNRRTATEDFTFRDVRFRRGDKVTLWWSSANRDESVFPDAMSFDVRRNPNPHLAFGRGPHVCLAVDLARLELRTLFTALLDRVAEVRLSGPVPWAANSKHTVALEVPVEFVRA", "perc_identity": 30.61}, "gnl|BL_ORD_ID|2774|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10706, "orf_end": 12010, "orf_from": "BGC0000049.1|E-492_8 ", "model_name": "OmpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3787", "ARO_accession": "3005044", "ARO_name": "OmpA", "ARO_category": {"41446": {"category_aro_accession": "3004282", "category_aro_cvterm_id": "41446", "category_aro_name": "General Bacterial Porin with reduced permeability to peptide antibiotics", "category_aro_description": "These are GBPs that are associated with decreased susceptibility to peptide antibiotics either through mutations in the porin protein, absence of the porin protein, or expression of the porin protein.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "37037": {"category_aro_accession": "3000693", "category_aro_cvterm_id": "37037", "category_aro_name": "defensin", "category_aro_description": "Defensins are natural cationic peptides that have antibiotic properties. It is part of the innate immune system of plants and animals.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36383": {"category_aro_accession": "3000244", "category_aro_cvterm_id": "36383", "category_aro_name": "reduced permeability to antibiotic", "category_aro_description": "Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.27995, "max_identities": 22, "bit_score": 26.5646, "cvterm_id": "35915", "query": "DWTEVVMGYEDRASGESSSRSQAALLAMYQYGVQLLARKRAEPAQDFLSV--IAAGELP-EGHGES", "match": "D + VV+GY DR   E+ +              Q L+ KRA+   D+L    I AG++   G GES", "sequence_from_db": "DGSAVVLGYTDRIGSEAYN--------------QQLSEKRAQSVVDYLVAKGIPAGKISARGMGES", "sequence_from_broadstreet": "MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA", "dna_sequence_from_broadstreet": "GTGAGGTCTTTTGTAACTTCATGGCGAATTTTGGATGATAATGAGGCGCAAAAAATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGACACCGGTTTCTACGGTAACGGTTTCCAGAACAACAACGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTCGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGACAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGACATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCTACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCGGGCACTGTGGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGCGTTTCCTACCGCTTCGGTCAGGAAGATGCTGCACCGGTTGTTGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTTCTGTTCAACTTCAACAAAGCTACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACTCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCTGTTGTTCTGGGCTACACCGACCGCATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTGAATCCACCCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGATTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCGGCGGCTTAA", "partial": "0", "query_start": 11285, "query_end": 11473, "hit_start": 837, "hit_end": 993, "orf_dna_sequence": "ATGTCGCTGGAGCAGCCCGCCGTTCCGACGTTACGCAGCGCCGCCGAGGTGGGCGGGGAGCAACTGCCCGCCGTGCTCGGCGGTTTCGACCTCAGCGACCAGGACCGTTTCACCGACGGCTTCCCGCACGAGGTGTTCGCCCGGCTGCGCAAGGAGGCACCCGTCCTGCGCCACCCGCCCGGACGGACCCGTGACGGCGAGGACTTCTGGGTCCTCTCCCGCTACGACGACGTGGTCGAGGCGGCGGAACACCCCCTGCTGTCCTCCCAGGGCGGCGGCGACCGCGAGGGCGGCGGCACCCACCTCGACGACCTGCCCGCCGGCACCTACTCCGGCGCGATGCTCAACATGATGGACGACCCGCGCCACCGCCTGCTGCGCGACCTGGTCAGCCCGTCCGTGACCGGGCCCGTGCTCGAGGCGCTGGGCCCGCTCATCACCGAGCGGGCCGAGGCGATCGTCTCCGAGGTCGTCGAGCGCGGCTCCTGCGACTTCCAGAACGACGTCGCCGGCCGCTTCTCCGTCGAGGTCATGGCCGCGTTGATGGGCGTACCGCGCGCCGACTGGCCGCAGTTCGTCGACTGGACCGAAGTGGTGATGGGGTACGAGGACCGTGCCTCCGGCGAGTCGTCCTCGCGCAGCCAGGCCGCCCTCCTCGCGATGTACCAGTACGGGGTGCAGCTGCTCGCCCGGAAGAGGGCCGAGCCGGCGCAGGACTTCCTGTCCGTCATCGCCGCGGGTGAACTCCCCGAGGGCCACGGCGAGTCGCCGTTGCGGCCCTACGAGCGGGAGGTGTTCGTCAACCTGCTGACCCTGGCCGGGAGCGAGCCGACCCGCAACGTCATCGCCGTCGGTCTGCTCGCCCTGGCCGAGCACCCCGAGCAGTGGCAGGCCCTGCGCGCGGACCGCTCCCTGCTGGACGGCGCCGTCGAGGAGATGATGCGCTGGTCCACGCCGACGCCGTACAACCGGCGCACGGCCACCGAGGACTTCACGTTCCGGGACGTGCGGTTCCGGCGCGGCGACAAGGTGACCCTGTGGTGGTCGTCGGCCAACCGGGACGAGAGCGTCTTCCCCGACGCCATGTCCTTCGACGTGCGCCGCAACCCCAACCCGCACCTCGCCTTCGGCCGCGGCCCCCACGTCTGCCTCGCCGTGGACCTCGCCCGGCTCGAACTGCGCACCCTGTTCACCGCGCTCCTCGACCGGGTCGCCGAGGTGCGCCTGAGCGGGCCGGTGCCGTGGGCCGCCAACAGCAAGCACACGGTGGCGTTGGAGGTCCCCGTGGAGTTCGTCCGGGCCTGA", "orf_prot_sequence": "MSLEQPAVPTLRSAAEVGGEQLPAVLGGFDLSDQDRFTDGFPHEVFARLRKEAPVLRHPPGRTRDGEDFWVLSRYDDVVEAAEHPLLSSQGGGDREGGGTHLDDLPAGTYSGAMLNMMDDPRHRLLRDLVSPSVTGPVLEALGPLITERAEAIVSEVVERGSCDFQNDVAGRFSVEVMAALMGVPRADWPQFVDWTEVVMGYEDRASGESSSRSQAALLAMYQYGVQLLARKRAEPAQDFLSVIAAGELPEGHGESPLRPYEREVFVNLLTLAGSEPTRNVIAVGLLALAEHPEQWQALRADRSLLDGAVEEMMRWSTPTPYNRRTATEDFTFRDVRFRRGDKVTLWWSSANRDESVFPDAMSFDVRRNPNPHLAFGRGPHVCLAVDLARLELRTLFTALLDRVAEVRLSGPVPWAANSKHTVALEVPVEFVRA", "perc_identity": 33.33}, "gnl|BL_ORD_ID|2143|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10706, "orf_end": 12010, "orf_from": "BGC0000049.1|E-492_8 ", "model_name": "ANT(4')-Ib", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "2383", "ARO_accession": "3003905", "ARO_name": "ANT(4')-Ib", "ARO_category": {"36368": {"category_aro_accession": "3000229", "category_aro_cvterm_id": "36368", "category_aro_name": "ANT(4')", "category_aro_description": "A category of aminoglycoside O-nucleotidyltransferase enzymes with modification regiospecificity based at the 4'-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics by transfer of an AMP group from an ATP substrate to the 4-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "36996": {"category_aro_accession": "3000652", "category_aro_cvterm_id": "36996", "category_aro_name": "isepamicin", "category_aro_description": "A semi-synthetic derivative of gentamicin B (hydroxyamino propionyl genamicin B). It is modified to combat microbial inactivation and has a slightly larger spectrum of activity compared to other aminoglycosides, including Ser marcescens, Enterobacteria, and K pneumoniae.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.74518, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "36882", "query": "PEGHGE--SPLRPYEREVFVNLLTLAGSEPTR", "match": "P  HG   SPLR Y+ E F   L LA   PT+", "sequence_from_db": "PLTHGPYFSPLRLYDPEGFFQRLRLAAESPTK", "sequence_from_broadstreet": "MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF", "dna_sequence_from_broadstreet": "ATGAATATGAATGGACCTGCATCAATGGCGCAAAAAGAAAGACTTCAAACTTGCCAAGAAATTGCCAAGAGATTACACGAGGTTTATGGCAACGACGTTCTCGCCATTGGCGTCTACGGTTCTGTGTCCAGAGGCACAGATGGCCCTTTCTCAGATATTGAGATGTTTTGCGTACTCCGTGACTCGGCTGAAACGGTAGATAAAAGTTATGAATGGTCAGCTGGACCGTGGAAAGCGGAAGTTAACGTTTGCAGTGCGAGTATACTGTTAAAAGACGCTGCAACCGTTGAAGACCGATGGCCGCTGACACATGGGCCTTACTTCTCTCCGCTTCGTCTCTATGATCCTGAAGGCTTCTTTCAACGCTTGCGGCTCGCAGCGGAATCGCCGACAAAAGAAGATTTCCGCCAAGCTATTCATGAAATTCTTGTAGGGGAAATGTATGAATATGTTGGCAAGCTTCGAAATGTAAATCGAAATGGCCCTTCTACCTACTTGCCATCCTTGGCATTGCGCTTTGCCCACTATGGCGCAATGTTGATCGGCCTCCACAATCAGACACTCTTTTCTACGGGCGCTATGGTTTTGCCTGAAGCGCTGAAACTGCCGCATCGGCCAAAAGGGTTCGACCATGTTGCTGAGTTAGCGATGTCTGGAGACTTAGCACAACCAGCGAAGATCGTGTCAGCGTGCGAAGATTTCTGGAAAGGCCTAGTCGCGTGGGCAGCGGAGCATGATTACGTCATTCACTCAAAACGAATCCCGTTTTGA", "partial": "0", "query_start": 11453, "query_end": 11542, "hit_start": 300, "hit_end": 396, "orf_dna_sequence": "ATGTCGCTGGAGCAGCCCGCCGTTCCGACGTTACGCAGCGCCGCCGAGGTGGGCGGGGAGCAACTGCCCGCCGTGCTCGGCGGTTTCGACCTCAGCGACCAGGACCGTTTCACCGACGGCTTCCCGCACGAGGTGTTCGCCCGGCTGCGCAAGGAGGCACCCGTCCTGCGCCACCCGCCCGGACGGACCCGTGACGGCGAGGACTTCTGGGTCCTCTCCCGCTACGACGACGTGGTCGAGGCGGCGGAACACCCCCTGCTGTCCTCCCAGGGCGGCGGCGACCGCGAGGGCGGCGGCACCCACCTCGACGACCTGCCCGCCGGCACCTACTCCGGCGCGATGCTCAACATGATGGACGACCCGCGCCACCGCCTGCTGCGCGACCTGGTCAGCCCGTCCGTGACCGGGCCCGTGCTCGAGGCGCTGGGCCCGCTCATCACCGAGCGGGCCGAGGCGATCGTCTCCGAGGTCGTCGAGCGCGGCTCCTGCGACTTCCAGAACGACGTCGCCGGCCGCTTCTCCGTCGAGGTCATGGCCGCGTTGATGGGCGTACCGCGCGCCGACTGGCCGCAGTTCGTCGACTGGACCGAAGTGGTGATGGGGTACGAGGACCGTGCCTCCGGCGAGTCGTCCTCGCGCAGCCAGGCCGCCCTCCTCGCGATGTACCAGTACGGGGTGCAGCTGCTCGCCCGGAAGAGGGCCGAGCCGGCGCAGGACTTCCTGTCCGTCATCGCCGCGGGTGAACTCCCCGAGGGCCACGGCGAGTCGCCGTTGCGGCCCTACGAGCGGGAGGTGTTCGTCAACCTGCTGACCCTGGCCGGGAGCGAGCCGACCCGCAACGTCATCGCCGTCGGTCTGCTCGCCCTGGCCGAGCACCCCGAGCAGTGGCAGGCCCTGCGCGCGGACCGCTCCCTGCTGGACGGCGCCGTCGAGGAGATGATGCGCTGGTCCACGCCGACGCCGTACAACCGGCGCACGGCCACCGAGGACTTCACGTTCCGGGACGTGCGGTTCCGGCGCGGCGACAAGGTGACCCTGTGGTGGTCGTCGGCCAACCGGGACGAGAGCGTCTTCCCCGACGCCATGTCCTTCGACGTGCGCCGCAACCCCAACCCGCACCTCGCCTTCGGCCGCGGCCCCCACGTCTGCCTCGCCGTGGACCTCGCCCGGCTCGAACTGCGCACCCTGTTCACCGCGCTCCTCGACCGGGTCGCCGAGGTGCGCCTGAGCGGGCCGGTGCCGTGGGCCGCCAACAGCAAGCACACGGTGGCGTTGGAGGTCCCCGTGGAGTTCGTCCGGGCCTGA", "orf_prot_sequence": "MSLEQPAVPTLRSAAEVGGEQLPAVLGGFDLSDQDRFTDGFPHEVFARLRKEAPVLRHPPGRTRDGEDFWVLSRYDDVVEAAEHPLLSSQGGGDREGGGTHLDDLPAGTYSGAMLNMMDDPRHRLLRDLVSPSVTGPVLEALGPLITERAEAIVSEVVERGSCDFQNDVAGRFSVEVMAALMGVPRADWPQFVDWTEVVMGYEDRASGESSSRSQAALLAMYQYGVQLLARKRAEPAQDFLSVIAAGELPEGHGESPLRPYEREVFVNLLTLAGSEPTRNVIAVGLLALAEHPEQWQALRADRSLLDGAVEEMMRWSTPTPYNRRTATEDFTFRDVRFRRGDKVTLWWSSANRDESVFPDAMSFDVRRNPNPHLAFGRGPHVCLAVDLARLELRTLFTALLDRVAEVRLSGPVPWAANSKHTVALEVPVEFVRA", "perc_identity": 46.88}}, "BGC0000049.1|E-492_9 # 12329 # 25069 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.762": {"gnl|BL_ORD_ID|148|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12329, "orf_end": 25069, "orf_from": "BGC0000049.1|E-492_9 ", "model_name": "tsnR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "49", "ARO_accession": "3003060", "ARO_name": "tsnR", "ARO_category": {"39499": {"category_aro_accession": "3003065", "category_aro_cvterm_id": "39499", "category_aro_name": "non-erm 23S ribosomal RNA methyltransferase (A1067)", "category_aro_description": "Non-erm 23S ribosomal RNA methyltransferases modify adenosine 1067 to confer resistance to peptide antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "37030": {"category_aro_accession": "3000686", "category_aro_cvterm_id": "37030", "category_aro_name": "thiostrepton", "category_aro_description": "Thiostrepton is a cyclic peptide active against Gram-positive bacteria. It is produced by streptomyces bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.648574, "max_identities": 30, "bit_score": 32.3426, "cvterm_id": "41352", "query": "DLRARCDARGVRARLIAVDYASHSPHVTTVKDELDGLLAGIAPRAVPVELYSTVTGQRLDPRELTGAYWYTNLRQTVRFADAVGAA----LDAGIGTF", "match": "DL A C+ RG+R RL++   A+        K E    + GIA +  P   ++ +     D   L G     N+   VR   A+GAA    +D+G+GT ", "sequence_from_db": "DLLAACEKRGIRVRLLSAAVANQ-----VFKTEKKPKVFGIA-KVPPAGRFADLESLSGDVVLLDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTI", "sequence_from_broadstreet": "MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVPFPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVLLDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDEALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPMNPAAESLNVSVSAGIALHRRARRNLSRPRG", "dna_sequence_from_broadstreet": "GTGGCCAATCTTGACGTTATTGTCGACCGTTCCGACCCCGCGGTGCAGCGCATCGTCGATGTGACCAAGCATTCCCGGTCCGTCGTGCGAACGGTGCTGATCGAGGACATCGAGCCCCTGACGCAGAGCATCCGCGCCGGGGTCGAGTTCACCGAGGTCTACGGTCTCGACACCGTGCCGTTCCCGGGTGATCTGCTCGCCGCCTGCGAAAAGCGCGGAATTCGGGTGCGGCTGCTCTCCGCCGCGGTCGCGAATCAGGTTTTCAAGACCGAGAAGAAGCCCAAGGTCTTCGGTATCGCGAAGGTTCCGCCGGCCGGCCGTTTCGCCGACCTGGAGAGCCTTTCCGGCGATGTCGTCCTGCTCGACGGCGTGAAGATCGTCGGCAACATCGGCGCCATCGTGCGGACGCGTTCGGCGCTCGGCGCCGCCGGCATCGTCCTGGTCGACAGCGGCCTCGGCACCATCGCGGACCGCCGGCTCATCCGCGCCAGCCGCGGCTACGTGTTCTCCCTGCCGATCGTGCTCGCGACGCGCGACGAGGCGCTGGCCTTCTTCCGTGACGGCGGGATGCGGCCCGTGGTCTTCGAGGCGGACGGCAAGCTGTCCATCGGAGAGCTCGACGGCATCGACGAGCGGCTCGTGCTCGTGTTCGGCAGCGAGAAGACCGGCCCGTCGGGCGAGTTCGCCGGGGTCGCCACCGAGTCGGTGTCCATCCCGATGAACCCCGCCGCCGAGTCGCTCAACGTCTCGGTGTCGGCCGGCATCGCCCTGCACCGGCGGGCCCGCCGCAACCTCTCGCGCCCGCGCGGCTGA", "partial": "0", "query_start": 22586, "query_end": 22867, "hit_start": 189, "hit_end": 465, "orf_dna_sequence": "ATGGGTGACCGCATGGACACCGCCCCCGCGCAGGTGCCCGTGGCCGTCGTCGGCCTGGCCTGCCGGCTGCCGGGGGCGGCCGACCCGGCCGCGTTCTGGGCACTGCTGCGCGAGGGGCGCGACGCCCTGGGCGAACCCGGCCCCCGGCGCACCCACTCGGACGGGCCCGCCGCCCCCGTGCTCCCGTCCGGCGAACCGGTGCGCGCCGGCTTCCTCGACCAGGTCGACTCCTTCGACGCGCAGTTCTTCGGCATCTCCCCGGGCGAGGCGGCCGTCATGGACCCCCAGCAGCGCCTTGTGCTGGAGCTGGCCTGGGAGGCGTTCGAGGACGCCGGCATCGTCCCCGGTGACGGGGGCGGCACCGACGGCGGCACCGGCGTGTACGTCGGCGCCACGTACGACGACTACGCCACCCTGCGCGGCGACCGGCTCAGCCCGCACTCGGCCACGGGCCGCAACCGGGCGATGATCGCCAACCGGGTGTCCTACGCGCTCCGCCTGAGCGGGCCGAGCATGGTGGTGGACAGCGCCCAGTCCTCCGCCCTGGTGGCCGTGCACGTGGCGTGCCGGGCCCTGGCGGCGGGCGAGTGCTCCGTGGCCGTCGTCGGCGGCGTCAACCTGAACATCGTCCAGGAGGGGTACGACGTCACCCGTGCGCTGGGAGCCGTCTCCCCGGACGGGCGCTGCCACACCTTCGACGCACGGGCCAACGGGTTCGTCCGCGGTGAGGGCGGCGCGGTGCTGCTGCTCAAGCCGCTGGCGGCGGCACTGGCCGACGGGGACACCGTGCACGCGGTGATCCTCGGCAGCGCCGCCAACAACGACGGCGGCGGCGACTCGCTGACCGCCCCCCGCCAGGAGGCCCAGCAGGACGTGCTGCGCGCCGCCTGCGCCTCGGCGGGGGTGGCACCCCAGGACGTGGACTACGTCGAACTGCACGGCACCGGCACGCCCCTCGGCGACCCGGTGGAGGCGTCGGCGCTCGGCGCGGTGGCGCGGGGCGGACGGCCCCTGCGCGTCGGCTCGGTGAAGACGAACATCGGACACCTGGAGGGCGCGGCCGGGATCGCGGGCCTGCTCAAGACGATCCTGTGCCTGTCCCACCGCGAGCTGGTGCCCAGCCTCAACTTCCGTACCCCCAACCCCCGCATCCCGCTCGACGACCTCGGGCTGCGCGTGGTCACCGAGGCGGAGCCGTGGCCCGACACCGGGGGGACGCCGCTCGCCGGGGTCAGCTCGTTCGGCATGGGCGGGGCCAACTGCCACGTCGTGCTGTCCGCGGCGCCCGACGCCGGTCCCGCCCGCCGGCCGGAGCAGCCGCGGTACGACGGCCCCGTCCTGGTCCCCGTGTCGGCGCGCACGCCGGCCGCGCTCACCGCACTGGCCGACCGCCTGACCACGACCGACGCACCGTCCCCGCTGGACCTGGCGTACTCACTGGCCACCACCCGCAGCCCGCTGCCGCAGCGCGCGGTCCTCGTCGCCGACACCCCCGGCGACGTGCCCGGCCTGCTGCGGGCCCTGGCCGCGGGAGAACCCCACGCCCGCGTGGTCCGCGGCACGGCCGCGCCCGGACGGACGGTGTTCCTCTTCGCCGGCCAGGGCAACCAGCGACCGGGCATGGGCCACGAGATCCACCTCCGCCACCCCGTGTACGCCGCGGCCGTGGAGGAGATCGCCGAAGAGATGCGCGCGCACCTGCAACGGCCCCTGCTGGACGTGATGTCCGCCGAGGAGGGATCGCGGGACGCGGCGCTGCTCGACGAACCGGAGTACACCCAGCCCGCGTTGTTCGCCGTCCAGGTCGCGCTGTTCCGCCTCGTGGAGAGCTGGGGCGTGCGCCCCGACGCGGTGCTCGGCCACTCCTTCGGCGAACTGGCCGCGCTGCACGTGGCCGGGGCGATGTCCCTGCCCGACGCCTGCGCCCTCGTGGCCACCCGCGGCCGGCTGATGCAGCACGTGCCGCCCGGCGGTGCCTCGGTCCTGGTGGAGGCGTCCGAGGCCGAACTGACCCCGGACGTGCGGGCGTCCGGCGGTGCGGTGTCGATCGCGGCGCTCAACACCCCCACCGCCACCGTCCTGGCGGGCGACGAGGAAGCCACCCTGGAGATCGCGCGGAAGTGGGAGCGGTCAGGGAGGCGCACCCGCCGCCTCCGGATCCGGTTCGCCAGCCACTCGGCGCACATGGACCCCATCCTCGACGGAATGCGGCAGGCCGCGTCCCGGGTCCGCTGGCAGCGGCCCCGGCTGCGGGTCATCTCCTCGTTCACCGGCGCCGAGCTCGACCCGACCGGGCTCGACTGGCCGGAATTCTGGGCGCGGCACACCCGTGACACCGTGCGGTTCGCCGACGCCGTCAGGACGGCGTGCGCGGGCGGTGCTCGGACGTTCCTCGAACTCGGCCCCGACGGCACCCTGTGCGCCATGGGACCGGCCAACGCGCCGGACGACGTGGCCTTCGCCGCCGCGATGACCGGCGGTGACCGCCCCGACCTGAGGTCGCTGCTCACCGCCGTCGCCCGGGTGCACGCCCGTGGCGTCCCGGTCGACTGGACGCGCTTCCACGCCGGGACCGGCGCCCGCCGTGTGCCCCTGCCGACGTACCCCTTCCAGCGGCGCAGGCACTGGATCACCGGCGCGACCACCCCCGTCACGGCCGGGACGCCGCAGGCGGAGGCGCCGGCCTCGCCCCTGGCCGCGCTGCCCGCTGCCCAACGGGCCCAGGCGGTCCGTACGTTGGTGCGCACGGAGGTGGCCGCGGCACTGGAACTGGAGTCCGCCGAACAGCTGGACCTGCGCCGGCCGTTCAAGGAGCTGGGCTTCAGCTCGCTGATGACCGTCGAGCTGGGACACCGGCTCGCCGAGGCCACCGGGCTGCGGGTGCCCCCGACCGCGGTGCTGACCCACGCCACCCCCGCGCGGATGATCGAGCACCTCGACGCCGAGCTCGCCGCCGTCCCGTCGGACGCGCCGGACCCGGCGCGCGGAGCAGGCGGGGAGACGGGTGCCCCCGCGTCCGTCGTGGACCCGGGGGCGGGGGCGGGGGCGTCCGTCGCCGAACCGATCGCCATCGTCGGGATGGCCTGCCGCTACCCCGGCGGGATCGCCTGCCCGGACGACCTGTGGGACCTCGTCGCCGCGGGCGGCGACGCGATCGGCGCGTTCCCCACCGACCGGGGCTGGGACCTGGACCGCCTCTTCGACTCCGACCCGGACCGGCCCGGACGCACCTACGCCCGTTCCGGTGGCTTCCTGTACGACGCGGCGCGCTTCGACGCGGGGCTGTTCGGGATCTCCCCGCGCGAGGCGCTCGCGATGGACCCGCAGCAGCGGCTGCTGCTGGAGACCTCCTGGGAGGCCCTGGAACGGGCCGGAGTGGACCCGCTGTCCCTGCGGGACTCGGACACCGGCGTGTTCGCCGGGGTCATGGCCCAGGACTACGGCCCCCGGATGCACGAGGGCGCCGCGGGCGCCGACGGCTACGTCCTCACCGGCACCACGGCGAGCGTGGCCTCCGGCCGCATCGCCTACACCCTGGGCCTGCGGGGCCCCGCGGTCACGGTGGACACCGCCTGCTCGTCCTCCCTGGTGGCGCTGCACATGGCGGCGCAGGCCCTGCGCGCGGGGGAGTGCTCCCTGGCCCTCGCGGGCGGCGCGACGGTGATGGCCACCCCCGGCATCTTCGTGGAGTTCTCCCGGCAGCGCGGGCTGTCGCCGGACGGACGCTGCAAGTCGTTCGCGGCGGCGGCCGACGGCACGGGCTGGGCGGAAGGCGTCGGCCTGCTGGTGCTGGAGCGCCTCTCCGACGCCCGGCGCGCGGGGCACCGCGTCCTCGGCGTGCTGCGGGGATCGGCGGTCAACCAGGACGGGGCGTCCAACGGCCTGACCGCGCCCAGCGGACTCGCCCAGGAGCAGGTGATCCGTTCGGCGCTGGGCACGGCCGGGCTGTCCGCGGCGGACGTCGACCTGGTCGAGGCGCACGGCACCGGTACGGCGCTCGGCGACCCGATCGAGGCGCAGGCCCTGCTGGCCACCTACGGCTCCCGCCGTGCCGAGTCCCCCGTGTGGCTGGGCTCGCTGAAGTCGAACATCGGGCACACCCAGGCGGCGGCCGGCGTGGCCGGAGTGATCAAGGCCGTGCAGGCGATGCGGCACGGGGTGCTGCCGCGCACCCTGCACGTGGACGAGCCGTCCCCGCACGTGGACTGGGAGTCGGGCGCGGTGCGGCTGCTCACCGAGGACCGGCCCTGGCCGGACACCGGACGGCCGCGCCGGGCCGCCGTCTCCTCCTTCGGCATCAGCGGCACCAACGCCCACGTCGTGCTGGAGCAGGCACCCGCGTACGCCGAAGAGGCCGAAGGAGAGGCGCAGTTGCGCCCCGGCCCCGTGCCCGTGGTGCTGTCCGGGCACACCGGAGCCGCCCTGCGCGCCCAGGCGGAGCGGCTCGCCACCCACGTGGAGACCCACCCCGCCGCCACCGTCCGGCAGGTCGCACGCGCGGCCGCCGGCCGCGCCGCTCTCACCCACCGGGCCGTGGTCACCGCCGACGACCCCACCGATCTGGCGCGCCGGCTGCGCGCGCTGGCGACCGACCAGGACGACCCCGGCCTCGTGCACGGACAGGCCGATGTCGACCCCCGCACGGTGTTCGTGTTCCCGGGTCAGGGGGCGCAGTGGGCGGGGATGGCGGTGGAACTGCTGGATGCGTCGCCGGTGTTCGCGGCGCGCATGGCGGAGTGTGCGGCGGCGTTGGGGGAGTTCACGGACTGGTCGTTGCTGGACGTGGTGCGGGGGGAGGGTGGTGCCGCGTCGCTGGAGCGGGTGGATGTGGTGCAGCCGGTGTCGTGGGCGGTGATGGTGTCGTTGGCGGCGTTGTGGCGGTCGTTCGGGGTGGAGCCGGACGCGGTGGTGGGTCATTCGCAGGGGGAGATCGCGGCCGCGTGCGTGGCGGGCGCGCTGTCCCTGCGCGACGCCGCCAAGGTGAGCGCCCTGCGCAGCGCCGCCCTGCGTGACCTGGCGGGCACCGGCGGCATGATGTCCGTGGCCCTCCCCGCCGCCGAGGTGGAACGGCGTCTCGCGGGCCGGGACGGCCGGGTGTCCGTGGCGGCCGTCAACGGACCCGCCGCGGTGGTCCTGGCGGGCGACCCCGCCGCCCTGGAGGGCCTGGCCGCCGAACTGACCGCCGACGGCGTGTGGGCCCGCCTCGTCGCGGTCGACTACGCCTCCCACTCCCCGCAGGTGGAACGGATCCGCACCACCCTCCTGGACCGCCTCGCCGGCCTCGAACCGCGCACCGCCGACATCCCCTTCTACTCCACCGTCACGGGCGAACCGATCGACACGGCCGCCCTGGACGCGGAGTACTGGTACCGCAACCTGCGGCACACCGTCCGCTTCGAGGAGGCCGTCCGCGCCCTGGACGGCGCCGGGCACCGGGCCTACGTCGAGGTCAGCCCGCACCCCCTCCTCACCGCCGCGGTGCAGGACACCGTGGAGTCGACGGGCAGCACCGCCGTGGTCGTCGGCACGCTGCGCCGCGACCAGGGCGGCCCCGACCGCTTCCTGCGGTCCCTGGCCGAGGCGTACGTACGCGGCGTACCCGTCGACTGGACCCCCGCGACCGGCACCGGCGGACCACGGCCCGACCTGCCCGCCTACGCCTTCCAGCGGCAGCACTACTGGCTGCCCGCCCCGGTCGGCGCGGCCGACCCGGCGGTGCTCGGCCTGGACCCCGCCACGCACCCGCTGCTGGGCGCCGCCGCCACCGTGGCCACCACCGGGGAGGTGCTCCTGACCGGGGAGCTGTCCCGGCAGCGCCAGCCCTGGCTGGCCGACCACGGCGTGCACGGCACGGTGGTCCTGCCGGGTGCCGCGTTCGTCGAACTCGCCGTGCACGCCGGGGACGAGACGGGCTGCACGGAACTGGAGGAGCTGACGGTCCACCGCCCCCTGCCGCTGCCCGAACGCGGCGGCGTGCGGGTGCAGACCGTCGTGGGCGCCCCCGACGACGACGGCGGCCGCACCGTGGACGTGTACGCGCGCACCACCGACCGACCGGACTGGACGCACCACGCCACCGGCCGGCTCGGCACGGCGCGGACGCCCGCGCCGGACACCGTCGACGGGCCGCCGACCGGGACCGCATCGGCCGAACCGGCCTTCCGCTACCGGGAGTTGGCGGGCCTCGGCTACGAGTACGGACCGGCCTTCCAGGGCCTGCGCCGGTGGTGGCGCAGCGGTGAGGACGTGTGGGCCGAGGCCGAGCTGCCGGAACCGGCCGCCGCCGACGCCGGGGCGTTCGGACTGCACCCGGCGCTGCTGGACGCCGCGCTGCACGCGGCCCTCCCCTCCGGGGAAGCGGCCGGCCCGGACGCGGCGACCGTGCTGCCGTTCTCGTTCAGCGGGGTCCGCCTGTACCGGTCCGGCGCCGACGCCGTGCGGGTCCGCCTGCGGCCCGCGGCCGGCGGCGCGGTGTCCGTGACCCTCACCGACGCCGCCGGCCGGACCGTCCTGGTCATCGACGCGCTGACCCTGCGCCCGGTACCGGCCGGACAGCTCACGGCGGACCGCCCCGACCACCTGTACCGCACCGCGTGGACACCCCTCGAGACGCCCGCCCCCGAAGTGGCCTGGTCCCAGCACGCCGACCTGGACGAGCTGGGCGACCACGTGCCCGCCGCGGTCGGCGTGCCGGTGACCTCGGCGACCGCGGCCCTGACACTCGCGCAACGCTGGCTGGCCGACGAACGGTTCGCCGCGTCCCGGCTCGTCCTCCTCACCCGAGGGGCCGTCGGCACGGCCGCGGACACCCCGCCGCCGGACCCCGCCACGGCGGCGGTCTGGGGTCTGATCCGCACCGCGCAGACGGAGCACCCGGACCGGTTCGTGCTGGTGGACACCGACGACCGCCCTGCCTCGACCGCCCTGTTGCCGCGTCTGGCCGGCACCGGCGAGCCCCAACTCGCCCTGCGCGACGGCCGCGTCCTGGTGCCGCGGCTGACCCCGGTGACCGACGACCCGGGAGTGAGCCCCTGGACGGCCACCGGCACCGTGCTGATCACCGGCGCGACCGGCACCCTGGGACGCCTGGTGGCACGGCACCTGGTCGACCGCCACGGGGTGAGGGACCTGGTGCTGGCTTCCCGCAGCGGCCAGGACGCGCCCGGGACCGCCGCCTTCACGGACGACCTGCGGGCGCTGGGCGTCCGGGTGACGGTCGTCGCCTGTGACGTGGCGGAGCGGGACGAGGTGGCCGCTCTGCTGGCCGCCCACCCCGTGACGGCCGTCGTCCACGCCGCGGGGGTCCTCGACGACGCCGTCCTGACCGCCCTCACCCCCGAGCGCGTGACCGACGTGTGCCGCGCCAAGGTCGACGGCGCACGCCACCTCGACGAACTGACCGGCCCCGGCTTGACCGCCTTCGTGCTCTTCTCGTCCGTGGCCGGGACGCTCGGCAACGCCGGGCAGGCCGCCTACGCCGCCGCCAACGCCGCGCTGGACGCGCTGGCCGAGCGCCGCCGGGCCGCCGGGCTCCCGGCCACCTCCATCGCCTGGGGGCTGTGGGCCGAGAGCAGCCGCATGACCGGCCACATGGACGACACCGACCGGGCCAGGCTCGCGCGGGCCGGCGTGCTGCCCCTGGACACCGACACGGGCCTGACCGCCTTCGACGTGGCCACCGCGCGCGACGTCCCGGCCGTGCTGGCCGCCCCCCTCGACCGGGAGGCGCTCCGGGCCCGGGCGTCCGAGGGCACCCTCCCCCCGCTGCTGTCCTCCCTGGTGCCGGTGGTGCGCCGGGCGGCCGCCGCGGACGGCCCGGCGGACGCCGCCGACGCCCTGCGCCGCAGGCTCGCCGAGCAGGACCCCCTCCGCGTCCTGCAGGACGTCGTCCTGACCCAGGCGGCCGTGGTCCTCGGCCACCCCGACCCCGCCGCGCTCGGCCCGGACCGGCCGTTCAAGGAGATCGGCTTCGACTCGCTGACCTCCGTGGAACTGCGCAACCGGCTCAGCCGGATCACCGGCACCCGGCTGCCCGCCACCGTCGTGTTCGACCACCCGACCCCGGCCGGGCTCGCCGCCCACCTGCGCGGCGAACTGGCCGGCGACACCCCCCCGGCCGCCGTCGTACCGGCCGCCACGGCCGCCGCCGACGAACCGGTCGCGATCGTCGGCATGGCGTGCCGCTTCCCGGGCGGCGTGGCCTCGCCGGAGGACTTGTGGCACCTCGTGTCCACGGGCGGCGACGCCATCGGCGGCTTCCCCACCGACCGGGGCTGGGACGTCGCCGGTCTGTACGACCCCGACCCGGACCGAGCCGGCCACTCGACCACGCGGTACGGCGGATTCCTGTACGACGCCGGGCAGTTCGACGCGTCCCTGTTCGGCATCTCCCCGCGCGAGGCACTGGCGATGGACCCCCAGCAGAGGCTGCTCCTGGAGACGGCCTGGGAGACGCTGGAACGGGCCGGCCTGGACCCGGCTTCGCTGCGCGGCAGCCGGACCGGCGTGTTCACCGGCGTCATGTACCACGACTACGCCTCCGCGCTCGCCGACGTCCCCGACGAGGTCGAGGGGCACCTGCTCACCGGCACCGCCGCCAGCGTCGCCTCCGGCCGCGTCTCCTACGCCCTCGGGCTGGAGGGCCCCGCGGTCACCGTGGACACCGCCTGCTCCTCCTCCCTGGTCGCCGTCCACCTGGCGGCCCAGGCCCTGCGCGCGGGGGAGTGCACGCTGGCACTCGCCGGCGGGGTGACGGTCATGGCCCGGCCCACCACCTTCACCGCCTTCTCCCGGCAGCGCGGACTGTCACCGGACGGACGGTGCAAGGCGTACGCCGGGGCCGCCGACGGAACCGGCTGGTCCGAGGGCGTCGGCCTGCTCCTGCTCGAACCGCTGTCCGCCGCCCGCCGCAACGGCCACCGCGTCCTCGCCGTCGTCCGCGGCTCCGCCGTCAACCAGGACGGAGCCTCCCACGGGCTCACCGCGCCCAACGGCCCCTCCCAGGAACGCGTCATCCGCGCCGCGCTCGCCGCCGCCGGACTGTCCCCGCACGAGGTCGACGCGGTCGAGGGCCACGGCACCGGCACCCCCCTGGGCGACCCCATCGAGGCACAGGCGCTCCTCGCCACCTACGGCCAGGAACGGGCCGGCGACCCCCTGTGGCTCGGCTCCGTCAAGTCCAACATCGGGCACGCACAAGCCGCCTCGGGCGTCGCCGGACTGATCAAGACGGTCCAGGCCATGCGGCACGGCGTACTGCCCCGCACCCTGCACGTCGACGAGCCGTCCCCGCACGTGGACTGGGAGTCGGGTGCGGTACGGCTGCTCACCGAGGACCGGCCCTGGCCGGACACCGGCCGGCCCCGGCGGGCAGGCGTGTCCTCCTTCGGCATCAGCGGCACCAACGCGCACATCGTCGTGGAGCAGCCCGACGGCAGCGAAGCGGCCCCACCGGAACCGGAGCACGCCCAGCCGCTGCGGCCCGTCCCGGTGGCCCTGTCCGGACACACCGAGGACGCCCTGCGCGCACAGGCCGCACGGCTCGCCGCGCACCTGACCACGCACCCCGACACCCCGCTGCGCGACATCGCCTTCACCGCCGCGTCCGGCCGGGCCGCCCTCGACCACCGCGCCGTCGTCCTCGCCGACGACCCGGAGCAGCTCGGCGAACGGCTGACCGCGCTGGCCGAGGGCCGCGACGTGCCCGACGTCGTCCGGGGCACCGCGGCCCCCAACGCCCGGCGGGTGGCGTTCGTCTTCCCCGGCCAGGGCTCCCAGTGGGCCGGGATGGCCCTGGAACTGCTCGACGCGGCACCGGTGTTCGCCGCCCGGCTCACCGAGTGCGCCGCGGCCGTCGAGGCCCACGCGGACTGGTCGGTGCTGGACGTCCTGCGACAGGTACCCGGCGCACCGGGACTGGACCGGGTGGACGTCGTCCAGCCCGTCACCTTCGCCGTCACCGTGTCGCTGGCGGCGCTGTGGCAGGCCCACGGCGTACGACCCGACGCGGTGATCGGCCACTCGCAGGGGGAGATCGCCGCCGCCTGCGTGGCCGGGGCCCTGTCCCTGGCCGACGCCGCCGCGGTGGTGTGCCTGCGCAGCCGCGCACTGACCCGGCTGTCGGGCAAGGGCGGCATGATGTCCGTGGCGCTGCCCGCCTCCGAGGTGCGGGAACTCTTCACCGACGACCGGCTGCACGTGGCCGCGGTCAACGGCCCCGCCTCCACCGTGGTCTCCGGCGACCCGTCCGCCCTGGAGGACCTGCGCGCCCGGTGCGACGCGCGCGGCGTCCGCGCCCGGCTGATCGCCGTCGACTACGCCTCCCACTCACCGCACGTCACCACCGTCAAGGACGAACTCGACGGCCTGCTCGCCGGCATCGCCCCGCGGGCCGTACCCGTCGAGCTGTACTCCACCGTCACCGGACAACGCCTGGACCCGCGCGAACTCACCGGCGCGTACTGGTACACCAACCTGCGGCAGACCGTCCGGTTCGCCGACGCCGTGGGGGCCGCCCTCGACGCCGGGATCGGCACCTTCCTGGAGGTGAGCCCCCACCCGGTGGTGGCACCGGGCGTGCAGGAGACGGTGGACGCCGCCGGAGCACGTGCCGTCGTCCTGTCCACCCTCCGCCGTGACGACGGCGGCCGGCCCCGGTTCACCCGGTCGCTGGCCGAGGCCCACGTGCGCGGGGTCGGCGTCCACCTGCCCGAGGTGTTCGCCGGCACCGGGGCACGGACCGTCGACCTGCCGACCTACGCCTTCCAGCACCAGTGGTACTGGCTCGCCGACCAGGCCGCCTCCCGGTCCCTCGGCTGGCGCTACCGCGTCGAGTGGCGCCCCGCCCGCCCGAACGGGCGCACGGAACCGGACGCCACATGGCTGGCCCTGGTGCCCGCCGGCTGCGACGAGGAGTGGCTGGAGCGGCTCACCGGAACACTCCCGGTCCGCGTCCTGCCCGTGGACGCCGAGCATGCCGACCGCGCCGCGCTCGGCGAACACCTGCGCCGCGCGCTGGCCGAGCACACCCCGCGGGGCCTGCTGTCCCTGCTGAGCGCCGACCGCCGGCCGCACCCCCGGCACCCGGCCGTGCCCGCGGGCGTGGCCGCCACCCTCGCCCTGGTGCAGGCGCTCGGCGACCTGACGGCGACCCTGCCCCTGTGGCTGGTCACCGCCGGCGCGGTGGGCACCGGGGACACCGACCCGCCCCACGACCCGGACGCCGCACAGGTCTGGGGCCTCGGCCGGGTCGCCATGCTGGAGTACCCCACCTTCTGGGGCGGCCTCGTCGACCTGCCCGCCCGCCCCGACGCGGACGCACTGGAAGAGCTGCGTACGATCATGGCCGGCGGCTTCGGGGACGAGGACCAACTCGCGGTACGGGCGTCCGGCACCCTCCTGCGACGCCTGGTCCGCGCCCCCTTGGACGGCACCCCGGCCGTCGGCTGGCAGGCCCGCGACACCGCCGTCGTGACCGGCGGCACCGGGGCGCTCGGCCCGGAAGCCGCCCGCTGGCTGGCCGGACTCGGCGCCGCGCACGTGGTGCTGGTCAGCCGCAGCGGTCCCGAGGCCGAGGGGGTCGCCGAGCTGACGAGCGAACTCGACGCCCGCGGCGTACGGCTGACCGCGCACGCCTGCGACGTCGCCGACCGCGCTGCCGTGGCAGCCCTCCTGACCGGACTGCGCGACCAGGGCGAGAAGGTACGCACCGTGCTGCACGCCGCCGCCCTGATGCGGCTGGCCGCACTGCCCGACACCGACCTCGCCGAGTACGCCGCCGTGCTCGACGCCAAGGTCCAGGGCGCCCGCCACCTCGTCGACCTCCTCGACCGGGACGAACTGGACGCCCTCGTCTTCTACTCCTCGATCGCCGGTGTCTGGGGCAGCGGGGACCACGGCGCCTACGCCGCGGCCAACGCCACCCTGGACGCGCTGGCCGAACAGGCCCGGGCCGACGGCCTGCCCGTCACCTCGGTGGCCTGGGGCGTGTGGGACGGGGCCCGCTTCCCCGAGGGCGTCGACGCCGGACAACTACGGCGCCAAGGACTGCCGTTGATCCACCCGGAATCCGCCCTCGAAGGACTGCGCGTCGTCCTGGAACGCGGCGAGAGCGGCCTGTCGATGGCCGACGTCGACTGGGCGGCGTTCATGCCGCTGTTCGCCTCGGCGCGCAGCCGGCCCCTGTTCGCCGAGATCCCGGAGGCCCGGCGCGCACTGGAGGGCGACGAGCCCACCGGGGCGCCGCCCACCGACGTCACCTGGGCGCAACGCCTGGCCGCTCTGCCGGAGGCCGAACGCCGCGCCGCCCTGCTCACCCTGGTCCGCGAACAGGCCGCCGTCGTCCTCGGCCTGTCCGACCCCGCGCAGATCGGCGACGAACGGCCCTTCCGCGACCTGGGCTACGACTCGCTGACCGGCATCGAACTGCGCAACCGGCTCGGCACCGTCACCGGGCTCACCCTGCCCGCCACGCTGGTGTTCGACCACCCCACCCCGGCCGCGGTGGCCGACCGCCTCGACACCTCGCTGGCCCCTGCCGAACCACCGCTCCTCGCCGAGCTGGACCGGCTCGCCGAACGGCTGGGCCGCACCGACGACGAGGACGAACGCACCACCGTCGCGCAGCGGCTGCGCGCCATGTTGTCGCTGGTCGACGGCGACCTGGACGAGGACGACGACTTCGACCCGGTGTCGAACGAGGAGATGTACGACCTCATCGACCGAGAGCTCGGGACGAGCTGA", "orf_prot_sequence": "MGDRMDTAPAQVPVAVVGLACRLPGAADPAAFWALLREGRDALGEPGPRRTHSDGPAAPVLPSGEPVRAGFLDQVDSFDAQFFGISPGEAAVMDPQQRLVLELAWEAFEDAGIVPGDGGGTDGGTGVYVGATYDDYATLRGDRLSPHSATGRNRAMIANRVSYALRLSGPSMVVDSAQSSALVAVHVACRALAAGECSVAVVGGVNLNIVQEGYDVTRALGAVSPDGRCHTFDARANGFVRGEGGAVLLLKPLAAALADGDTVHAVILGSAANNDGGGDSLTAPRQEAQQDVLRAACASAGVAPQDVDYVELHGTGTPLGDPVEASALGAVARGGRPLRVGSVKTNIGHLEGAAGIAGLLKTILCLSHRELVPSLNFRTPNPRIPLDDLGLRVVTEAEPWPDTGGTPLAGVSSFGMGGANCHVVLSAAPDAGPARRPEQPRYDGPVLVPVSARTPAALTALADRLTTTDAPSPLDLAYSLATTRSPLPQRAVLVADTPGDVPGLLRALAAGEPHARVVRGTAAPGRTVFLFAGQGNQRPGMGHEIHLRHPVYAAAVEEIAEEMRAHLQRPLLDVMSAEEGSRDAALLDEPEYTQPALFAVQVALFRLVESWGVRPDAVLGHSFGELAALHVAGAMSLPDACALVATRGRLMQHVPPGGASVLVEASEAELTPDVRASGGAVSIAALNTPTATVLAGDEEATLEIARKWERSGRRTRRLRIRFASHSAHMDPILDGMRQAASRVRWQRPRLRVISSFTGAELDPTGLDWPEFWARHTRDTVRFADAVRTACAGGARTFLELGPDGTLCAMGPANAPDDVAFAAAMTGGDRPDLRSLLTAVARVHARGVPVDWTRFHAGTGARRVPLPTYPFQRRRHWITGATTPVTAGTPQAEAPASPLAALPAAQRAQAVRTLVRTEVAAALELESAEQLDLRRPFKELGFSSLMTVELGHRLAEATGLRVPPTAVLTHATPARMIEHLDAELAAVPSDAPDPARGAGGETGAPASVVDPGAGAGASVAEPIAIVGMACRYPGGIACPDDLWDLVAAGGDAIGAFPTDRGWDLDRLFDSDPDRPGRTYARSGGFLYDAARFDAGLFGISPREALAMDPQQRLLLETSWEALERAGVDPLSLRDSDTGVFAGVMAQDYGPRMHEGAAGADGYVLTGTTASVASGRIAYTLGLRGPAVTVDTACSSSLVALHMAAQALRAGECSLALAGGATVMATPGIFVEFSRQRGLSPDGRCKSFAAAADGTGWAEGVGLLVLERLSDARRAGHRVLGVLRGSAVNQDGASNGLTAPSGLAQEQVIRSALGTAGLSAADVDLVEAHGTGTALGDPIEAQALLATYGSRRAESPVWLGSLKSNIGHTQAAAGVAGVIKAVQAMRHGVLPRTLHVDEPSPHVDWESGAVRLLTEDRPWPDTGRPRRAAVSSFGISGTNAHVVLEQAPAYAEEAEGEAQLRPGPVPVVLSGHTGAALRAQAERLATHVETHPAATVRQVARAAAGRAALTHRAVVTADDPTDLARRLRALATDQDDPGLVHGQADVDPRTVFVFPGQGAQWAGMAVELLDASPVFAARMAECAAALGEFTDWSLLDVVRGEGGAASLERVDVVQPVSWAVMVSLAALWRSFGVEPDAVVGHSQGEIAAACVAGALSLRDAAKVSALRSAALRDLAGTGGMMSVALPAAEVERRLAGRDGRVSVAAVNGPAAVVLAGDPAALEGLAAELTADGVWARLVAVDYASHSPQVERIRTTLLDRLAGLEPRTADIPFYSTVTGEPIDTAALDAEYWYRNLRHTVRFEEAVRALDGAGHRAYVEVSPHPLLTAAVQDTVESTGSTAVVVGTLRRDQGGPDRFLRSLAEAYVRGVPVDWTPATGTGGPRPDLPAYAFQRQHYWLPAPVGAADPAVLGLDPATHPLLGAAATVATTGEVLLTGELSRQRQPWLADHGVHGTVVLPGAAFVELAVHAGDETGCTELEELTVHRPLPLPERGGVRVQTVVGAPDDDGGRTVDVYARTTDRPDWTHHATGRLGTARTPAPDTVDGPPTGTASAEPAFRYRELAGLGYEYGPAFQGLRRWWRSGEDVWAEAELPEPAAADAGAFGLHPALLDAALHAALPSGEAAGPDAATVLPFSFSGVRLYRSGADAVRVRLRPAAGGAVSVTLTDAAGRTVLVIDALTLRPVPAGQLTADRPDHLYRTAWTPLETPAPEVAWSQHADLDELGDHVPAAVGVPVTSATAALTLAQRWLADERFAASRLVLLTRGAVGTAADTPPPDPATAAVWGLIRTAQTEHPDRFVLVDTDDRPASTALLPRLAGTGEPQLALRDGRVLVPRLTPVTDDPGVSPWTATGTVLITGATGTLGRLVARHLVDRHGVRDLVLASRSGQDAPGTAAFTDDLRALGVRVTVVACDVAERDEVAALLAAHPVTAVVHAAGVLDDAVLTALTPERVTDVCRAKVDGARHLDELTGPGLTAFVLFSSVAGTLGNAGQAAYAAANAALDALAERRRAAGLPATSIAWGLWAESSRMTGHMDDTDRARLARAGVLPLDTDTGLTAFDVATARDVPAVLAAPLDREALRARASEGTLPPLLSSLVPVVRRAAAADGPADAADALRRRLAEQDPLRVLQDVVLTQAAVVLGHPDPAALGPDRPFKEIGFDSLTSVELRNRLSRITGTRLPATVVFDHPTPAGLAAHLRGELAGDTPPAAVVPAATAAADEPVAIVGMACRFPGGVASPEDLWHLVSTGGDAIGGFPTDRGWDVAGLYDPDPDRAGHSTTRYGGFLYDAGQFDASLFGISPREALAMDPQQRLLLETAWETLERAGLDPASLRGSRTGVFTGVMYHDYASALADVPDEVEGHLLTGTAASVASGRVSYALGLEGPAVTVDTACSSSLVAVHLAAQALRAGECTLALAGGVTVMARPTTFTAFSRQRGLSPDGRCKAYAGAADGTGWSEGVGLLLLEPLSAARRNGHRVLAVVRGSAVNQDGASHGLTAPNGPSQERVIRAALAAAGLSPHEVDAVEGHGTGTPLGDPIEAQALLATYGQERAGDPLWLGSVKSNIGHAQAASGVAGLIKTVQAMRHGVLPRTLHVDEPSPHVDWESGAVRLLTEDRPWPDTGRPRRAGVSSFGISGTNAHIVVEQPDGSEAAPPEPEHAQPLRPVPVALSGHTEDALRAQAARLAAHLTTHPDTPLRDIAFTAASGRAALDHRAVVLADDPEQLGERLTALAEGRDVPDVVRGTAAPNARRVAFVFPGQGSQWAGMALELLDAAPVFAARLTECAAAVEAHADWSVLDVLRQVPGAPGLDRVDVVQPVTFAVTVSLAALWQAHGVRPDAVIGHSQGEIAAACVAGALSLADAAAVVCLRSRALTRLSGKGGMMSVALPASEVRELFTDDRLHVAAVNGPASTVVSGDPSALEDLRARCDARGVRARLIAVDYASHSPHVTTVKDELDGLLAGIAPRAVPVELYSTVTGQRLDPRELTGAYWYTNLRQTVRFADAVGAALDAGIGTFLEVSPHPVVAPGVQETVDAAGARAVVLSTLRRDDGGRPRFTRSLAEAHVRGVGVHLPEVFAGTGARTVDLPTYAFQHQWYWLADQAASRSLGWRYRVEWRPARPNGRTEPDATWLALVPAGCDEEWLERLTGTLPVRVLPVDAEHADRAALGEHLRRALAEHTPRGLLSLLSADRRPHPRHPAVPAGVAATLALVQALGDLTATLPLWLVTAGAVGTGDTDPPHDPDAAQVWGLGRVAMLEYPTFWGGLVDLPARPDADALEELRTIMAGGFGDEDQLAVRASGTLLRRLVRAPLDGTPAVGWQARDTAVVTGGTGALGPEAARWLAGLGAAHVVLVSRSGPEAEGVAELTSELDARGVRLTAHACDVADRAAVAALLTGLRDQGEKVRTVLHAAALMRLAALPDTDLAEYAAVLDAKVQGARHLVDLLDRDELDALVFYSSIAGVWGSGDHGAYAAANATLDALAEQARADGLPVTSVAWGVWDGARFPEGVDAGQLRRQGLPLIHPESALEGLRVVLERGESGLSMADVDWAAFMPLFASARSRPLFAEIPEARRALEGDEPTGAPPTDVTWAQRLAALPEAERRAALLTLVREQAAVVLGLSDPAQIGDERPFRDLGYDSLTGIELRNRLGTVTGLTLPATLVFDHPTPAAVADRLDTSLAPAEPPLLAELDRLAERLGRTDDEDERTTVAQRLRAMLSLVDGDLDEDDDFDPVSNEEMYDLIDRELGTS", "perc_identity": 30.61}, "gnl|BL_ORD_ID|2698|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12329, "orf_end": 25069, "orf_from": "BGC0000049.1|E-492_9 ", "model_name": "tet(52)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3289", "ARO_accession": "3004587", "ARO_name": "tet(52)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.88553, "max_identities": 27, "bit_score": 31.187, "cvterm_id": "36791", "query": "GTGALGPEAARWLAGLGAAHVVLVSRSGPEAEGVAELTSELDARGVRLTAHACDVADRAAVAALLTGLRDQGEKVRTV", "match": "G G  GP A  WL   G +  VLV RS    +G       LD RGV     A D+  R  +   +  +R Q E  R V", "sequence_from_db": "GAGIAGPAACYWLRRFGFSP-VLVERSASLRKG----GHALDVRGV-----AIDLVKRMGIYQKIYNMRTQLEFGRHV", "sequence_from_broadstreet": "MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH", "dna_sequence_from_broadstreet": "ATGTCTAATGTGAATAAAATTCTCGTCATCGGGGCTGGCATTGCTGGCCCCGCGGCTTGTTATTGGTTAAGAAGATTCGGATTTTCTCCCGTCCTCGTAGAAAGATCTGCCAGTTTACGAAAAGGCGGTCATGCACTGGACGTTCGAGGTGTTGCAATAGACCTCGTCAAAAGAATGGGTATTTATCAGAAAATATATAATATGCGCACTCAGCTGGAGTTTGGGCGGCATGTTGACCCCGAAGGGAATACGCTTCATGAAGAGAAGGGCGAAAGATTTGGCTTTAGGGAAGGTCAAGATGTTGAAATTATCCGCAGTGATTTGGTCGAGATATTGATAGATTCCATTGAAGGCGTCCCCCTTCAGTTCAATCAAACGATTGAGAGCGTTAAACAGACTGATGCTGTTGTCGAAGTTCAATTTAAAGATGGCAGAACCGAACACTTCGATTTGGTTATCGGGGCTGACGGCTTGCACTCAACAACAAGACGTATCGTATTTGATAAACATGAATATAAATTAAATGACCTTGGTGCTTACTTTAGTGTTTTCAGTATTCCAAATTATCTAAATTTGAATAACACCGAAGTTCAGTGCGAAGCTAATCAAAAACTGTTATCTATAACGAGCGACAAGAACCGCAAGATGGCTGAGGTCGCATTCTCATTTCGTGGCCAGAATGTTTTGAATAATGTTCGTGATGAAAGCGAGCAACGGCGAGTCCTACGCGACACTTTTCAAGACTTTGGCTGGGAAGCACCAAGAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTCTGATTCATTCACTCAGGTAATAATGAAATCATGGACTAAAGGTCGAGTTGCATTATTGGGAGATGCTGCGTACAGCGCGTCGCCAATATCGGGGCAAGGTAATAATCTGGCCCTGGTCGGCGCTTATGTTTTGGCAGGAGAACTAAAACAGGCAGGCGGCAATTATAAGCGGGCATTTGATCGTTATAATGAAATATTACGTCCATTTATTGAAGCTAATCAAAAATTGGGAGTCTTGGTTAACGAATCGTTTCTTGTTCGCGATGAAGTCTCTAAAGAGGTTGCGGAAGAACGGTCAAATAATATTATGGAACAGGTAAAAATCGCATCGAACATGATTGTGTTGCAGGATTACGCCAATCCGCACTGA", "partial": "0", "query_start": 23807, "query_end": 24040, "hit_start": 30, "hit_end": 234, "orf_dna_sequence": "ATGGGTGACCGCATGGACACCGCCCCCGCGCAGGTGCCCGTGGCCGTCGTCGGCCTGGCCTGCCGGCTGCCGGGGGCGGCCGACCCGGCCGCGTTCTGGGCACTGCTGCGCGAGGGGCGCGACGCCCTGGGCGAACCCGGCCCCCGGCGCACCCACTCGGACGGGCCCGCCGCCCCCGTGCTCCCGTCCGGCGAACCGGTGCGCGCCGGCTTCCTCGACCAGGTCGACTCCTTCGACGCGCAGTTCTTCGGCATCTCCCCGGGCGAGGCGGCCGTCATGGACCCCCAGCAGCGCCTTGTGCTGGAGCTGGCCTGGGAGGCGTTCGAGGACGCCGGCATCGTCCCCGGTGACGGGGGCGGCACCGACGGCGGCACCGGCGTGTACGTCGGCGCCACGTACGACGACTACGCCACCCTGCGCGGCGACCGGCTCAGCCCGCACTCGGCCACGGGCCGCAACCGGGCGATGATCGCCAACCGGGTGTCCTACGCGCTCCGCCTGAGCGGGCCGAGCATGGTGGTGGACAGCGCCCAGTCCTCCGCCCTGGTGGCCGTGCACGTGGCGTGCCGGGCCCTGGCGGCGGGCGAGTGCTCCGTGGCCGTCGTCGGCGGCGTCAACCTGAACATCGTCCAGGAGGGGTACGACGTCACCCGTGCGCTGGGAGCCGTCTCCCCGGACGGGCGCTGCCACACCTTCGACGCACGGGCCAACGGGTTCGTCCGCGGTGAGGGCGGCGCGGTGCTGCTGCTCAAGCCGCTGGCGGCGGCACTGGCCGACGGGGACACCGTGCACGCGGTGATCCTCGGCAGCGCCGCCAACAACGACGGCGGCGGCGACTCGCTGACCGCCCCCCGCCAGGAGGCCCAGCAGGACGTGCTGCGCGCCGCCTGCGCCTCGGCGGGGGTGGCACCCCAGGACGTGGACTACGTCGAACTGCACGGCACCGGCACGCCCCTCGGCGACCCGGTGGAGGCGTCGGCGCTCGGCGCGGTGGCGCGGGGCGGACGGCCCCTGCGCGTCGGCTCGGTGAAGACGAACATCGGACACCTGGAGGGCGCGGCCGGGATCGCGGGCCTGCTCAAGACGATCCTGTGCCTGTCCCACCGCGAGCTGGTGCCCAGCCTCAACTTCCGTACCCCCAACCCCCGCATCCCGCTCGACGACCTCGGGCTGCGCGTGGTCACCGAGGCGGAGCCGTGGCCCGACACCGGGGGGACGCCGCTCGCCGGGGTCAGCTCGTTCGGCATGGGCGGGGCCAACTGCCACGTCGTGCTGTCCGCGGCGCCCGACGCCGGTCCCGCCCGCCGGCCGGAGCAGCCGCGGTACGACGGCCCCGTCCTGGTCCCCGTGTCGGCGCGCACGCCGGCCGCGCTCACCGCACTGGCCGACCGCCTGACCACGACCGACGCACCGTCCCCGCTGGACCTGGCGTACTCACTGGCCACCACCCGCAGCCCGCTGCCGCAGCGCGCGGTCCTCGTCGCCGACACCCCCGGCGACGTGCCCGGCCTGCTGCGGGCCCTGGCCGCGGGAGAACCCCACGCCCGCGTGGTCCGCGGCACGGCCGCGCCCGGACGGACGGTGTTCCTCTTCGCCGGCCAGGGCAACCAGCGACCGGGCATGGGCCACGAGATCCACCTCCGCCACCCCGTGTACGCCGCGGCCGTGGAGGAGATCGCCGAAGAGATGCGCGCGCACCTGCAACGGCCCCTGCTGGACGTGATGTCCGCCGAGGAGGGATCGCGGGACGCGGCGCTGCTCGACGAACCGGAGTACACCCAGCCCGCGTTGTTCGCCGTCCAGGTCGCGCTGTTCCGCCTCGTGGAGAGCTGGGGCGTGCGCCCCGACGCGGTGCTCGGCCACTCCTTCGGCGAACTGGCCGCGCTGCACGTGGCCGGGGCGATGTCCCTGCCCGACGCCTGCGCCCTCGTGGCCACCCGCGGCCGGCTGATGCAGCACGTGCCGCCCGGCGGTGCCTCGGTCCTGGTGGAGGCGTCCGAGGCCGAACTGACCCCGGACGTGCGGGCGTCCGGCGGTGCGGTGTCGATCGCGGCGCTCAACACCCCCACCGCCACCGTCCTGGCGGGCGACGAGGAAGCCACCCTGGAGATCGCGCGGAAGTGGGAGCGGTCAGGGAGGCGCACCCGCCGCCTCCGGATCCGGTTCGCCAGCCACTCGGCGCACATGGACCCCATCCTCGACGGAATGCGGCAGGCCGCGTCCCGGGTCCGCTGGCAGCGGCCCCGGCTGCGGGTCATCTCCTCGTTCACCGGCGCCGAGCTCGACCCGACCGGGCTCGACTGGCCGGAATTCTGGGCGCGGCACACCCGTGACACCGTGCGGTTCGCCGACGCCGTCAGGACGGCGTGCGCGGGCGGTGCTCGGACGTTCCTCGAACTCGGCCCCGACGGCACCCTGTGCGCCATGGGACCGGCCAACGCGCCGGACGACGTGGCCTTCGCCGCCGCGATGACCGGCGGTGACCGCCCCGACCTGAGGTCGCTGCTCACCGCCGTCGCCCGGGTGCACGCCCGTGGCGTCCCGGTCGACTGGACGCGCTTCCACGCCGGGACCGGCGCCCGCCGTGTGCCCCTGCCGACGTACCCCTTCCAGCGGCGCAGGCACTGGATCACCGGCGCGACCACCCCCGTCACGGCCGGGACGCCGCAGGCGGAGGCGCCGGCCTCGCCCCTGGCCGCGCTGCCCGCTGCCCAACGGGCCCAGGCGGTCCGTACGTTGGTGCGCACGGAGGTGGCCGCGGCACTGGAACTGGAGTCCGCCGAACAGCTGGACCTGCGCCGGCCGTTCAAGGAGCTGGGCTTCAGCTCGCTGATGACCGTCGAGCTGGGACACCGGCTCGCCGAGGCCACCGGGCTGCGGGTGCCCCCGACCGCGGTGCTGACCCACGCCACCCCCGCGCGGATGATCGAGCACCTCGACGCCGAGCTCGCCGCCGTCCCGTCGGACGCGCCGGACCCGGCGCGCGGAGCAGGCGGGGAGACGGGTGCCCCCGCGTCCGTCGTGGACCCGGGGGCGGGGGCGGGGGCGTCCGTCGCCGAACCGATCGCCATCGTCGGGATGGCCTGCCGCTACCCCGGCGGGATCGCCTGCCCGGACGACCTGTGGGACCTCGTCGCCGCGGGCGGCGACGCGATCGGCGCGTTCCCCACCGACCGGGGCTGGGACCTGGACCGCCTCTTCGACTCCGACCCGGACCGGCCCGGACGCACCTACGCCCGTTCCGGTGGCTTCCTGTACGACGCGGCGCGCTTCGACGCGGGGCTGTTCGGGATCTCCCCGCGCGAGGCGCTCGCGATGGACCCGCAGCAGCGGCTGCTGCTGGAGACCTCCTGGGAGGCCCTGGAACGGGCCGGAGTGGACCCGCTGTCCCTGCGGGACTCGGACACCGGCGTGTTCGCCGGGGTCATGGCCCAGGACTACGGCCCCCGGATGCACGAGGGCGCCGCGGGCGCCGACGGCTACGTCCTCACCGGCACCACGGCGAGCGTGGCCTCCGGCCGCATCGCCTACACCCTGGGCCTGCGGGGCCCCGCGGTCACGGTGGACACCGCCTGCTCGTCCTCCCTGGTGGCGCTGCACATGGCGGCGCAGGCCCTGCGCGCGGGGGAGTGCTCCCTGGCCCTCGCGGGCGGCGCGACGGTGATGGCCACCCCCGGCATCTTCGTGGAGTTCTCCCGGCAGCGCGGGCTGTCGCCGGACGGACGCTGCAAGTCGTTCGCGGCGGCGGCCGACGGCACGGGCTGGGCGGAAGGCGTCGGCCTGCTGGTGCTGGAGCGCCTCTCCGACGCCCGGCGCGCGGGGCACCGCGTCCTCGGCGTGCTGCGGGGATCGGCGGTCAACCAGGACGGGGCGTCCAACGGCCTGACCGCGCCCAGCGGACTCGCCCAGGAGCAGGTGATCCGTTCGGCGCTGGGCACGGCCGGGCTGTCCGCGGCGGACGTCGACCTGGTCGAGGCGCACGGCACCGGTACGGCGCTCGGCGACCCGATCGAGGCGCAGGCCCTGCTGGCCACCTACGGCTCCCGCCGTGCCGAGTCCCCCGTGTGGCTGGGCTCGCTGAAGTCGAACATCGGGCACACCCAGGCGGCGGCCGGCGTGGCCGGAGTGATCAAGGCCGTGCAGGCGATGCGGCACGGGGTGCTGCCGCGCACCCTGCACGTGGACGAGCCGTCCCCGCACGTGGACTGGGAGTCGGGCGCGGTGCGGCTGCTCACCGAGGACCGGCCCTGGCCGGACACCGGACGGCCGCGCCGGGCCGCCGTCTCCTCCTTCGGCATCAGCGGCACCAACGCCCACGTCGTGCTGGAGCAGGCACCCGCGTACGCCGAAGAGGCCGAAGGAGAGGCGCAGTTGCGCCCCGGCCCCGTGCCCGTGGTGCTGTCCGGGCACACCGGAGCCGCCCTGCGCGCCCAGGCGGAGCGGCTCGCCACCCACGTGGAGACCCACCCCGCCGCCACCGTCCGGCAGGTCGCACGCGCGGCCGCCGGCCGCGCCGCTCTCACCCACCGGGCCGTGGTCACCGCCGACGACCCCACCGATCTGGCGCGCCGGCTGCGCGCGCTGGCGACCGACCAGGACGACCCCGGCCTCGTGCACGGACAGGCCGATGTCGACCCCCGCACGGTGTTCGTGTTCCCGGGTCAGGGGGCGCAGTGGGCGGGGATGGCGGTGGAACTGCTGGATGCGTCGCCGGTGTTCGCGGCGCGCATGGCGGAGTGTGCGGCGGCGTTGGGGGAGTTCACGGACTGGTCGTTGCTGGACGTGGTGCGGGGGGAGGGTGGTGCCGCGTCGCTGGAGCGGGTGGATGTGGTGCAGCCGGTGTCGTGGGCGGTGATGGTGTCGTTGGCGGCGTTGTGGCGGTCGTTCGGGGTGGAGCCGGACGCGGTGGTGGGTCATTCGCAGGGGGAGATCGCGGCCGCGTGCGTGGCGGGCGCGCTGTCCCTGCGCGACGCCGCCAAGGTGAGCGCCCTGCGCAGCGCCGCCCTGCGTGACCTGGCGGGCACCGGCGGCATGATGTCCGTGGCCCTCCCCGCCGCCGAGGTGGAACGGCGTCTCGCGGGCCGGGACGGCCGGGTGTCCGTGGCGGCCGTCAACGGACCCGCCGCGGTGGTCCTGGCGGGCGACCCCGCCGCCCTGGAGGGCCTGGCCGCCGAACTGACCGCCGACGGCGTGTGGGCCCGCCTCGTCGCGGTCGACTACGCCTCCCACTCCCCGCAGGTGGAACGGATCCGCACCACCCTCCTGGACCGCCTCGCCGGCCTCGAACCGCGCACCGCCGACATCCCCTTCTACTCCACCGTCACGGGCGAACCGATCGACACGGCCGCCCTGGACGCGGAGTACTGGTACCGCAACCTGCGGCACACCGTCCGCTTCGAGGAGGCCGTCCGCGCCCTGGACGGCGCCGGGCACCGGGCCTACGTCGAGGTCAGCCCGCACCCCCTCCTCACCGCCGCGGTGCAGGACACCGTGGAGTCGACGGGCAGCACCGCCGTGGTCGTCGGCACGCTGCGCCGCGACCAGGGCGGCCCCGACCGCTTCCTGCGGTCCCTGGCCGAGGCGTACGTACGCGGCGTACCCGTCGACTGGACCCCCGCGACCGGCACCGGCGGACCACGGCCCGACCTGCCCGCCTACGCCTTCCAGCGGCAGCACTACTGGCTGCCCGCCCCGGTCGGCGCGGCCGACCCGGCGGTGCTCGGCCTGGACCCCGCCACGCACCCGCTGCTGGGCGCCGCCGCCACCGTGGCCACCACCGGGGAGGTGCTCCTGACCGGGGAGCTGTCCCGGCAGCGCCAGCCCTGGCTGGCCGACCACGGCGTGCACGGCACGGTGGTCCTGCCGGGTGCCGCGTTCGTCGAACTCGCCGTGCACGCCGGGGACGAGACGGGCTGCACGGAACTGGAGGAGCTGACGGTCCACCGCCCCCTGCCGCTGCCCGAACGCGGCGGCGTGCGGGTGCAGACCGTCGTGGGCGCCCCCGACGACGACGGCGGCCGCACCGTGGACGTGTACGCGCGCACCACCGACCGACCGGACTGGACGCACCACGCCACCGGCCGGCTCGGCACGGCGCGGACGCCCGCGCCGGACACCGTCGACGGGCCGCCGACCGGGACCGCATCGGCCGAACCGGCCTTCCGCTACCGGGAGTTGGCGGGCCTCGGCTACGAGTACGGACCGGCCTTCCAGGGCCTGCGCCGGTGGTGGCGCAGCGGTGAGGACGTGTGGGCCGAGGCCGAGCTGCCGGAACCGGCCGCCGCCGACGCCGGGGCGTTCGGACTGCACCCGGCGCTGCTGGACGCCGCGCTGCACGCGGCCCTCCCCTCCGGGGAAGCGGCCGGCCCGGACGCGGCGACCGTGCTGCCGTTCTCGTTCAGCGGGGTCCGCCTGTACCGGTCCGGCGCCGACGCCGTGCGGGTCCGCCTGCGGCCCGCGGCCGGCGGCGCGGTGTCCGTGACCCTCACCGACGCCGCCGGCCGGACCGTCCTGGTCATCGACGCGCTGACCCTGCGCCCGGTACCGGCCGGACAGCTCACGGCGGACCGCCCCGACCACCTGTACCGCACCGCGTGGACACCCCTCGAGACGCCCGCCCCCGAAGTGGCCTGGTCCCAGCACGCCGACCTGGACGAGCTGGGCGACCACGTGCCCGCCGCGGTCGGCGTGCCGGTGACCTCGGCGACCGCGGCCCTGACACTCGCGCAACGCTGGCTGGCCGACGAACGGTTCGCCGCGTCCCGGCTCGTCCTCCTCACCCGAGGGGCCGTCGGCACGGCCGCGGACACCCCGCCGCCGGACCCCGCCACGGCGGCGGTCTGGGGTCTGATCCGCACCGCGCAGACGGAGCACCCGGACCGGTTCGTGCTGGTGGACACCGACGACCGCCCTGCCTCGACCGCCCTGTTGCCGCGTCTGGCCGGCACCGGCGAGCCCCAACTCGCCCTGCGCGACGGCCGCGTCCTGGTGCCGCGGCTGACCCCGGTGACCGACGACCCGGGAGTGAGCCCCTGGACGGCCACCGGCACCGTGCTGATCACCGGCGCGACCGGCACCCTGGGACGCCTGGTGGCACGGCACCTGGTCGACCGCCACGGGGTGAGGGACCTGGTGCTGGCTTCCCGCAGCGGCCAGGACGCGCCCGGGACCGCCGCCTTCACGGACGACCTGCGGGCGCTGGGCGTCCGGGTGACGGTCGTCGCCTGTGACGTGGCGGAGCGGGACGAGGTGGCCGCTCTGCTGGCCGCCCACCCCGTGACGGCCGTCGTCCACGCCGCGGGGGTCCTCGACGACGCCGTCCTGACCGCCCTCACCCCCGAGCGCGTGACCGACGTGTGCCGCGCCAAGGTCGACGGCGCACGCCACCTCGACGAACTGACCGGCCCCGGCTTGACCGCCTTCGTGCTCTTCTCGTCCGTGGCCGGGACGCTCGGCAACGCCGGGCAGGCCGCCTACGCCGCCGCCAACGCCGCGCTGGACGCGCTGGCCGAGCGCCGCCGGGCCGCCGGGCTCCCGGCCACCTCCATCGCCTGGGGGCTGTGGGCCGAGAGCAGCCGCATGACCGGCCACATGGACGACACCGACCGGGCCAGGCTCGCGCGGGCCGGCGTGCTGCCCCTGGACACCGACACGGGCCTGACCGCCTTCGACGTGGCCACCGCGCGCGACGTCCCGGCCGTGCTGGCCGCCCCCCTCGACCGGGAGGCGCTCCGGGCCCGGGCGTCCGAGGGCACCCTCCCCCCGCTGCTGTCCTCCCTGGTGCCGGTGGTGCGCCGGGCGGCCGCCGCGGACGGCCCGGCGGACGCCGCCGACGCCCTGCGCCGCAGGCTCGCCGAGCAGGACCCCCTCCGCGTCCTGCAGGACGTCGTCCTGACCCAGGCGGCCGTGGTCCTCGGCCACCCCGACCCCGCCGCGCTCGGCCCGGACCGGCCGTTCAAGGAGATCGGCTTCGACTCGCTGACCTCCGTGGAACTGCGCAACCGGCTCAGCCGGATCACCGGCACCCGGCTGCCCGCCACCGTCGTGTTCGACCACCCGACCCCGGCCGGGCTCGCCGCCCACCTGCGCGGCGAACTGGCCGGCGACACCCCCCCGGCCGCCGTCGTACCGGCCGCCACGGCCGCCGCCGACGAACCGGTCGCGATCGTCGGCATGGCGTGCCGCTTCCCGGGCGGCGTGGCCTCGCCGGAGGACTTGTGGCACCTCGTGTCCACGGGCGGCGACGCCATCGGCGGCTTCCCCACCGACCGGGGCTGGGACGTCGCCGGTCTGTACGACCCCGACCCGGACCGAGCCGGCCACTCGACCACGCGGTACGGCGGATTCCTGTACGACGCCGGGCAGTTCGACGCGTCCCTGTTCGGCATCTCCCCGCGCGAGGCACTGGCGATGGACCCCCAGCAGAGGCTGCTCCTGGAGACGGCCTGGGAGACGCTGGAACGGGCCGGCCTGGACCCGGCTTCGCTGCGCGGCAGCCGGACCGGCGTGTTCACCGGCGTCATGTACCACGACTACGCCTCCGCGCTCGCCGACGTCCCCGACGAGGTCGAGGGGCACCTGCTCACCGGCACCGCCGCCAGCGTCGCCTCCGGCCGCGTCTCCTACGCCCTCGGGCTGGAGGGCCCCGCGGTCACCGTGGACACCGCCTGCTCCTCCTCCCTGGTCGCCGTCCACCTGGCGGCCCAGGCCCTGCGCGCGGGGGAGTGCACGCTGGCACTCGCCGGCGGGGTGACGGTCATGGCCCGGCCCACCACCTTCACCGCCTTCTCCCGGCAGCGCGGACTGTCACCGGACGGACGGTGCAAGGCGTACGCCGGGGCCGCCGACGGAACCGGCTGGTCCGAGGGCGTCGGCCTGCTCCTGCTCGAACCGCTGTCCGCCGCCCGCCGCAACGGCCACCGCGTCCTCGCCGTCGTCCGCGGCTCCGCCGTCAACCAGGACGGAGCCTCCCACGGGCTCACCGCGCCCAACGGCCCCTCCCAGGAACGCGTCATCCGCGCCGCGCTCGCCGCCGCCGGACTGTCCCCGCACGAGGTCGACGCGGTCGAGGGCCACGGCACCGGCACCCCCCTGGGCGACCCCATCGAGGCACAGGCGCTCCTCGCCACCTACGGCCAGGAACGGGCCGGCGACCCCCTGTGGCTCGGCTCCGTCAAGTCCAACATCGGGCACGCACAAGCCGCCTCGGGCGTCGCCGGACTGATCAAGACGGTCCAGGCCATGCGGCACGGCGTACTGCCCCGCACCCTGCACGTCGACGAGCCGTCCCCGCACGTGGACTGGGAGTCGGGTGCGGTACGGCTGCTCACCGAGGACCGGCCCTGGCCGGACACCGGCCGGCCCCGGCGGGCAGGCGTGTCCTCCTTCGGCATCAGCGGCACCAACGCGCACATCGTCGTGGAGCAGCCCGACGGCAGCGAAGCGGCCCCACCGGAACCGGAGCACGCCCAGCCGCTGCGGCCCGTCCCGGTGGCCCTGTCCGGACACACCGAGGACGCCCTGCGCGCACAGGCCGCACGGCTCGCCGCGCACCTGACCACGCACCCCGACACCCCGCTGCGCGACATCGCCTTCACCGCCGCGTCCGGCCGGGCCGCCCTCGACCACCGCGCCGTCGTCCTCGCCGACGACCCGGAGCAGCTCGGCGAACGGCTGACCGCGCTGGCCGAGGGCCGCGACGTGCCCGACGTCGTCCGGGGCACCGCGGCCCCCAACGCCCGGCGGGTGGCGTTCGTCTTCCCCGGCCAGGGCTCCCAGTGGGCCGGGATGGCCCTGGAACTGCTCGACGCGGCACCGGTGTTCGCCGCCCGGCTCACCGAGTGCGCCGCGGCCGTCGAGGCCCACGCGGACTGGTCGGTGCTGGACGTCCTGCGACAGGTACCCGGCGCACCGGGACTGGACCGGGTGGACGTCGTCCAGCCCGTCACCTTCGCCGTCACCGTGTCGCTGGCGGCGCTGTGGCAGGCCCACGGCGTACGACCCGACGCGGTGATCGGCCACTCGCAGGGGGAGATCGCCGCCGCCTGCGTGGCCGGGGCCCTGTCCCTGGCCGACGCCGCCGCGGTGGTGTGCCTGCGCAGCCGCGCACTGACCCGGCTGTCGGGCAAGGGCGGCATGATGTCCGTGGCGCTGCCCGCCTCCGAGGTGCGGGAACTCTTCACCGACGACCGGCTGCACGTGGCCGCGGTCAACGGCCCCGCCTCCACCGTGGTCTCCGGCGACCCGTCCGCCCTGGAGGACCTGCGCGCCCGGTGCGACGCGCGCGGCGTCCGCGCCCGGCTGATCGCCGTCGACTACGCCTCCCACTCACCGCACGTCACCACCGTCAAGGACGAACTCGACGGCCTGCTCGCCGGCATCGCCCCGCGGGCCGTACCCGTCGAGCTGTACTCCACCGTCACCGGACAACGCCTGGACCCGCGCGAACTCACCGGCGCGTACTGGTACACCAACCTGCGGCAGACCGTCCGGTTCGCCGACGCCGTGGGGGCCGCCCTCGACGCCGGGATCGGCACCTTCCTGGAGGTGAGCCCCCACCCGGTGGTGGCACCGGGCGTGCAGGAGACGGTGGACGCCGCCGGAGCACGTGCCGTCGTCCTGTCCACCCTCCGCCGTGACGACGGCGGCCGGCCCCGGTTCACCCGGTCGCTGGCCGAGGCCCACGTGCGCGGGGTCGGCGTCCACCTGCCCGAGGTGTTCGCCGGCACCGGGGCACGGACCGTCGACCTGCCGACCTACGCCTTCCAGCACCAGTGGTACTGGCTCGCCGACCAGGCCGCCTCCCGGTCCCTCGGCTGGCGCTACCGCGTCGAGTGGCGCCCCGCCCGCCCGAACGGGCGCACGGAACCGGACGCCACATGGCTGGCCCTGGTGCCCGCCGGCTGCGACGAGGAGTGGCTGGAGCGGCTCACCGGAACACTCCCGGTCCGCGTCCTGCCCGTGGACGCCGAGCATGCCGACCGCGCCGCGCTCGGCGAACACCTGCGCCGCGCGCTGGCCGAGCACACCCCGCGGGGCCTGCTGTCCCTGCTGAGCGCCGACCGCCGGCCGCACCCCCGGCACCCGGCCGTGCCCGCGGGCGTGGCCGCCACCCTCGCCCTGGTGCAGGCGCTCGGCGACCTGACGGCGACCCTGCCCCTGTGGCTGGTCACCGCCGGCGCGGTGGGCACCGGGGACACCGACCCGCCCCACGACCCGGACGCCGCACAGGTCTGGGGCCTCGGCCGGGTCGCCATGCTGGAGTACCCCACCTTCTGGGGCGGCCTCGTCGACCTGCCCGCCCGCCCCGACGCGGACGCACTGGAAGAGCTGCGTACGATCATGGCCGGCGGCTTCGGGGACGAGGACCAACTCGCGGTACGGGCGTCCGGCACCCTCCTGCGACGCCTGGTCCGCGCCCCCTTGGACGGCACCCCGGCCGTCGGCTGGCAGGCCCGCGACACCGCCGTCGTGACCGGCGGCACCGGGGCGCTCGGCCCGGAAGCCGCCCGCTGGCTGGCCGGACTCGGCGCCGCGCACGTGGTGCTGGTCAGCCGCAGCGGTCCCGAGGCCGAGGGGGTCGCCGAGCTGACGAGCGAACTCGACGCCCGCGGCGTACGGCTGACCGCGCACGCCTGCGACGTCGCCGACCGCGCTGCCGTGGCAGCCCTCCTGACCGGACTGCGCGACCAGGGCGAGAAGGTACGCACCGTGCTGCACGCCGCCGCCCTGATGCGGCTGGCCGCACTGCCCGACACCGACCTCGCCGAGTACGCCGCCGTGCTCGACGCCAAGGTCCAGGGCGCCCGCCACCTCGTCGACCTCCTCGACCGGGACGAACTGGACGCCCTCGTCTTCTACTCCTCGATCGCCGGTGTCTGGGGCAGCGGGGACCACGGCGCCTACGCCGCGGCCAACGCCACCCTGGACGCGCTGGCCGAACAGGCCCGGGCCGACGGCCTGCCCGTCACCTCGGTGGCCTGGGGCGTGTGGGACGGGGCCCGCTTCCCCGAGGGCGTCGACGCCGGACAACTACGGCGCCAAGGACTGCCGTTGATCCACCCGGAATCCGCCCTCGAAGGACTGCGCGTCGTCCTGGAACGCGGCGAGAGCGGCCTGTCGATGGCCGACGTCGACTGGGCGGCGTTCATGCCGCTGTTCGCCTCGGCGCGCAGCCGGCCCCTGTTCGCCGAGATCCCGGAGGCCCGGCGCGCACTGGAGGGCGACGAGCCCACCGGGGCGCCGCCCACCGACGTCACCTGGGCGCAACGCCTGGCCGCTCTGCCGGAGGCCGAACGCCGCGCCGCCCTGCTCACCCTGGTCCGCGAACAGGCCGCCGTCGTCCTCGGCCTGTCCGACCCCGCGCAGATCGGCGACGAACGGCCCTTCCGCGACCTGGGCTACGACTCGCTGACCGGCATCGAACTGCGCAACCGGCTCGGCACCGTCACCGGGCTCACCCTGCCCGCCACGCTGGTGTTCGACCACCCCACCCCGGCCGCGGTGGCCGACCGCCTCGACACCTCGCTGGCCCCTGCCGAACCACCGCTCCTCGCCGAGCTGGACCGGCTCGCCGAACGGCTGGGCCGCACCGACGACGAGGACGAACGCACCACCGTCGCGCAGCGGCTGCGCGCCATGTTGTCGCTGGTCGACGGCGACCTGGACGAGGACGACGACTTCGACCCGGTGTCGAACGAGGAGATGTACGACCTCATCGACCGAGAGCTCGGGACGAGCTGA", "orf_prot_sequence": "MGDRMDTAPAQVPVAVVGLACRLPGAADPAAFWALLREGRDALGEPGPRRTHSDGPAAPVLPSGEPVRAGFLDQVDSFDAQFFGISPGEAAVMDPQQRLVLELAWEAFEDAGIVPGDGGGTDGGTGVYVGATYDDYATLRGDRLSPHSATGRNRAMIANRVSYALRLSGPSMVVDSAQSSALVAVHVACRALAAGECSVAVVGGVNLNIVQEGYDVTRALGAVSPDGRCHTFDARANGFVRGEGGAVLLLKPLAAALADGDTVHAVILGSAANNDGGGDSLTAPRQEAQQDVLRAACASAGVAPQDVDYVELHGTGTPLGDPVEASALGAVARGGRPLRVGSVKTNIGHLEGAAGIAGLLKTILCLSHRELVPSLNFRTPNPRIPLDDLGLRVVTEAEPWPDTGGTPLAGVSSFGMGGANCHVVLSAAPDAGPARRPEQPRYDGPVLVPVSARTPAALTALADRLTTTDAPSPLDLAYSLATTRSPLPQRAVLVADTPGDVPGLLRALAAGEPHARVVRGTAAPGRTVFLFAGQGNQRPGMGHEIHLRHPVYAAAVEEIAEEMRAHLQRPLLDVMSAEEGSRDAALLDEPEYTQPALFAVQVALFRLVESWGVRPDAVLGHSFGELAALHVAGAMSLPDACALVATRGRLMQHVPPGGASVLVEASEAELTPDVRASGGAVSIAALNTPTATVLAGDEEATLEIARKWERSGRRTRRLRIRFASHSAHMDPILDGMRQAASRVRWQRPRLRVISSFTGAELDPTGLDWPEFWARHTRDTVRFADAVRTACAGGARTFLELGPDGTLCAMGPANAPDDVAFAAAMTGGDRPDLRSLLTAVARVHARGVPVDWTRFHAGTGARRVPLPTYPFQRRRHWITGATTPVTAGTPQAEAPASPLAALPAAQRAQAVRTLVRTEVAAALELESAEQLDLRRPFKELGFSSLMTVELGHRLAEATGLRVPPTAVLTHATPARMIEHLDAELAAVPSDAPDPARGAGGETGAPASVVDPGAGAGASVAEPIAIVGMACRYPGGIACPDDLWDLVAAGGDAIGAFPTDRGWDLDRLFDSDPDRPGRTYARSGGFLYDAARFDAGLFGISPREALAMDPQQRLLLETSWEALERAGVDPLSLRDSDTGVFAGVMAQDYGPRMHEGAAGADGYVLTGTTASVASGRIAYTLGLRGPAVTVDTACSSSLVALHMAAQALRAGECSLALAGGATVMATPGIFVEFSRQRGLSPDGRCKSFAAAADGTGWAEGVGLLVLERLSDARRAGHRVLGVLRGSAVNQDGASNGLTAPSGLAQEQVIRSALGTAGLSAADVDLVEAHGTGTALGDPIEAQALLATYGSRRAESPVWLGSLKSNIGHTQAAAGVAGVIKAVQAMRHGVLPRTLHVDEPSPHVDWESGAVRLLTEDRPWPDTGRPRRAAVSSFGISGTNAHVVLEQAPAYAEEAEGEAQLRPGPVPVVLSGHTGAALRAQAERLATHVETHPAATVRQVARAAAGRAALTHRAVVTADDPTDLARRLRALATDQDDPGLVHGQADVDPRTVFVFPGQGAQWAGMAVELLDASPVFAARMAECAAALGEFTDWSLLDVVRGEGGAASLERVDVVQPVSWAVMVSLAALWRSFGVEPDAVVGHSQGEIAAACVAGALSLRDAAKVSALRSAALRDLAGTGGMMSVALPAAEVERRLAGRDGRVSVAAVNGPAAVVLAGDPAALEGLAAELTADGVWARLVAVDYASHSPQVERIRTTLLDRLAGLEPRTADIPFYSTVTGEPIDTAALDAEYWYRNLRHTVRFEEAVRALDGAGHRAYVEVSPHPLLTAAVQDTVESTGSTAVVVGTLRRDQGGPDRFLRSLAEAYVRGVPVDWTPATGTGGPRPDLPAYAFQRQHYWLPAPVGAADPAVLGLDPATHPLLGAAATVATTGEVLLTGELSRQRQPWLADHGVHGTVVLPGAAFVELAVHAGDETGCTELEELTVHRPLPLPERGGVRVQTVVGAPDDDGGRTVDVYARTTDRPDWTHHATGRLGTARTPAPDTVDGPPTGTASAEPAFRYRELAGLGYEYGPAFQGLRRWWRSGEDVWAEAELPEPAAADAGAFGLHPALLDAALHAALPSGEAAGPDAATVLPFSFSGVRLYRSGADAVRVRLRPAAGGAVSVTLTDAAGRTVLVIDALTLRPVPAGQLTADRPDHLYRTAWTPLETPAPEVAWSQHADLDELGDHVPAAVGVPVTSATAALTLAQRWLADERFAASRLVLLTRGAVGTAADTPPPDPATAAVWGLIRTAQTEHPDRFVLVDTDDRPASTALLPRLAGTGEPQLALRDGRVLVPRLTPVTDDPGVSPWTATGTVLITGATGTLGRLVARHLVDRHGVRDLVLASRSGQDAPGTAAFTDDLRALGVRVTVVACDVAERDEVAALLAAHPVTAVVHAAGVLDDAVLTALTPERVTDVCRAKVDGARHLDELTGPGLTAFVLFSSVAGTLGNAGQAAYAAANAALDALAERRRAAGLPATSIAWGLWAESSRMTGHMDDTDRARLARAGVLPLDTDTGLTAFDVATARDVPAVLAAPLDREALRARASEGTLPPLLSSLVPVVRRAAAADGPADAADALRRRLAEQDPLRVLQDVVLTQAAVVLGHPDPAALGPDRPFKEIGFDSLTSVELRNRLSRITGTRLPATVVFDHPTPAGLAAHLRGELAGDTPPAAVVPAATAAADEPVAIVGMACRFPGGVASPEDLWHLVSTGGDAIGGFPTDRGWDVAGLYDPDPDRAGHSTTRYGGFLYDAGQFDASLFGISPREALAMDPQQRLLLETAWETLERAGLDPASLRGSRTGVFTGVMYHDYASALADVPDEVEGHLLTGTAASVASGRVSYALGLEGPAVTVDTACSSSLVAVHLAAQALRAGECTLALAGGVTVMARPTTFTAFSRQRGLSPDGRCKAYAGAADGTGWSEGVGLLLLEPLSAARRNGHRVLAVVRGSAVNQDGASHGLTAPNGPSQERVIRAALAAAGLSPHEVDAVEGHGTGTPLGDPIEAQALLATYGQERAGDPLWLGSVKSNIGHAQAASGVAGLIKTVQAMRHGVLPRTLHVDEPSPHVDWESGAVRLLTEDRPWPDTGRPRRAGVSSFGISGTNAHIVVEQPDGSEAAPPEPEHAQPLRPVPVALSGHTEDALRAQAARLAAHLTTHPDTPLRDIAFTAASGRAALDHRAVVLADDPEQLGERLTALAEGRDVPDVVRGTAAPNARRVAFVFPGQGSQWAGMALELLDAAPVFAARLTECAAAVEAHADWSVLDVLRQVPGAPGLDRVDVVQPVTFAVTVSLAALWQAHGVRPDAVIGHSQGEIAAACVAGALSLADAAAVVCLRSRALTRLSGKGGMMSVALPASEVRELFTDDRLHVAAVNGPASTVVSGDPSALEDLRARCDARGVRARLIAVDYASHSPHVTTVKDELDGLLAGIAPRAVPVELYSTVTGQRLDPRELTGAYWYTNLRQTVRFADAVGAALDAGIGTFLEVSPHPVVAPGVQETVDAAGARAVVLSTLRRDDGGRPRFTRSLAEAHVRGVGVHLPEVFAGTGARTVDLPTYAFQHQWYWLADQAASRSLGWRYRVEWRPARPNGRTEPDATWLALVPAGCDEEWLERLTGTLPVRVLPVDAEHADRAALGEHLRRALAEHTPRGLLSLLSADRRPHPRHPAVPAGVAATLALVQALGDLTATLPLWLVTAGAVGTGDTDPPHDPDAAQVWGLGRVAMLEYPTFWGGLVDLPARPDADALEELRTIMAGGFGDEDQLAVRASGTLLRRLVRAPLDGTPAVGWQARDTAVVTGGTGALGPEAARWLAGLGAAHVVLVSRSGPEAEGVAELTSELDARGVRLTAHACDVADRAAVAALLTGLRDQGEKVRTVLHAAALMRLAALPDTDLAEYAAVLDAKVQGARHLVDLLDRDELDALVFYSSIAGVWGSGDHGAYAAANATLDALAEQARADGLPVTSVAWGVWDGARFPEGVDAGQLRRQGLPLIHPESALEGLRVVLERGESGLSMADVDWAAFMPLFASARSRPLFAEIPEARRALEGDEPTGAPPTDVTWAQRLAALPEAERRAALLTLVREQAAVVLGLSDPAQIGDERPFRDLGYDSLTGIELRNRLGTVTGLTLPATLVFDHPTPAAVADRLDTSLAPAEPPLLAELDRLAERLGRTDDEDERTTVAQRLRAMLSLVDGDLDEDDDFDPVSNEEMYDLIDRELGTS", "perc_identity": 34.62}}, "BGC0000049.1|E-492_10 # 25084 # 35349 # 1 # ID=1_10;partial=01;start_type=ATG;rbs_motif=AGGGGG;rbs_spacer=6bp;gc_cont=0.740": {"gnl|BL_ORD_ID|2387|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 25084, "orf_end": 35349, "orf_from": "BGC0000049.1|E-492_10 ", "model_name": "LpeB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1700", "model_id": "2759", "ARO_accession": "3004100", "ARO_name": "LpeB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.409435, "max_identities": 27, "bit_score": 33.4982, "cvterm_id": "41208", "query": "QRYWLHTDSVPTHPGGHPLLDATVELAEEDGFVLSGRLDTRSQTWLADHTVLGSTVVPGSVFAELALHAAAEAGLAGVVELTLERPLL", "match": "+  W H +S      G   LDA ++ A E GF +     T S  +L    + G   + G +F E A+  A    ++G+V LTL  PL+", "sequence_from_db": "ENIWRHIES------GLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQG---MLGQLFVEFAVALAGSVFISGIVALTLS-PLM", "sequence_from_broadstreet": "MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE", "dna_sequence_from_broadstreet": "ATGAAACTCACCAGCTATTTCATCAAACATCCTGTAATCACCATCATCTTAAACGCCATGATTGTTGTTCTGGGGTTATTATGTCTCTATAATTTATCCGTTAGGGAATATCCTGATATCAATTTTCCTACAATAACTGTTTCAGCAAGCTACCCCAACGCCAGTCCCGATTTAGTTGAAACCGCAATAACCAATGTTCTGGAGGACCGTCTTGCAGGTATAGAAGGGTTAGAAACAATTACGTCGCAATCAAGTGCAGGCTATGCGCAAATCACCTTGATGTTTCGTTCCGGAACATCCATGGATAGAGCACTGAGTACCACTCAAGACGCCGTAGGAGTAGCCAAAGCACTTCTGCCACCGGAGGTAAGATCGCCAACAGTTGAACGCCAACGCAAATCCAATGGCCTTCCTTTTATTGGGATTTCATTGGAATCAACATCCAAAGACTTTGGTGAGCTGACTCATTACGCTAATCTTAATTTAAAAAATGTCTTTCGCAGTGTGCAAGGTGTTGCTTCCGTTGAAGTATGGGGGCAACCCTATACATACAACATTACCCTTCAACCTGAAAAATTATTTTCTTTTGGAGTTAATGTTGATGAAATAGTGAATGCGCTCGCAAAAAATCGTATTTCGTTGCCCGCAGGTAATTATAGAAATAAAATTCCCAGTACTCTTAATTCTGAGCTGAAAACCCGGGAAGATTATGAGAATCTTTTAATCAAGGCAAATTCCAAACATCCCATTTTACTCAAATCACTGGCTAATGTCGCATTGGAAACCGATAACTCACAAATGCGAGTTCGCGTTAATGGGCACGCTGGTGTTGTGCTTTCTATCAATAAAGCGAATGAAGCCAATCCTATTGAAGTCTCTAAAGAAATTAGAAAAGTGATTAAAGGATTACAACAAGGGTTGCCCAAGGATCTGAAAATAAACACTATTATTGATCAATCGGATTTTATTAATGCCTCCATTAAAAACATTAGATCCGCGATTGGTGAAGCCATTTTTTTAGTCTTAATCATAGTCTTCCTTTTTTTACGTAATATTAAAGCCACCATCATCCCTCTAATTACCATTCCAATTTCATTATTGGGGTCCTTGCTTTTCCTTAAATTGTTTGGTTTTTCAATCAATTTAATGACCTTACTGGCTATGGTATTGGCAATCGGTTTGGTTGTAGACGATGCGATTATTGTCTTGGAAAACATTTGGCGTCATATTGAAAGCGGATTATCTCCTTTGGATGCTGCGCTTAAAGGAGCACGTGAAATTGGCTTCGCCATTATAGCGATGACATTTACCCTTAGCAGTGTTTATTTGCCTATAGCCTTTATCCAGGGGATGCTGGGACAGCTCTTCGTTGAATTTGCTGTTGCTCTGGCAGGCAGTGTTTTCATTTCGGGGATTGTTGCCCTGACACTTTCACCATTGATGTGTGCCAACCTTTTGAGTGCATCTTCTAAAAACTGGTGGCCACAATTCGATAATGCTCTTGAAAAGTTAACTAAACATTACTCCAATATTTTACAATTCATTCTGAAACACCAAAAGATTACTTTGCTAACAGCTCTAATTTCTGTCGTTGCTTGCTTTGGATTTTATAATTTAATTAGCCATGAAACCGCTCCTAAAGAAGATCGAGGTTTAATAGGTATTTATATCCCTCCTGTAGCAGGAGAAGACATAGGGATGTTGGACAACAAAACAGGAAAACTTGAAAAAAAACTAGATGCCATCCCCGAGGCAAATAATCGCCTGACTTTTATTGGTGACTGGGGCGGGTCAATAGTACTGCCATTAAAACCTCATGCTCAACGTCATCGAAGTGCGAACCAGATTGTTGAGAAATTAAGACCTTCTTTTAACCACTTCCCCTCCATGGATCCTCATGTATGGAGTTGGGATACAGGCTTACCAGGAGTTGATGATGCCGGGAGTGGATCTGAATTGACTCTGGTTATTTCTACCCCAGACCATTTCAGGCAATTATTTGATGAAACTGAAAAATTAAAAAGTGTTCTAGACAAGAGCAAATTATTTGCAGCAGTGAACTATGACCTTCGCCTTGATACCATGGGATACAATATAGACCTTGATTATAACCAACTGGCGAAACTTGGACTGACAGCAAATCAGGTGGCAAAGACGATTGAGGTATTTTTCAGTGGCGACAAGTCACAAACCTTTGAAAAAGATGGGGTCGTTTATAATATATCGATTAAAGGAGATTCCTCCCCCTGGACTTTGAATGAACTTTATTTAACTACAAATGAAGGGAAGTCTGTTTCATTGGGAGCTATTACCAAAATGCAGCCCAAGGCTCAACCGGCAACTCTTGATCATTATCAGCAAATGCGTTCGACCACTCTCCATGTCCAATTACATAAGGGAGACTCTATGGCAAAGGCTATTGAAAAATTATGGGGCACTACCAAAGAAGTGATGCCTCAACACTATAAACTGACCTGGATTGGTGCGGCCAAAGCATTCCATGAATCTTCCAATTCCATGTTATTTTTGTTTTTCTTATCTTTGGCTTTCATCTATGCCATTTTATGCACACAATTCGAGAATTTTACTGACCCCTTCATTATTCTATTCACTGTACCACTAGCCTGCTCGGGCGCCTTATTATTCACTTATTTATTTGGACAATCCTTAAACATTTATACTCAGGTAGGTTTGATTACTTTAATCGGGCTCATTAGCAAACACGGTATTTTAATAGTGGAATTTGCTAATAAACTTCATAAAGATGGTGCTTCGTTGCCAGAAGCTATACAGAAATCAGCTGCATTGCGTTTACGGCCTATATTAATGACAACTGGCGCCATGGTTTTTGGCGCCATCCCTTTGGTATTATCGCATGATGCGGGTTCTGAATCCCGGCATGCCATAGGAACTGTATTGATTAGCGGGCTCGGTCTTGGAACACTATTTACCCTATTTGTTTTGCCTGCGGTTTACAACATCATCAAATCCAAACTAATTGATATGCAAAAAACAGGGGGCAAAAAACGGTGCAGCAAAGAATAA", "partial": "0", "query_start": 32770, "query_end": 33033, "hit_start": 1209, "hit_end": 1443, "orf_dna_sequence": "ATGTCCGAGGAAGAGAAGCTCAGGGGTTACCTGAAGCGGGTCATGAACGACCTGCGCAAGGCCAACCGCCGCCTGGAGAAGGCGGAACGGGCCCGCACCGAGCCCATCGCGATCGTCGGCATGGCCTGCCGCCTCCCCGGCGGCGTGCGCTCACCGGAGGACCTGTGGCAGGTGCTCGCCGAGGGCCGTGACCTCACGGGCGACCTGCCCACCGACCGCGGCTGGGACGTCGACGCCCTCTACGACCCCGACCCCGAGCGCTCCGGCCACCTCTATGTGCGGCGCGGCGGCTTCCTCGACGACCCGGCCGCCTTCGACGCCGCCTTCTTCGGGATCTCACCCCGCGAGGCGCTGGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGACCTCGTGGGAGGCGCTGGAGCGGGCCGGTATCGACCCGCTGTCGCTGCGCGGCAGCCGCACCGGCGTGTTCGTCGGCCAGAACCACCAGGAGTACGGAACCAGGCTCGCGCACGCCCCCACCAGCGTCGAGGGCCACCTCGTCACCGGCGTGGTACCCAGCGTGCTGTCGGGCCGCATCTCCTACACCCTCGGCCTCGAGGGCCCCGCCGTCACCGTGGACACGGCCTGCTCCACCTCCCTGGTCACCCTGCACCTGGCCGTGCAGTCCCTGCGCAACGGCGAGTCCTCGCTCGCGGTGACGGGCGGCGTCACCGTCCTGGCCAACCCCGGCCCCCTGGTGGAGTTCAGCAGGCAGCGCGTGCTGGCCGCGGACGGCCGCTGCAAGGCGTTCTCCGCCGCCGCGGACGGCATGGGCATGGCCGAGGGCGTCGGCGTACTGGTCCTGGAGCGGCTCTCGGACGCCCGGCGCAACGGGCACCGGGTGCTGGCCGTCGTCCGGGGCTCGGCGGTGAACCAGGACGGCGCCTCCAACGGCCTGACCGCACCCAACGGCCCCTCCCAGCAACGCGTCATCCGGGCCGCGCTGGCGAACGCGGGGCTCGCCCCGGCGGACATCGACGTCGTGGAGGCGCACGGCACCGGCACCTCGCTCGGCGACCCGATCGAGGCCCAGGCCCTGCTGGCCACCTACGGTGTCCACCGCGAACGGCCGCTGCACCTGGGCACGGTGAAGTCCAACATCGGCCACACCCTCGCCGCGGCGGGCGTGGCCGGCGTCATCAAGTCCGTCCTCGCCCTGCGCCACGGCACCGTGCCGAAGACGCTGCACGCGGAAACCCCTTCCCCGCACATCGACTGGTCCTCCGGCGCCCTCCTGCTCGCGACGGAGGCGACCCCCTGGCCGAGCGGCGAACGGCCGCGCCGCGCCGCGGTCTCCTCCTTCGGCATCAGCGGCACGAATGCGCACGTGGTGCTGGAGGAGGCGCCGGTGGGGGAGGAGGTGCCGGTTGGTGAGGGGGTTGGTGACCCGGTGGTGCCGGTGCCGGTGCCGGTGGTGGTGTCGGGGCGGGATGAGGTGGGGTTGGGCGTTGCGGCGGGTCGGCTGGGTGCTTTTGTGTCGGCTGATGTGGGTGTGTCGGTGGTGGGGATGGCGCGTGCTGCGGGGGTGGGTCGTGCCGCATTGGAGTGCCGGGGCGCGGTGGTGGCCGCGGACCGCGATGACTTGCTGGCGGGGTTGGAGGAGTTGTCAGCCGGGGACGGGATCCGTGGTGTGGCAGGCCGTGGCGGGCTGACCGGGTTTGTGTTCTCGGGTCAGGGGTCGCAGTGGTCGGGGATGGGGGGTGAGCTGGCGCGGGCGTTCCCGCTGTTCGGTGAGGTGTTCGGTGAGGTGTGCGGTCGGTTGGGGGAGCGGCTGGGCTTCGGGTTGCGTGAGGTGGTGTTGAGCGGCGGCGAAGCTGTCGACGGGACGGTGGTCGCCCAGTGCGGGCTGTTCGCTTTCGAGGTGGCGTTGTTCCGGTTGGTGGAGTCGTTCGGTGTGGTGCCGGAGTTCGTGGTGGGTCATTCGGTGGGGGAGGTGGCGGCAGCTCATGTGGCGGGAGTGCTGTCGCTGGAGGATGCGGTGCGGCTGGTGGCGGCGCGGGCGGTGTTGATGGGGGACTTGCCGTCGGGTGGGGCGATGCTGGCGGTGGGTGCCCCGGAGGCAGAGATCGGCGAGGTGCTCCAGGGTCTGGAGGGTGTTGTAGGGGTGGCGGCGGTCAATGGTGCGTCGTCGGTGGTGGTGTCGGGGGATGCGCGGGCGGTCGGTGAGGTGCAGCTGGTGGCGGCTGGGCGGGGCTGGCGGCACAGGCGGTTGCGGGTGAGTCACGCGTTTCATTCGCCCTTGATGGAGCCGGTGTTGGACCGCTTCCGGGAGGCGGTCGAAGGGATCGAGTTCGGCCGCCCCCGGTTGGGTTTCGTCTCCTCGGTCGAGGTGGGTGCGGCTGCGGACTCGGCGGAGTACTGGGTACGCAATGTGCGGCAGACGGTGCGCTTCGCGGATGCGGTCGGGCATGCGTGGCGGCAGGGCGTGAGGCGTTTCGTGGAGATAGGTCCCGACAGTGCGCTGACCGCTGCGGGTGCGGACTGTGTCCCGGGTGACGCGGGGGTGTCGTTCGTCGCGTTGCAGCGTCGCGAGCGGCCGCAGGCGCGGGCACTGGCGGAGGGCTTGGCGCGTTTCCACGTGGCGGGCGGGTCGGTGGACTGGGCGGCGTATCTGCCCCCGGCCGGCCACGTGGACCTGCCCACCACCGCCTTCCGGCACCAGCGCTACTGGCTGGACTCCACCGAAGTGACCGACCCCGCCGCGCTGGGCGCGGTACCCGTCCGGCACCCCCTGCTCGGCGCGCTGGTCCCGATGCCGGGCGAGCTCGGCTCCGTGTTCACCGGGCGGCTCGGCCTGCGGGGTCAGCCCTGGATCGCCGACCACCGCGTCACCGGCGCGGCCGTGCTGCCCGGCACCGCGTTCCTCGAACTCGCCCGGCGCGCCGGCGAACTCCTCGGCGACCTGCGCGTGGAGGAGCTGGTCCTCGAAGTGCCCCTGACGTTGCCCGCCGAGGGCGACACCGCCCTGCGCGTCGTCGTCGGCGAACCCGACGCCGCGGGGCGCCGTACCGTCGAGGCGCATACCCGGCCGGAGGAGCCCGGGTCACCGTGGACCCGGCACGCCACGGGCGTCCTGGTCGAGGACACGGACGACACGCCTGCCGCCGGGGGCAGCCCGGTCGCGGAACTGGTGCAGTGGCCCCCGACCGCCGCCGAAGCCGTCGACCTGGACGACCTCTACCCGCGCCTGGCCGGGACCGGGCTGGAGTACGGCCCGGCGTTCCAGGGCCTGCGCGCGGCCTGGCAGCGCGGCGAGGAGCTCTTCGCCGAGGTCGCCCTGGCCGAGCAGGAGCGCGGCCGGGCGCAGGAGTTCGGGATGCACCCGGCGCTGATGGACGCCGCCCTGCACGCCCTCGGCGTGGACGACCGCCACGGACTGCGGCTGCCGTTCGCCTTCCACGGTGTCCGTACGTACGCCCCCGGCACGTCGGAGCTGCGGGTCCGCCTCGCCCCGGTCGGGGAGGACTCGATCCGCGTCGACCTCGCGGACTCCCTCGGCACCCCGGTGGCCACCGTCGAACGTCTGGTGCTGCGCGCCCTCACGGGCGAGCTGCGCCCCGTACGACCGAGCTCGCTCCACCGGCTCGACTGGACACCCGTGCCCACCCCCCAGGGAGGCGGTCAGGGCACCGCCACGTTCTTCCGCGTCCCGCACCTCCCGGTCGCCGAGTGCACCGCCGCGGTGCTGGAGCGACTGCGCGAACGGCTCGGTGAGGACGACGCCACGGACACCCGGCTGGTCGTGGTCACCGAGGGCGCGGTGGCCGCCACCGACGACGAGACGCCCGATCCGGCCGGCGCGGCCGTGTGGGGCCTGGTGCGGTCGGCGCAGGCCGAGTGGCCCGACCGCTTCGTCCTGCTGGACACCCTCGGAGCCGCCGCCACGGACACGGAACTGACCCGGGCCCTGAGCACCGGTGAACCCCAACTCGCCCTGCGCGACGGACGTGTGCTCGTGCCGCGGCTCGCTCGCGTCACCGGTACGGCCGACCGGGCGCCCTGGTCCGCGGAGGACACCGTCCTGATCACCGGCGCCGCTGGCACCCTCGGGCAGCTGGTCGCCCGGCACCTGGTCGCGCGACACCACGTCCGGCGGCTCGTACTGGCGTCCCGGCGCGGTGCCGAAGCACCCTCCCTGACGGACCTGACCGCCGAACTGCGCGCCCAGGGCACCGACGTCACCGTGGTGGCCTGCGACGTCGCGGAACGGCAGGCGGTGGCGGCGCTGCTGGCCGCCCACCCGGTGACAGCGGTCGTGCACGCCGCCGGAGTCGTCGACGACGCCCTGATCACGGACCTGGACGAGGAACGGCTGCGCGCCGTGATGGCACCCAAGGTGCTCGGCGCGCGCTGGCTGGACGAACTGACCCGCGACCGCGACCTGCACCGCTTCGTGCTGTTCTCCTCCGCCTCGGCCGTCCTCGGGAACCCCGGACAGGCCGCCTACTCCGCCGCCAACGCCGTCCTCGAAGCGGTGGCCCGCGACCGCCGGGCCGCCGGTCTCCCGGCCGTCTCGCTGGCCTGGGGGCTGTGGGAGGAGACCAGCGGCATCACCTCCCGCCTCACCGACGCCGACCGGGCCCGCATCGCCCGCGGCGGCATCGCCGCCCTCCCCACGGAGGAGGCCCTGGACCTCCTCGACACGGCGGTCGGGTCGGACGAGGCGGCCGTGGTGCCGGTACGGCTGGACACCGCCGCCCTGCACCGCCTCGACCCGCTGCCTCCCGTGTTCGCCGGCCTGGTCCGCGGAAGCCGTCGTACGCCGAGGCGGTCCGGCTGGGCCGACCGGCTGCGCGCGCTGTCCGACACCGACCGCCGACGCGTCGCCCTCGACCTGGTCCGCGGCCGTGCGGCCGGCGTGCTGGACCTGGCCTCGGCCGCGCAGATCGACGCCGAGCGGACCTTCACCGACCTCGGCTTCGACTCGCTGACCGCGCTGGAACTGCGCAACCAGCTCGGCACCGCCACCGGATTGCGCCTCCCCTCGACCCTCGTCTTCGACCACCCCACCCCGGCCGCGCTCGCCGACTTCGTGCTCGCGGAGGCCGGCGGACGGAGCACGGAGCCGGAGCCCGACCCCGCTGCGAGCGCGGCGGTGGTCACCGTCACCCCCGACGAGCCGATCGCGATCGTGGGGATGGCGTGCCGTTTCCCGGGTGGGGTGGGCTCGCCCGAGGACCTGTGGGACCTGGTGGTGGACGGCCGGGACGGAATCACGGCGTTTCCGCAGGACCGGGGTTGGGACCTGGCGGGGTTGCCGGTGGGACTGGGCGGGTTCGTTGCGGGTGCCGCCGACTTCGATCCGGGGTTCTTCGGGATCTCGCCGCGTGAGGCGTTGGCGATGGATCCGCAGCAGCGGTTGTTGCTGGAGACGTCGTGGGAGGCGCTGGAGCGGGCCGGGATCGACCCGCTGTCGGTGCGCGGCAGCCGCAGCGGTGTGTTCGCCGGAGTGATGTACCACGACTACGCGACCCGTCTCACGCACGTCCCGCAGGAGCTGGAGGGGTACGTCGGCAACGGCAACCTGGGCAGTGTCGCCACCGGCCGGGTCGCCTACGTCCTGGGCCTCACCGGACCGGCGATGACCGTGGACACGGCCTGCTCGTCCTCGCTCGTGGCGCTCCACCTCGCAGCACAGTCGCTGCGTTCGGGAGAGTCCGCCCTGGCGCTGGCGGGCGGCGTCACGATCATGTCCAGCCCGACGCCGTTCCGCGAGTTCGACCGCCAGGGCGGTCTCGCGGCCGACGGCCGCTGCAAGTCCTTCTCCGCCGCCGCGGACGGCACCGGTTGGTCCGAGGGCGTCGGGATGCTGGTCCTGGAGCGGCTGTCGGACGCCCGGCGCAACGGACACCGCGTCCTGGCCGTCGTGCGCGGCTCGGCGGTGAACCAGGATGGCGCCTCCAACGGCCTGACGCGCCGACGGACCGGCGCAGGACGGGTGATCCGTCGGCCGTTGGCGGCGGCGGGTGTCGGCGCGGGACGTGACGTGGTGGAGGCGCACGGTACGGGGACGACGCTGGGTGATCCGATCGAGGCGCAGGCGTTGCTGGCGACCTATGGCCGGGAGCGGGAGGGTGAGCCGTTGTGGCTGGGGTCGGTGAAGTCGAACATCGGTCACACGCAGGCGGCTTCGGGTGTGGCGGGGATCATCAAGACGGTGCTGGCGCTGGGGGAGGGGGTGTTGCCGCGGACGTGCCAGGGGAAGCCAAGTCCGCACGTGGACTGGTCCTCGGGTGCGGTGTCGCTGCTGAGTGAGGCGCGTCCCTGGCCGGAGACCGGTCGGCCGCGCCGTGCGGCGGTCTCCTCCTTCGGGGTGAGCGGCACCAATGCCCATGTCGTCATCGAGCAGGCCCCCGAGGAAGCCGTGGCGCAGGCCGGGGTGAGTTCCCCGGTGCCGGTGGCGGTGCCGGTGGTGGTGTCGGGGCGGGATGAGGTGGGGTTGGGGGTTGCGGCGGGTCGGTTGGGTGGGTTCGTTTCGGGTGACGTGGGTGTGTCGGTGGTAGAGGTTGCGCGTGCCGCTGGGGTGGGTCGTGCTGCGTTGGAGTGCCGGGGTGCGGTGGTGGCTGCTGACCGGGCTGAACTGCTGGCAGGTCTGGAGGAGTTGGCGGGTGGTGGCGGGCTTCGGGGTGTGGCCGGTCGTGGTGGGTTGACGGGGTTCTTGTTCTCGGGGCAGGGCTCGCAGTGGTCGGGGATGGGGGGTGAGCTGGCGCAGGCGTTTCCGCTGTTCGGTGAGGTGTTCGGTGAGGTGTGCGGGCGGTTGGAGGACCGCCTGGGTTTCGGACTGCGTGAGGTGGTGTGGGGCGGCGGTGACGCCGTGGACGGGACGGCGGTCGCGCAGTGTGGGTTGTTCGCGTTCGAGGTGGCGTTGTTCCGGTTGGTGGAGTCGTTCGGTGTGGTGCCGGAGTTCGTGGTGGGTCATTCGGTGGGGGAGGTGGCGGCGGCTCATGTGGCGGGGGTGTTGTCGCTGGAGGACGCGGTGCGGTTGGTAGCGGCGCGGGCGACGTTGATGGGAGAGCTGCCCTCAGGTGGGGCGATGCTGGCGGTGGGTGCCTCGGAGGACGAGGTGCTCCGAGTGCTCCAGGGGCTGTCGGGTGTGGTGGAAGTGGCGGCGGTCAATGGCGCGTCGTCGGTGGTGGTGTCGGGGGATGCGGCTGCGGTTGGTGCGGTGGAGACCGTGGCGGCCGAGCAGGGCTGGCGCCACCGGCGGTTGCGGGTGAGTCACGCGTTCCACTCGCCGCTGGTGGAGCCGGTGTTGGACCGTTTCCGTGAGGCGATCGAGGGGATCGAGTTCGGCCGTCCGAGATTGGGGTTTGTCTCGTCGGTCGAGGTGGGTGCGGCTGCGGACTCAGTGGAGTACTGGGTGCGCAACGTGCGGCAGACGGTGCGGTTCGCCGATGCGGTGACCCATGCCTGGAGGCAGGGCGTGACCCGGTTCGTGGAGATCGGCCCCGACAGTGCGTTGAGCGCCGCGGGCGCGGATTGTGTCCCGGACGACGCGGCCGTCTCGTTCGTCGCGTTGCAGCGTCGCGGGCGGCCGCAGGCGCGGGCACTCGCGGAGGGCCTGGCGCGTTTCCACGTGGCCGGCGGATCGGTCGACTGGGCGGCGTATCTCCCGCCGGCCAGGCACGTGGACCTGCCCACCACCGCCTTCCGGCGCCAACGCTACTGGCTGCACACCGACTCGGTGCCGACGCACCCCGGCGGGCACCCGCTGCTGGACGCGACCGTGGAGCTGGCCGAGGAGGACGGGTTCGTGCTGTCCGGGCGACTGGACACCCGGTCCCAGACCTGGCTGGCGGACCACACCGTGCTCGGCTCGACCGTGGTGCCCGGCAGCGTGTTCGCGGAACTGGCCCTGCACGCCGCGGCGGAGGCCGGACTCGCCGGAGTCGTCGAACTGACCCTTGAGAGACCGCTGTTGCTGCCGGAGGACACCTCGATCGAAATGCAACTGCGCGTCGGCGCACCCGGCGCGACGGGAGAACGGCCGCTGGCCGTCCACGCCCGGCCGACGGGGGAGACCGCCCCGTGGACCACCTGTGCCCGCGCCGTGCTCGGTTCCGTGACGGAGACGCCCCGGGCCGGTGCAGCCGCCGCCTGGCCGCCGCTCGACGCGACACCGATCGACGTCGGCACGGCGTACGCGGACTTCGCCGCCGCCGGGCTGGAGTACGGCCCGGCGTTCCAGGGCCTGCGCGCGGCCTGGCGGCGCGGCGAGGAGGTATTCGCCGAGATCGCCCTGCCGGACCTCACCGGCAGCGGCGGCCGGTACCAGCTGCACCCGGCCCTGCTGGACGCGGCGTTGCACGCCCTGCGCTACCTGGACGGCACCCCGGACGACCGCGCCCTGCTCCCCTTCGCGTGGAACGGGCTGGCGGTGTCCCGGACCGGCGCGACCGCGCTCAGGGTGCGCCTTTCCCCCCTGGCCGCCGGGTCGGCCCGCCTCGACCTCACCGACCCGGAAGGGGCGCCGGTCGGTGTCGTGGACGCCCTCGTCGTACGGCCGGTGACGGCAGCCCAACTCGGTCAGCAGGACACGCTGTTCGCCGAGGAACTGGTGCCCGCCACCCCCTCGGCCGACCCGGAGCCGGCCGTGGTGACGTGCACGGGCCTGGCTGAACTGGCCGAACTGGCCGAGCTGGGCGAACTAGCCGAACTGGCCGACCGGGAACCGCCCGCGGTGGTGGTGCTGCGAGACCGTCCCGAAGACGACCCGGCCCTCGCGGCCGGCCGGGCGCTGGACGCGGTGCAGACCTGGCTGGCGGAGGACCGGTTCGCCGGCAGCCGGCTGGCGCTGTGCACCCGGAACGCGCGACGCGACCCGGCCGCATCCGCCGTGTGGGGCCTCGTGCGCTCGGCACAGCAGGAACACCCGGACCGCTTCCTGCTCGCCGACATCGAGGACCCGGACGTCGAGGACGGCACGCCCGCGGACGCGGACGGCACACACACGCGCCCGGACGGCACACACGACCGTGCTGCCGCTGAGCCGGACACCACCGTCCCCGCCGCCGTCTGGAACGTGCCCGGCGGCCAGGTGGTCGTACGCGACGGTGTCCCGCTCGTCCCGCGGCTGACGCCCCTCGCCCTGTCCGCCCTCCCCGAGCGCCGCGACGCCGCTCGCCCGTTCACCGGCCCGGTGCTGATCACCGGCGGCCTCGGCACGCTCGGCGCTGCCCTGGCCCGCCACCTGGCGGCCGCCTGCGGCGTGCGTGACCTGGTGCTCACCGGGCGCCGAGGACCGGACACCCCGGGCGCCGCCGCCCTGGCCGACGAACTCGCCCGGCTCGGTGCCGTCACCCGGATCGTGGCCTGCGACGTGACGGACCGGGATGCCGTGGCCGCCCTGCTGGAGCAGCACCCGGTCACGGCCGTGGTGCACACGGCGGGCACCGTGGACGACGGCGTGGTCACCGCCCTGAGCCAGGAACGGCTCGCGGCGGTACTGGCTCCGAAGGTGCTCGGCGCCCGCTGGCTCGACGAACTGACCCGGGACCGGGAACTGACCGACTTCGTGCTGTTCTCCTCCGCCGCCGGACTCCTCGGCTCGCCCGGACAGGGCGCCTACGCGGCGGCCAACGCCGCCCTCGACGCGCTGGCCCGCCGGCGCCGGGCCGCCGGTCTCCCGGCCGTCTCGCTGGCCTGGGGGCTGTGGGAGGAGACCAGCGGCATCACCGCGCACCTCACCGACGCCGACCGGGCACGCATCGCCCGCACCGGGCTGCGGCCCCTGGCCACCTCCGAGGCGCTGGAGCTGTTCGACCTGGCGCGGACCACCGACGAGCCGGTGCTCGCTCCGATGCGCCTCGACCGGGCGGCCGTCAGGTCGGCGGGCCCGGTGCCGGCGGTGCTCCGGAGCCTGGTGCGGGGCGCCCCCGCCCCGGCCACCGGCGCCCAGGCGGCCGACGACCCGACCTCACCGAGCACCCTGACCTCACTGTCCGGACCGGAACGGGAGAAGGCCCTGCTGGCCCTGGTGCGCGCCGAGGCGGCGGCCGTCCTCGCCCACGACTCACCGGACGCCGTCCTCGGGCACCGCACCTTCGCCGAACTCGGCGTCGACTCCCTGGCCGCCGTGGAACTGCGCAACCGTCTCGCCGCACGGACCGGCGTCCGGCTCCCCGCCGCCGTCGTGTTCGAGCATCCGACCCCGGCGGCCCTCGCGGCACACCTGTCCGCGAGCCTGCCCGACACCGACGGCACCGCGGGCGTCTCCGTGAGCGATACCGTCGACCTG", "orf_prot_sequence": "MSEEEKLRGYLKRVMNDLRKANRRLEKAERARTEPIAIVGMACRLPGGVRSPEDLWQVLAEGRDLTGDLPTDRGWDVDALYDPDPERSGHLYVRRGGFLDDPAAFDAAFFGISPREALAMDPQQRLLLETSWEALERAGIDPLSLRGSRTGVFVGQNHQEYGTRLAHAPTSVEGHLVTGVVPSVLSGRISYTLGLEGPAVTVDTACSTSLVTLHLAVQSLRNGESSLAVTGGVTVLANPGPLVEFSRQRVLAADGRCKAFSAAADGMGMAEGVGVLVLERLSDARRNGHRVLAVVRGSAVNQDGASNGLTAPNGPSQQRVIRAALANAGLAPADIDVVEAHGTGTSLGDPIEAQALLATYGVHRERPLHLGTVKSNIGHTLAAAGVAGVIKSVLALRHGTVPKTLHAETPSPHIDWSSGALLLATEATPWPSGERPRRAAVSSFGISGTNAHVVLEEAPVGEEVPVGEGVGDPVVPVPVPVVVSGRDEVGLGVAAGRLGAFVSADVGVSVVGMARAAGVGRAALECRGAVVAADRDDLLAGLEELSAGDGIRGVAGRGGLTGFVFSGQGSQWSGMGGELARAFPLFGEVFGEVCGRLGERLGFGLREVVLSGGEAVDGTVVAQCGLFAFEVALFRLVESFGVVPEFVVGHSVGEVAAAHVAGVLSLEDAVRLVAARAVLMGDLPSGGAMLAVGAPEAEIGEVLQGLEGVVGVAAVNGASSVVVSGDARAVGEVQLVAAGRGWRHRRLRVSHAFHSPLMEPVLDRFREAVEGIEFGRPRLGFVSSVEVGAAADSAEYWVRNVRQTVRFADAVGHAWRQGVRRFVEIGPDSALTAAGADCVPGDAGVSFVALQRRERPQARALAEGLARFHVAGGSVDWAAYLPPAGHVDLPTTAFRHQRYWLDSTEVTDPAALGAVPVRHPLLGALVPMPGELGSVFTGRLGLRGQPWIADHRVTGAAVLPGTAFLELARRAGELLGDLRVEELVLEVPLTLPAEGDTALRVVVGEPDAAGRRTVEAHTRPEEPGSPWTRHATGVLVEDTDDTPAAGGSPVAELVQWPPTAAEAVDLDDLYPRLAGTGLEYGPAFQGLRAAWQRGEELFAEVALAEQERGRAQEFGMHPALMDAALHALGVDDRHGLRLPFAFHGVRTYAPGTSELRVRLAPVGEDSIRVDLADSLGTPVATVERLVLRALTGELRPVRPSSLHRLDWTPVPTPQGGGQGTATFFRVPHLPVAECTAAVLERLRERLGEDDATDTRLVVVTEGAVAATDDETPDPAGAAVWGLVRSAQAEWPDRFVLLDTLGAAATDTELTRALSTGEPQLALRDGRVLVPRLARVTGTADRAPWSAEDTVLITGAAGTLGQLVARHLVARHHVRRLVLASRRGAEAPSLTDLTAELRAQGTDVTVVACDVAERQAVAALLAAHPVTAVVHAAGVVDDALITDLDEERLRAVMAPKVLGARWLDELTRDRDLHRFVLFSSASAVLGNPGQAAYSAANAVLEAVARDRRAAGLPAVSLAWGLWEETSGITSRLTDADRARIARGGIAALPTEEALDLLDTAVGSDEAAVVPVRLDTAALHRLDPLPPVFAGLVRGSRRTPRRSGWADRLRALSDTDRRRVALDLVRGRAAGVLDLASAAQIDAERTFTDLGFDSLTALELRNQLGTATGLRLPSTLVFDHPTPAALADFVLAEAGGRSTEPEPDPAASAAVVTVTPDEPIAIVGMACRFPGGVGSPEDLWDLVVDGRDGITAFPQDRGWDLAGLPVGLGGFVAGAADFDPGFFGISPREALAMDPQQRLLLETSWEALERAGIDPLSVRGSRSGVFAGVMYHDYATRLTHVPQELEGYVGNGNLGSVATGRVAYVLGLTGPAMTVDTACSSSLVALHLAAQSLRSGESALALAGGVTIMSSPTPFREFDRQGGLAADGRCKSFSAAADGTGWSEGVGMLVLERLSDARRNGHRVLAVVRGSAVNQDGASNGLTRRRTGAGRVIRRPLAAAGVGAGRDVVEAHGTGTTLGDPIEAQALLATYGREREGEPLWLGSVKSNIGHTQAASGVAGIIKTVLALGEGVLPRTCQGKPSPHVDWSSGAVSLLSEARPWPETGRPRRAAVSSFGVSGTNAHVVIEQAPEEAVAQAGVSSPVPVAVPVVVSGRDEVGLGVAAGRLGGFVSGDVGVSVVEVARAAGVGRAALECRGAVVAADRAELLAGLEELAGGGGLRGVAGRGGLTGFLFSGQGSQWSGMGGELAQAFPLFGEVFGEVCGRLEDRLGFGLREVVWGGGDAVDGTAVAQCGLFAFEVALFRLVESFGVVPEFVVGHSVGEVAAAHVAGVLSLEDAVRLVAARATLMGELPSGGAMLAVGASEDEVLRVLQGLSGVVEVAAVNGASSVVVSGDAAAVGAVETVAAEQGWRHRRLRVSHAFHSPLVEPVLDRFREAIEGIEFGRPRLGFVSSVEVGAAADSVEYWVRNVRQTVRFADAVTHAWRQGVTRFVEIGPDSALSAAGADCVPDDAAVSFVALQRRGRPQARALAEGLARFHVAGGSVDWAAYLPPARHVDLPTTAFRRQRYWLHTDSVPTHPGGHPLLDATVELAEEDGFVLSGRLDTRSQTWLADHTVLGSTVVPGSVFAELALHAAAEAGLAGVVELTLERPLLLPEDTSIEMQLRVGAPGATGERPLAVHARPTGETAPWTTCARAVLGSVTETPRAGAAAAWPPLDATPIDVGTAYADFAAAGLEYGPAFQGLRAAWRRGEEVFAEIALPDLTGSGGRYQLHPALLDAALHALRYLDGTPDDRALLPFAWNGLAVSRTGATALRVRLSPLAAGSARLDLTDPEGAPVGVVDALVVRPVTAAQLGQQDTLFAEELVPATPSADPEPAVVTCTGLAELAELAELGELAELADREPPAVVVLRDRPEDDPALAAGRALDAVQTWLAEDRFAGSRLALCTRNARRDPAASAVWGLVRSAQQEHPDRFLLADIEDPDVEDGTPADADGTHTRPDGTHDRAAAEPDTTVPAAVWNVPGGQVVVRDGVPLVPRLTPLALSALPERRDAARPFTGPVLITGGLGTLGAALARHLAAACGVRDLVLTGRRGPDTPGAAALADELARLGAVTRIVACDVTDRDAVAALLEQHPVTAVVHTAGTVDDGVVTALSQERLAAVLAPKVLGARWLDELTRDRELTDFVLFSSAAGLLGSPGQGAYAAANAALDALARRRRAAGLPAVSLAWGLWEETSGITAHLTDADRARIARTGLRPLATSEALELFDLARTTDEPVLAPMRLDRAAVRSAGPVPAVLRSLVRGAPAPATGAQAADDPTSPSTLTSLSGPEREKALLALVRAEAAAVLAHDSPDAVLGHRTFAELGVDSLAAVELRNRLAARTGVRLPAAVVFEHPTPAALAAHLSASLPDTDGTAGVSVSDTVDL", "perc_identity": 30.68}, "gnl|BL_ORD_ID|3707|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 25084, "orf_end": 35349, "orf_from": "BGC0000049.1|E-492_10 ", "model_name": "MYX-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4777", "ARO_accession": "3006955", "ARO_name": "MYX-1", "ARO_category": {"43887": {"category_aro_accession": "3005427", "category_aro_cvterm_id": "43887", "category_aro_name": "MYX beta-lactamase", "category_aro_description": "MYX beta-lactamases are class B1 beta-lactamases found in Myxococcus.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.40185, "max_identities": 33, "bit_score": 28.8758, "cvterm_id": "45474", "query": "FFGISPREALAMDPQQRLLLETSWEALERAGIDPLSVRGSRSGVFAGVMYHDYATRLTHVPQELEGYVGNGNLGSVATGRVAYVLGLTGPAMTVDTACSSSLVALHL", "match": "F  +S    +  D +  LL++T W+A + A +   +    R  V A V+ H +  RL  VP       G    G   T R+A  LGL GP  T   A +S++ +L L", "sequence_from_db": "FGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHEDRLGGVPALAPH--GIPVHGLEETARIATSLGLPGPTETF--AKTSTVDSLEL", "sequence_from_broadstreet": "MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAPGVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPGAGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVVVPGHGQPGGPELLGHTEALLR", "dna_sequence_from_broadstreet": "ATGACGTTGTTTCCTCTTCGTTGGTTTTGTGCCGGTGCTCTTCTCATCACCCTGAGCACCGCCTGCACCCGCTCCACGCCGGCCGCGACGGTGGAGCGGAACATCCCCGTGAAGGCGCAGTCCCAGGGTCCGGACGAATACGTGCTGGCGGATGACGTGAGCGTGCGGAAGCTCGCGCCTGGCGTGTGGCTGCACATCACGGTGGTGACGTTGGAGCCATTCGGCCGCGTCTCCACCAACGGGCTCATCATCGAGGACGGTGAAACGTCCTTGCTGGTCGACACGGGCTGGGATGCACGGCAGGGCGCGCTACTGCTCGACTGGGCCCGGGACACGCTTCGGCGTCCGGTCCGCGCGGCGGTGGTGACGCACTTCCATGAAGATCGCCTCGGTGGTGTTCCGGCGCTCGCCCCGCATGGCATCCCCGTCCATGGCTTGGAGGAGACGGCACGGATTGCCACGTCCCTGGGCCTGCCAGGCCCCACGGAGACCTTCGCCAAGACGAGCACGGTGGACTCCCTGGAGCTCTTCTTCCCGGGGGCGGGCCACGCGAAGGACAACATCGTCGTGTGGCACCGGGACAGCGGCGTGCTGTTCGGCGGCTGCTTCGTGAAGGACGGCGCCTCGACGAACCTGGGCAACGTGGCGGACGCGGACGTAGCGGCCTGGCCCGCGAGCCTGTCGCGGACGCGGCAGCGGTTTCCGGAGGCGCGCGTGGTGGTCCCGGGTCACGGACAGCCCGGTGGGCCGGAGCTGCTGGGCCACACGGAAGCGCTGCTCCGCTGA", "partial": "0", "query_start": 30421, "query_end": 30741, "hit_start": 219, "hit_end": 528, "orf_dna_sequence": "ATGTCCGAGGAAGAGAAGCTCAGGGGTTACCTGAAGCGGGTCATGAACGACCTGCGCAAGGCCAACCGCCGCCTGGAGAAGGCGGAACGGGCCCGCACCGAGCCCATCGCGATCGTCGGCATGGCCTGCCGCCTCCCCGGCGGCGTGCGCTCACCGGAGGACCTGTGGCAGGTGCTCGCCGAGGGCCGTGACCTCACGGGCGACCTGCCCACCGACCGCGGCTGGGACGTCGACGCCCTCTACGACCCCGACCCCGAGCGCTCCGGCCACCTCTATGTGCGGCGCGGCGGCTTCCTCGACGACCCGGCCGCCTTCGACGCCGCCTTCTTCGGGATCTCACCCCGCGAGGCGCTGGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGACCTCGTGGGAGGCGCTGGAGCGGGCCGGTATCGACCCGCTGTCGCTGCGCGGCAGCCGCACCGGCGTGTTCGTCGGCCAGAACCACCAGGAGTACGGAACCAGGCTCGCGCACGCCCCCACCAGCGTCGAGGGCCACCTCGTCACCGGCGTGGTACCCAGCGTGCTGTCGGGCCGCATCTCCTACACCCTCGGCCTCGAGGGCCCCGCCGTCACCGTGGACACGGCCTGCTCCACCTCCCTGGTCACCCTGCACCTGGCCGTGCAGTCCCTGCGCAACGGCGAGTCCTCGCTCGCGGTGACGGGCGGCGTCACCGTCCTGGCCAACCCCGGCCCCCTGGTGGAGTTCAGCAGGCAGCGCGTGCTGGCCGCGGACGGCCGCTGCAAGGCGTTCTCCGCCGCCGCGGACGGCATGGGCATGGCCGAGGGCGTCGGCGTACTGGTCCTGGAGCGGCTCTCGGACGCCCGGCGCAACGGGCACCGGGTGCTGGCCGTCGTCCGGGGCTCGGCGGTGAACCAGGACGGCGCCTCCAACGGCCTGACCGCACCCAACGGCCCCTCCCAGCAACGCGTCATCCGGGCCGCGCTGGCGAACGCGGGGCTCGCCCCGGCGGACATCGACGTCGTGGAGGCGCACGGCACCGGCACCTCGCTCGGCGACCCGATCGAGGCCCAGGCCCTGCTGGCCACCTACGGTGTCCACCGCGAACGGCCGCTGCACCTGGGCACGGTGAAGTCCAACATCGGCCACACCCTCGCCGCGGCGGGCGTGGCCGGCGTCATCAAGTCCGTCCTCGCCCTGCGCCACGGCACCGTGCCGAAGACGCTGCACGCGGAAACCCCTTCCCCGCACATCGACTGGTCCTCCGGCGCCCTCCTGCTCGCGACGGAGGCGACCCCCTGGCCGAGCGGCGAACGGCCGCGCCGCGCCGCGGTCTCCTCCTTCGGCATCAGCGGCACGAATGCGCACGTGGTGCTGGAGGAGGCGCCGGTGGGGGAGGAGGTGCCGGTTGGTGAGGGGGTTGGTGACCCGGTGGTGCCGGTGCCGGTGCCGGTGGTGGTGTCGGGGCGGGATGAGGTGGGGTTGGGCGTTGCGGCGGGTCGGCTGGGTGCTTTTGTGTCGGCTGATGTGGGTGTGTCGGTGGTGGGGATGGCGCGTGCTGCGGGGGTGGGTCGTGCCGCATTGGAGTGCCGGGGCGCGGTGGTGGCCGCGGACCGCGATGACTTGCTGGCGGGGTTGGAGGAGTTGTCAGCCGGGGACGGGATCCGTGGTGTGGCAGGCCGTGGCGGGCTGACCGGGTTTGTGTTCTCGGGTCAGGGGTCGCAGTGGTCGGGGATGGGGGGTGAGCTGGCGCGGGCGTTCCCGCTGTTCGGTGAGGTGTTCGGTGAGGTGTGCGGTCGGTTGGGGGAGCGGCTGGGCTTCGGGTTGCGTGAGGTGGTGTTGAGCGGCGGCGAAGCTGTCGACGGGACGGTGGTCGCCCAGTGCGGGCTGTTCGCTTTCGAGGTGGCGTTGTTCCGGTTGGTGGAGTCGTTCGGTGTGGTGCCGGAGTTCGTGGTGGGTCATTCGGTGGGGGAGGTGGCGGCAGCTCATGTGGCGGGAGTGCTGTCGCTGGAGGATGCGGTGCGGCTGGTGGCGGCGCGGGCGGTGTTGATGGGGGACTTGCCGTCGGGTGGGGCGATGCTGGCGGTGGGTGCCCCGGAGGCAGAGATCGGCGAGGTGCTCCAGGGTCTGGAGGGTGTTGTAGGGGTGGCGGCGGTCAATGGTGCGTCGTCGGTGGTGGTGTCGGGGGATGCGCGGGCGGTCGGTGAGGTGCAGCTGGTGGCGGCTGGGCGGGGCTGGCGGCACAGGCGGTTGCGGGTGAGTCACGCGTTTCATTCGCCCTTGATGGAGCCGGTGTTGGACCGCTTCCGGGAGGCGGTCGAAGGGATCGAGTTCGGCCGCCCCCGGTTGGGTTTCGTCTCCTCGGTCGAGGTGGGTGCGGCTGCGGACTCGGCGGAGTACTGGGTACGCAATGTGCGGCAGACGGTGCGCTTCGCGGATGCGGTCGGGCATGCGTGGCGGCAGGGCGTGAGGCGTTTCGTGGAGATAGGTCCCGACAGTGCGCTGACCGCTGCGGGTGCGGACTGTGTCCCGGGTGACGCGGGGGTGTCGTTCGTCGCGTTGCAGCGTCGCGAGCGGCCGCAGGCGCGGGCACTGGCGGAGGGCTTGGCGCGTTTCCACGTGGCGGGCGGGTCGGTGGACTGGGCGGCGTATCTGCCCCCGGCCGGCCACGTGGACCTGCCCACCACCGCCTTCCGGCACCAGCGCTACTGGCTGGACTCCACCGAAGTGACCGACCCCGCCGCGCTGGGCGCGGTACCCGTCCGGCACCCCCTGCTCGGCGCGCTGGTCCCGATGCCGGGCGAGCTCGGCTCCGTGTTCACCGGGCGGCTCGGCCTGCGGGGTCAGCCCTGGATCGCCGACCACCGCGTCACCGGCGCGGCCGTGCTGCCCGGCACCGCGTTCCTCGAACTCGCCCGGCGCGCCGGCGAACTCCTCGGCGACCTGCGCGTGGAGGAGCTGGTCCTCGAAGTGCCCCTGACGTTGCCCGCCGAGGGCGACACCGCCCTGCGCGTCGTCGTCGGCGAACCCGACGCCGCGGGGCGCCGTACCGTCGAGGCGCATACCCGGCCGGAGGAGCCCGGGTCACCGTGGACCCGGCACGCCACGGGCGTCCTGGTCGAGGACACGGACGACACGCCTGCCGCCGGGGGCAGCCCGGTCGCGGAACTGGTGCAGTGGCCCCCGACCGCCGCCGAAGCCGTCGACCTGGACGACCTCTACCCGCGCCTGGCCGGGACCGGGCTGGAGTACGGCCCGGCGTTCCAGGGCCTGCGCGCGGCCTGGCAGCGCGGCGAGGAGCTCTTCGCCGAGGTCGCCCTGGCCGAGCAGGAGCGCGGCCGGGCGCAGGAGTTCGGGATGCACCCGGCGCTGATGGACGCCGCCCTGCACGCCCTCGGCGTGGACGACCGCCACGGACTGCGGCTGCCGTTCGCCTTCCACGGTGTCCGTACGTACGCCCCCGGCACGTCGGAGCTGCGGGTCCGCCTCGCCCCGGTCGGGGAGGACTCGATCCGCGTCGACCTCGCGGACTCCCTCGGCACCCCGGTGGCCACCGTCGAACGTCTGGTGCTGCGCGCCCTCACGGGCGAGCTGCGCCCCGTACGACCGAGCTCGCTCCACCGGCTCGACTGGACACCCGTGCCCACCCCCCAGGGAGGCGGTCAGGGCACCGCCACGTTCTTCCGCGTCCCGCACCTCCCGGTCGCCGAGTGCACCGCCGCGGTGCTGGAGCGACTGCGCGAACGGCTCGGTGAGGACGACGCCACGGACACCCGGCTGGTCGTGGTCACCGAGGGCGCGGTGGCCGCCACCGACGACGAGACGCCCGATCCGGCCGGCGCGGCCGTGTGGGGCCTGGTGCGGTCGGCGCAGGCCGAGTGGCCCGACCGCTTCGTCCTGCTGGACACCCTCGGAGCCGCCGCCACGGACACGGAACTGACCCGGGCCCTGAGCACCGGTGAACCCCAACTCGCCCTGCGCGACGGACGTGTGCTCGTGCCGCGGCTCGCTCGCGTCACCGGTACGGCCGACCGGGCGCCCTGGTCCGCGGAGGACACCGTCCTGATCACCGGCGCCGCTGGCACCCTCGGGCAGCTGGTCGCCCGGCACCTGGTCGCGCGACACCACGTCCGGCGGCTCGTACTGGCGTCCCGGCGCGGTGCCGAAGCACCCTCCCTGACGGACCTGACCGCCGAACTGCGCGCCCAGGGCACCGACGTCACCGTGGTGGCCTGCGACGTCGCGGAACGGCAGGCGGTGGCGGCGCTGCTGGCCGCCCACCCGGTGACAGCGGTCGTGCACGCCGCCGGAGTCGTCGACGACGCCCTGATCACGGACCTGGACGAGGAACGGCTGCGCGCCGTGATGGCACCCAAGGTGCTCGGCGCGCGCTGGCTGGACGAACTGACCCGCGACCGCGACCTGCACCGCTTCGTGCTGTTCTCCTCCGCCTCGGCCGTCCTCGGGAACCCCGGACAGGCCGCCTACTCCGCCGCCAACGCCGTCCTCGAAGCGGTGGCCCGCGACCGCCGGGCCGCCGGTCTCCCGGCCGTCTCGCTGGCCTGGGGGCTGTGGGAGGAGACCAGCGGCATCACCTCCCGCCTCACCGACGCCGACCGGGCCCGCATCGCCCGCGGCGGCATCGCCGCCCTCCCCACGGAGGAGGCCCTGGACCTCCTCGACACGGCGGTCGGGTCGGACGAGGCGGCCGTGGTGCCGGTACGGCTGGACACCGCCGCCCTGCACCGCCTCGACCCGCTGCCTCCCGTGTTCGCCGGCCTGGTCCGCGGAAGCCGTCGTACGCCGAGGCGGTCCGGCTGGGCCGACCGGCTGCGCGCGCTGTCCGACACCGACCGCCGACGCGTCGCCCTCGACCTGGTCCGCGGCCGTGCGGCCGGCGTGCTGGACCTGGCCTCGGCCGCGCAGATCGACGCCGAGCGGACCTTCACCGACCTCGGCTTCGACTCGCTGACCGCGCTGGAACTGCGCAACCAGCTCGGCACCGCCACCGGATTGCGCCTCCCCTCGACCCTCGTCTTCGACCACCCCACCCCGGCCGCGCTCGCCGACTTCGTGCTCGCGGAGGCCGGCGGACGGAGCACGGAGCCGGAGCCCGACCCCGCTGCGAGCGCGGCGGTGGTCACCGTCACCCCCGACGAGCCGATCGCGATCGTGGGGATGGCGTGCCGTTTCCCGGGTGGGGTGGGCTCGCCCGAGGACCTGTGGGACCTGGTGGTGGACGGCCGGGACGGAATCACGGCGTTTCCGCAGGACCGGGGTTGGGACCTGGCGGGGTTGCCGGTGGGACTGGGCGGGTTCGTTGCGGGTGCCGCCGACTTCGATCCGGGGTTCTTCGGGATCTCGCCGCGTGAGGCGTTGGCGATGGATCCGCAGCAGCGGTTGTTGCTGGAGACGTCGTGGGAGGCGCTGGAGCGGGCCGGGATCGACCCGCTGTCGGTGCGCGGCAGCCGCAGCGGTGTGTTCGCCGGAGTGATGTACCACGACTACGCGACCCGTCTCACGCACGTCCCGCAGGAGCTGGAGGGGTACGTCGGCAACGGCAACCTGGGCAGTGTCGCCACCGGCCGGGTCGCCTACGTCCTGGGCCTCACCGGACCGGCGATGACCGTGGACACGGCCTGCTCGTCCTCGCTCGTGGCGCTCCACCTCGCAGCACAGTCGCTGCGTTCGGGAGAGTCCGCCCTGGCGCTGGCGGGCGGCGTCACGATCATGTCCAGCCCGACGCCGTTCCGCGAGTTCGACCGCCAGGGCGGTCTCGCGGCCGACGGCCGCTGCAAGTCCTTCTCCGCCGCCGCGGACGGCACCGGTTGGTCCGAGGGCGTCGGGATGCTGGTCCTGGAGCGGCTGTCGGACGCCCGGCGCAACGGACACCGCGTCCTGGCCGTCGTGCGCGGCTCGGCGGTGAACCAGGATGGCGCCTCCAACGGCCTGACGCGCCGACGGACCGGCGCAGGACGGGTGATCCGTCGGCCGTTGGCGGCGGCGGGTGTCGGCGCGGGACGTGACGTGGTGGAGGCGCACGGTACGGGGACGACGCTGGGTGATCCGATCGAGGCGCAGGCGTTGCTGGCGACCTATGGCCGGGAGCGGGAGGGTGAGCCGTTGTGGCTGGGGTCGGTGAAGTCGAACATCGGTCACACGCAGGCGGCTTCGGGTGTGGCGGGGATCATCAAGACGGTGCTGGCGCTGGGGGAGGGGGTGTTGCCGCGGACGTGCCAGGGGAAGCCAAGTCCGCACGTGGACTGGTCCTCGGGTGCGGTGTCGCTGCTGAGTGAGGCGCGTCCCTGGCCGGAGACCGGTCGGCCGCGCCGTGCGGCGGTCTCCTCCTTCGGGGTGAGCGGCACCAATGCCCATGTCGTCATCGAGCAGGCCCCCGAGGAAGCCGTGGCGCAGGCCGGGGTGAGTTCCCCGGTGCCGGTGGCGGTGCCGGTGGTGGTGTCGGGGCGGGATGAGGTGGGGTTGGGGGTTGCGGCGGGTCGGTTGGGTGGGTTCGTTTCGGGTGACGTGGGTGTGTCGGTGGTAGAGGTTGCGCGTGCCGCTGGGGTGGGTCGTGCTGCGTTGGAGTGCCGGGGTGCGGTGGTGGCTGCTGACCGGGCTGAACTGCTGGCAGGTCTGGAGGAGTTGGCGGGTGGTGGCGGGCTTCGGGGTGTGGCCGGTCGTGGTGGGTTGACGGGGTTCTTGTTCTCGGGGCAGGGCTCGCAGTGGTCGGGGATGGGGGGTGAGCTGGCGCAGGCGTTTCCGCTGTTCGGTGAGGTGTTCGGTGAGGTGTGCGGGCGGTTGGAGGACCGCCTGGGTTTCGGACTGCGTGAGGTGGTGTGGGGCGGCGGTGACGCCGTGGACGGGACGGCGGTCGCGCAGTGTGGGTTGTTCGCGTTCGAGGTGGCGTTGTTCCGGTTGGTGGAGTCGTTCGGTGTGGTGCCGGAGTTCGTGGTGGGTCATTCGGTGGGGGAGGTGGCGGCGGCTCATGTGGCGGGGGTGTTGTCGCTGGAGGACGCGGTGCGGTTGGTAGCGGCGCGGGCGACGTTGATGGGAGAGCTGCCCTCAGGTGGGGCGATGCTGGCGGTGGGTGCCTCGGAGGACGAGGTGCTCCGAGTGCTCCAGGGGCTGTCGGGTGTGGTGGAAGTGGCGGCGGTCAATGGCGCGTCGTCGGTGGTGGTGTCGGGGGATGCGGCTGCGGTTGGTGCGGTGGAGACCGTGGCGGCCGAGCAGGGCTGGCGCCACCGGCGGTTGCGGGTGAGTCACGCGTTCCACTCGCCGCTGGTGGAGCCGGTGTTGGACCGTTTCCGTGAGGCGATCGAGGGGATCGAGTTCGGCCGTCCGAGATTGGGGTTTGTCTCGTCGGTCGAGGTGGGTGCGGCTGCGGACTCAGTGGAGTACTGGGTGCGCAACGTGCGGCAGACGGTGCGGTTCGCCGATGCGGTGACCCATGCCTGGAGGCAGGGCGTGACCCGGTTCGTGGAGATCGGCCCCGACAGTGCGTTGAGCGCCGCGGGCGCGGATTGTGTCCCGGACGACGCGGCCGTCTCGTTCGTCGCGTTGCAGCGTCGCGGGCGGCCGCAGGCGCGGGCACTCGCGGAGGGCCTGGCGCGTTTCCACGTGGCCGGCGGATCGGTCGACTGGGCGGCGTATCTCCCGCCGGCCAGGCACGTGGACCTGCCCACCACCGCCTTCCGGCGCCAACGCTACTGGCTGCACACCGACTCGGTGCCGACGCACCCCGGCGGGCACCCGCTGCTGGACGCGACCGTGGAGCTGGCCGAGGAGGACGGGTTCGTGCTGTCCGGGCGACTGGACACCCGGTCCCAGACCTGGCTGGCGGACCACACCGTGCTCGGCTCGACCGTGGTGCCCGGCAGCGTGTTCGCGGAACTGGCCCTGCACGCCGCGGCGGAGGCCGGACTCGCCGGAGTCGTCGAACTGACCCTTGAGAGACCGCTGTTGCTGCCGGAGGACACCTCGATCGAAATGCAACTGCGCGTCGGCGCACCCGGCGCGACGGGAGAACGGCCGCTGGCCGTCCACGCCCGGCCGACGGGGGAGACCGCCCCGTGGACCACCTGTGCCCGCGCCGTGCTCGGTTCCGTGACGGAGACGCCCCGGGCCGGTGCAGCCGCCGCCTGGCCGCCGCTCGACGCGACACCGATCGACGTCGGCACGGCGTACGCGGACTTCGCCGCCGCCGGGCTGGAGTACGGCCCGGCGTTCCAGGGCCTGCGCGCGGCCTGGCGGCGCGGCGAGGAGGTATTCGCCGAGATCGCCCTGCCGGACCTCACCGGCAGCGGCGGCCGGTACCAGCTGCACCCGGCCCTGCTGGACGCGGCGTTGCACGCCCTGCGCTACCTGGACGGCACCCCGGACGACCGCGCCCTGCTCCCCTTCGCGTGGAACGGGCTGGCGGTGTCCCGGACCGGCGCGACCGCGCTCAGGGTGCGCCTTTCCCCCCTGGCCGCCGGGTCGGCCCGCCTCGACCTCACCGACCCGGAAGGGGCGCCGGTCGGTGTCGTGGACGCCCTCGTCGTACGGCCGGTGACGGCAGCCCAACTCGGTCAGCAGGACACGCTGTTCGCCGAGGAACTGGTGCCCGCCACCCCCTCGGCCGACCCGGAGCCGGCCGTGGTGACGTGCACGGGCCTGGCTGAACTGGCCGAACTGGCCGAGCTGGGCGAACTAGCCGAACTGGCCGACCGGGAACCGCCCGCGGTGGTGGTGCTGCGAGACCGTCCCGAAGACGACCCGGCCCTCGCGGCCGGCCGGGCGCTGGACGCGGTGCAGACCTGGCTGGCGGAGGACCGGTTCGCCGGCAGCCGGCTGGCGCTGTGCACCCGGAACGCGCGACGCGACCCGGCCGCATCCGCCGTGTGGGGCCTCGTGCGCTCGGCACAGCAGGAACACCCGGACCGCTTCCTGCTCGCCGACATCGAGGACCCGGACGTCGAGGACGGCACGCCCGCGGACGCGGACGGCACACACACGCGCCCGGACGGCACACACGACCGTGCTGCCGCTGAGCCGGACACCACCGTCCCCGCCGCCGTCTGGAACGTGCCCGGCGGCCAGGTGGTCGTACGCGACGGTGTCCCGCTCGTCCCGCGGCTGACGCCCCTCGCCCTGTCCGCCCTCCCCGAGCGCCGCGACGCCGCTCGCCCGTTCACCGGCCCGGTGCTGATCACCGGCGGCCTCGGCACGCTCGGCGCTGCCCTGGCCCGCCACCTGGCGGCCGCCTGCGGCGTGCGTGACCTGGTGCTCACCGGGCGCCGAGGACCGGACACCCCGGGCGCCGCCGCCCTGGCCGACGAACTCGCCCGGCTCGGTGCCGTCACCCGGATCGTGGCCTGCGACGTGACGGACCGGGATGCCGTGGCCGCCCTGCTGGAGCAGCACCCGGTCACGGCCGTGGTGCACACGGCGGGCACCGTGGACGACGGCGTGGTCACCGCCCTGAGCCAGGAACGGCTCGCGGCGGTACTGGCTCCGAAGGTGCTCGGCGCCCGCTGGCTCGACGAACTGACCCGGGACCGGGAACTGACCGACTTCGTGCTGTTCTCCTCCGCCGCCGGACTCCTCGGCTCGCCCGGACAGGGCGCCTACGCGGCGGCCAACGCCGCCCTCGACGCGCTGGCCCGCCGGCGCCGGGCCGCCGGTCTCCCGGCCGTCTCGCTGGCCTGGGGGCTGTGGGAGGAGACCAGCGGCATCACCGCGCACCTCACCGACGCCGACCGGGCACGCATCGCCCGCACCGGGCTGCGGCCCCTGGCCACCTCCGAGGCGCTGGAGCTGTTCGACCTGGCGCGGACCACCGACGAGCCGGTGCTCGCTCCGATGCGCCTCGACCGGGCGGCCGTCAGGTCGGCGGGCCCGGTGCCGGCGGTGCTCCGGAGCCTGGTGCGGGGCGCCCCCGCCCCGGCCACCGGCGCCCAGGCGGCCGACGACCCGACCTCACCGAGCACCCTGACCTCACTGTCCGGACCGGAACGGGAGAAGGCCCTGCTGGCCCTGGTGCGCGCCGAGGCGGCGGCCGTCCTCGCCCACGACTCACCGGACGCCGTCCTCGGGCACCGCACCTTCGCCGAACTCGGCGTCGACTCCCTGGCCGCCGTGGAACTGCGCAACCGTCTCGCCGCACGGACCGGCGTCCGGCTCCCCGCCGCCGTCGTGTTCGAGCATCCGACCCCGGCGGCCCTCGCGGCACACCTGTCCGCGAGCCTGCCCGACACCGACGGCACCGCGGGCGTCTCCGTGAGCGATACCGTCGACCTG", "orf_prot_sequence": "MSEEEKLRGYLKRVMNDLRKANRRLEKAERARTEPIAIVGMACRLPGGVRSPEDLWQVLAEGRDLTGDLPTDRGWDVDALYDPDPERSGHLYVRRGGFLDDPAAFDAAFFGISPREALAMDPQQRLLLETSWEALERAGIDPLSLRGSRTGVFVGQNHQEYGTRLAHAPTSVEGHLVTGVVPSVLSGRISYTLGLEGPAVTVDTACSTSLVTLHLAVQSLRNGESSLAVTGGVTVLANPGPLVEFSRQRVLAADGRCKAFSAAADGMGMAEGVGVLVLERLSDARRNGHRVLAVVRGSAVNQDGASNGLTAPNGPSQQRVIRAALANAGLAPADIDVVEAHGTGTSLGDPIEAQALLATYGVHRERPLHLGTVKSNIGHTLAAAGVAGVIKSVLALRHGTVPKTLHAETPSPHIDWSSGALLLATEATPWPSGERPRRAAVSSFGISGTNAHVVLEEAPVGEEVPVGEGVGDPVVPVPVPVVVSGRDEVGLGVAAGRLGAFVSADVGVSVVGMARAAGVGRAALECRGAVVAADRDDLLAGLEELSAGDGIRGVAGRGGLTGFVFSGQGSQWSGMGGELARAFPLFGEVFGEVCGRLGERLGFGLREVVLSGGEAVDGTVVAQCGLFAFEVALFRLVESFGVVPEFVVGHSVGEVAAAHVAGVLSLEDAVRLVAARAVLMGDLPSGGAMLAVGAPEAEIGEVLQGLEGVVGVAAVNGASSVVVSGDARAVGEVQLVAAGRGWRHRRLRVSHAFHSPLMEPVLDRFREAVEGIEFGRPRLGFVSSVEVGAAADSAEYWVRNVRQTVRFADAVGHAWRQGVRRFVEIGPDSALTAAGADCVPGDAGVSFVALQRRERPQARALAEGLARFHVAGGSVDWAAYLPPAGHVDLPTTAFRHQRYWLDSTEVTDPAALGAVPVRHPLLGALVPMPGELGSVFTGRLGLRGQPWIADHRVTGAAVLPGTAFLELARRAGELLGDLRVEELVLEVPLTLPAEGDTALRVVVGEPDAAGRRTVEAHTRPEEPGSPWTRHATGVLVEDTDDTPAAGGSPVAELVQWPPTAAEAVDLDDLYPRLAGTGLEYGPAFQGLRAAWQRGEELFAEVALAEQERGRAQEFGMHPALMDAALHALGVDDRHGLRLPFAFHGVRTYAPGTSELRVRLAPVGEDSIRVDLADSLGTPVATVERLVLRALTGELRPVRPSSLHRLDWTPVPTPQGGGQGTATFFRVPHLPVAECTAAVLERLRERLGEDDATDTRLVVVTEGAVAATDDETPDPAGAAVWGLVRSAQAEWPDRFVLLDTLGAAATDTELTRALSTGEPQLALRDGRVLVPRLARVTGTADRAPWSAEDTVLITGAAGTLGQLVARHLVARHHVRRLVLASRRGAEAPSLTDLTAELRAQGTDVTVVACDVAERQAVAALLAAHPVTAVVHAAGVVDDALITDLDEERLRAVMAPKVLGARWLDELTRDRDLHRFVLFSSASAVLGNPGQAAYSAANAVLEAVARDRRAAGLPAVSLAWGLWEETSGITSRLTDADRARIARGGIAALPTEEALDLLDTAVGSDEAAVVPVRLDTAALHRLDPLPPVFAGLVRGSRRTPRRSGWADRLRALSDTDRRRVALDLVRGRAAGVLDLASAAQIDAERTFTDLGFDSLTALELRNQLGTATGLRLPSTLVFDHPTPAALADFVLAEAGGRSTEPEPDPAASAAVVTVTPDEPIAIVGMACRFPGGVGSPEDLWDLVVDGRDGITAFPQDRGWDLAGLPVGLGGFVAGAADFDPGFFGISPREALAMDPQQRLLLETSWEALERAGIDPLSVRGSRSGVFAGVMYHDYATRLTHVPQELEGYVGNGNLGSVATGRVAYVLGLTGPAMTVDTACSSSLVALHLAAQSLRSGESALALAGGVTIMSSPTPFREFDRQGGLAADGRCKSFSAAADGTGWSEGVGMLVLERLSDARRNGHRVLAVVRGSAVNQDGASNGLTRRRTGAGRVIRRPLAAAGVGAGRDVVEAHGTGTTLGDPIEAQALLATYGREREGEPLWLGSVKSNIGHTQAASGVAGIIKTVLALGEGVLPRTCQGKPSPHVDWSSGAVSLLSEARPWPETGRPRRAAVSSFGVSGTNAHVVIEQAPEEAVAQAGVSSPVPVAVPVVVSGRDEVGLGVAAGRLGGFVSGDVGVSVVEVARAAGVGRAALECRGAVVAADRAELLAGLEELAGGGGLRGVAGRGGLTGFLFSGQGSQWSGMGGELAQAFPLFGEVFGEVCGRLEDRLGFGLREVVWGGGDAVDGTAVAQCGLFAFEVALFRLVESFGVVPEFVVGHSVGEVAAAHVAGVLSLEDAVRLVAARATLMGELPSGGAMLAVGASEDEVLRVLQGLSGVVEVAAVNGASSVVVSGDAAAVGAVETVAAEQGWRHRRLRVSHAFHSPLVEPVLDRFREAIEGIEFGRPRLGFVSSVEVGAAADSVEYWVRNVRQTVRFADAVTHAWRQGVTRFVEIGPDSALSAAGADCVPDDAAVSFVALQRRGRPQARALAEGLARFHVAGGSVDWAAYLPPARHVDLPTTAFRRQRYWLHTDSVPTHPGGHPLLDATVELAEEDGFVLSGRLDTRSQTWLADHTVLGSTVVPGSVFAELALHAAAEAGLAGVVELTLERPLLLPEDTSIEMQLRVGAPGATGERPLAVHARPTGETAPWTTCARAVLGSVTETPRAGAAAAWPPLDATPIDVGTAYADFAAAGLEYGPAFQGLRAAWRRGEEVFAEIALPDLTGSGGRYQLHPALLDAALHALRYLDGTPDDRALLPFAWNGLAVSRTGATALRVRLSPLAAGSARLDLTDPEGAPVGVVDALVVRPVTAAQLGQQDTLFAEELVPATPSADPEPAVVTCTGLAELAELAELGELAELADREPPAVVVLRDRPEDDPALAAGRALDAVQTWLAEDRFAGSRLALCTRNARRDPAASAVWGLVRSAQQEHPDRFLLADIEDPDVEDGTPADADGTHTRPDGTHDRAAAEPDTTVPAAVWNVPGGQVVVRDGVPLVPRLTPLALSALPERRDAARPFTGPVLITGGLGTLGAALARHLAAACGVRDLVLTGRRGPDTPGAAALADELARLGAVTRIVACDVTDRDAVAALLEQHPVTAVVHTAGTVDDGVVTALSQERLAAVLAPKVLGARWLDELTRDRELTDFVLFSSAAGLLGSPGQGAYAAANAALDALARRRRAAGLPAVSLAWGLWEETSGITAHLTDADRARIARTGLRPLATSEALELFDLARTTDEPVLAPMRLDRAAVRSAGPVPAVLRSLVRGAPAPATGAQAADDPTSPSTLTSLSGPEREKALLALVRAEAAAVLAHDSPDAVLGHRTFAELGVDSLAAVELRNRLAARTGVRLPAAVVFEHPTPAALAAHLSASLPDTDGTAGVSVSDTVDL", "perc_identity": 30.84}}}